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This dissertation explores the ethical reflections of parents as they negotiate the 
uncertain cultural, moral, and corporeal risks and benefits of the human papillomavirus 
(HPV) vaccine with desires to protect their children from potential harm. The “facts” of the 
HPV vaccine remain unsettled and highly contested. Within the scientific and medical 
community, as well as the public sphere, consensus over the benefits, risks, and safety of the 
vaccine has not been reached. Despite these uncertainties, significant promotional efforts 
have been made by pharmaceutical companies and governmental agencies to encourage (or 
mandate) parents to vaccinate their children, constituting parents as moral subjects 
responsible for protecting their children against HPV and, by extension, ensuring the health 
of the nation. Drawing from ethnographic field research among parents living in the San 
Francisco Bay Area, this dissertation examines how parents are negotiating these 
uncertainties, and considers how categories of risk and responsibility are being configured 
through—and configuring—these deliberations. My results suggest that communication 
between healthcare providers and patients play a significant role in HPV vaccination 
decisions. Additionally, I found that the majority of parents who had not yet vaccinated their 
child expressed desires to delay rather than refuse vaccination based on uncertainties 
regarding the safety of the vaccine, temporal assessments of their child’s sexuality 
(in)activity and perceived risk, and provider support to delay vaccination. In conclusion, I 
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identify novel ways in which social workers can assist in assessing structural and 
interpersonal factors contributing to health outcomes inside the clinical encounter as well as 









CHAPTER ONE: INTRODUCTION 
 
HPV vaccine is a safe and effective way to prevent cancer. How can anyone be against that?  
–William Schaffner1, MD 
 
Gardasil is associated with serious adverse events, including death. If Gardasil is given to 11 
year olds, and the vaccine does not last at least fifteen years, then there is no benefit—and 
only risk—for the young girl  
–Dr. Diane Harper2, MD 
 
How can we facilitate a more informed debate about the uncertainties of the science, 
effectiveness, and true costs of therapeutic advancements?  
–Joao Biehl3  
 
 
The 'facts' of the HPV vaccine remain unsettled and highly contested. Within the 
scientific and medical community, as well as the public sphere, consensus over the benefits, 
risks, and safety of the vaccine has not been reached. Despite these uncertainties, significant 
promotional efforts have been made by pharmaceutical companies and governmental 
agencies to encourage (or mandate) parents to vaccinate their children, constituting parents as 
moral subjects responsible for protecting their children against HPV and, by extension, 
ensuring the health of the nation. Drawing from ethnographic field research among parents 
living in the San Francisco Bay Area, this dissertation presents qualitative and quantitative 
                                                        
1 Schaffner (2011) 
2 Harper quoted in Yerman (2009) 
3 Biehl (2011) 
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data on how parents are negotiating these uncertainties, and considers how categories of risk 
and responsibility are being configured through—and configuring—these deliberations. 
Furthermore, drawing on Lakoff and Collier's (2004) notion of regimes of living, this 
dissertation examines the specific values, norms, and practices parents invoke as they reflect 
upon the best way to care for their children amid the uncertainties of technological 
transformation. Beyond theoretical considerations, this project has several implications for 
social workers and other care professionals engaged in the practice of health promotion, 
health education, and health care in the United States. Drawing from long-standing 
theoretical approaches to understanding health inequalities and behaviors (Link & Phelan 
1995), as well as more recent critical engagements with public health promotion as a moral 
practice (Metzl & Kirkland 2010), I will identify ways in which social workers can assist in 
reducing structural and interpersonal factors contributing to health inequalities inside the 
clinical encounter as well as in the external arenas of policy and research. Furthermore, I will 
consider how and why highly educated parents with access to material and social resources, 
including information and quality healthcare, are “choosing” against vaccination (or at least 
delaying vaccination), and consider the practical and ethical implications of designing 
interventions for those in positions of power. 
 
I. BACKGROUND: DESIGN, MARKETING, AND CONTROVERSIES OF THE HPV VACCINE 
 The human papillomavirus (HPV) is argued to be the most common sexually 
transmitted infection (STI) in the United States with an estimated 6.2 million individuals 
newly infected annually (Food & Drug Administration 2006a).  In the early 1990s, 
epidemiological studies showing the consistent association of HPV with precancerous 
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cervical lesions led to a concentrated effort by two pharmaceutical companies, Merck and 
Co. and GlaxoSmithKline, to develop a vaccine that could prevent the spread of the virus 
(Kahn 2005; Koutsky et al. 2002).  Gardasil, developed by Merck, was the first HPV vaccine 
to be licensed for use in the United States in June 2006. Following a series of randomized 
controlled trials documenting the immunogenicity and safety of the vaccine (Villa et al 
2006), the Food and Drug Administration (FDA) originally licensed the vaccine for use in 
girls and young women ages 9-26 for the prevention of cervical cancer (Centers for Disease 
Control & Prevention 2007; Food & Drug Administration 2006b). A few weeks later, the 
Advisory Committee on Immunization Practices (ACIP) formally recommended that all 
females ages 11-12 receive the HPV vaccine. In October 2009, the FDA extended the 
approved use of Gardasil for the prevention of genital warts in boys and young men aged 9-
26 (Food & Drug Administration 2009). More recently in October 2011, based on a growing 
number of studies linking HPV with anal, penile, neck and other cancers that directly affect 
males (Haddad & Shin 2008; Palefsky et. al 2011), the ACIP recommended routine 
vaccination for boys ages 11-12 (Centers for Disease Control & Prevention 2011).  
 Shortly after the June 2006 FDA licensure of Gardasil, the “One Less” marketing 
campaign developed by Merck began appearing on televisions and computer screens around 
the United States. Framed by the phrase “I choose to be one less,” the advertisements urged 
girls and young women to choose to be vaccinated and be one less victim of cervical cancer, 
encouraging the “safeguarding” of female bodies through vaccination (Prescott 2010). 
Markedly absent from these advertisements were discussions of the links between the 
vaccine, genital warts, and the sexual transmission of HPV (Aronowitz 2010; Rothman & 
Rothman 2009). In addition, connections between HPV and anal cancer, particularly among 
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men who have sex with men (MSM), were silenced (Epstein 2010; Palefsky et. al 2011). 
Even though the primary function of Gardasil is to prevent the spread of a sexually 
transmitted virus, the initial marketing campaign desexualized the vaccine by discursively 
framing it as a (female) cancer vaccine (Epstein & Huff 2010), and produced girls and their 
bodies as ideal subjects of vaccination (Mamo, Nelson & Clark 2010). This project proposes 
that the initial marketing campaigns and the more recent campaigns promoting vaccination 
for both boys and girls are producing parents as moral subjects of HPV vaccination 
responsible for protecting the bodies of girls and boys—and the collective public—by 
“choosing” to vaccinate.  
 Despite Merck’s attempt to avoid controversies, Gardasil and its implementation 
quickly became a contentious and unsettled topic, situated within cultural anxieties over the 
sexuality of young women, the role of the state in parenting decisions, the efficacy of the 
vaccine, and the financial incentives of pharmaceutical companies (Casper & Carpenter 
2008; Wailoo et al. 2010). For some, the HPV vaccine represented a pathway to promiscuity 
and risky sexual behavior (Forster, Wardle & Waller 2010). For others, the vaccine signaled 
the overextended arm of the government interfering in the private decisions of parents 
(Livingston, Wailoo & Cooper 2010). For many, the lack of the sufficient evidence showing 
the long-term efficacy (and cost-effectiveness) of the vaccine caused hesitation and fear that 
the vaccine may lead to more risk than benefit (Berlinger & Jost 2010; Yerman 2009).  
Nearly six years after the initial FDA licensure, controversies around the HPV 
vaccine remain, exemplified by the recent comments of the “very dangerous side effects” of 
the vaccine made by Tea-Party/Republican Presidential Candidate, Michele Bachmann (New 
York Times 2011). Although Bachmann’s statements prompted immediate dismissal by 
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medical groups (Burton 2011; Martin 2011), there continues to be debate over the risks and 
benefits of HPV vaccination. Most of these debates have occurred in the expert realm of 
scientific conferences and journals (Huang 2009; Tomlijenovic & Shaw 2011); however, Dr. 
Diane M. Harper, who conducted early clinical trials for the HPV vaccine, has been 
outspoken in her opinion that the promotion of HPV vaccination has glossed over many of its 
potential risks. “Gardasil is associated with serious adverse events, including death. If 
Gardasil is given to 11 year olds, and the vaccine does not last at least fifteen years, then 
there is no benefit—and only risk—for the young girl” (Harper quoted in Yerman 2009) 
More than mere words, these claims of risk and danger are thought to be having a direct 
effect on the uptake the HPV vaccine as public health officials argue “misinformation” and 
“myth” are the central reasons behind lagging numbers of vaccination rates in the United 
States (Tucker 2011). Drawing on ethnographic research in the San Francisco Bay Area, this 
dissertation examines how parents are negotiating these uncertainties, and consider how 
categories of risk and responsibility are being configured through—and configuring—these 
deliberations. Furthermore, I will examine the specific values, norms, and practices parents 
invoke as they reflect upon the best way to care for their children amid the uncertainties of 
technological transformations. 
 
II. THEORETICAL FRAMEWORK AND LITERATURE REVIEW 
 
Technologies, Subjects, and Ethics 
A rich body of literature in science and technology studies (Franklin 1995; Haraway 
1997; Hacking 1999; Jain 2004; Latour 1987, 2005; Pickering 1992) and medical 
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anthropology (Kleinman 1995; Lindenbaum & Lock 1993; Lock 2001; Ong 2003) exists 
around the ways in which new medical technologies or biotechnologies produce and 
transform local and global categories of being and understanding the world (Bray 2007; 
Gibbon & Novas 2008; Oudshoorn & Pinch 2003; Rose 2001). Within these technological 
transformations, “living” has become problematic—meaning these technologies have 
implications for the social and biological life of individuals and collectives (Lakoff & Collier 
2004: 420). A significant portion of this work has focused on the beginnings and ends of life, 
particularly around reproductive technologies (Cohen 2002; Inhorn 2003; Kaufman 2005; 
Roberts 2011); however, increasingly a variety of biotechnological practices including brain 
imaging (Dumit 2003), organ transplantation (Lock 2002; Sharp 2006), and genetic testing 
(Novas & Rose 2000; Taussig, Rapp & Heath 2001) are being examined. The concepts of 
bio-power—and related notions of bio-politics and anatomo-politics—are central to these 
undertakings (Foucault 1990).  
 In his historical examination of 17th-century Europe, Michel Foucault (1990) claims 
a shift in the ways by which individuals are subjected to power occurred from a repressive 
structure to a productive system that operates through subtle yet ubiquitous power over life—
namely bio-power (140). Bio-power is exercised through visible and covert techniques at the 
level of the individual (anatomo-politics) and the population (bio-politics), which 
simultaneously work together to promote certain ways of being (Foucault 1990:140). These 
concepts have been useful for thinking through the implications of biotechnologies as they 
signal the variety of subtle and overt ways individuals are subjected to—and subjected 
themselves to—certain practices, as well as indicate that these historically-specific, power-
laden techniques are productive rather than repressive, resulting in the novel categories of 
7 
 
being in and experiencing society (Collier & Ong 2005; Faubion 2011; Lakoff & Collier 
2004; Petryna, Lakoff & Kleinman 2006; Rabinow 2003).  
For this dissertation, Lakoff and Collier’s (2004) notion of regimes of living is 
particularly insightful.  Drawing from Foucault (1997), the authors define regimes of living 
as the “configurations of normative, technical, and political elements that are brought into 
alignment in problematic or uncertain situations” (Lakoff & Collier 2004: 427).  In uncertain 
situations, a given regime offers one (among many) possible means by which to organize, 
reason, and live ethically—with “respect to a specific understanding of the good” (Lakoff & 
Collier 2004: 427). Different actors (individual or collective) may invoke different regimes 
of living to give these situations a certain moral or ethical structure. In the case the HPV 
vaccine, this analytic concept is particularly insightful due to the scientific and cultural 
uncertainty of the situation, as well as the conflicting moral structures offered by different 
actors surrounding HPV vaccination. This project will build upon these theoretical and 
methodological approaches by examining what practices, norms, and modes of reasoning 




 Social theorists have proposed that modern society is a “risk society” (Beck 1992, 
1999; Giddens 1990), whereby risk is “fundamental to the way both lay actors and technical 
specialists organize the social world” (Giddens 1990:3). Risk is seemingly everywhere—
from the air we breathe to the food we eat, leaving individuals to engage in risk management 
(Lupton 1993, 1999). However, risk is not merely an object to be observed, but is made 
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known through power-laden networks of institutions, knowledges, and practices, particularly 
in the realm of science (Hess 1997; Nader 1996). Scientific understandings of the world have 
shifted from singular, mechanistic models to complex, interrelated models of environment, 
social, and genetics, leaving individuals to “evaluate the heterogeneous supply of scientific 
interpretations” (Beck 1992: 157). Science and technology itself is a potential source of risk 
(Douglas & Wildavsky 1982), and scientific fact as absolute truth is to be questioned and 
studied (Hess 1997; Kuhn 1962; Star 1983). Feminist technoscientific studies have continued 
and inspired aligned approaches highlighting the ways many categories of being, particularly 
sex and gender, are co-produced through scientific practices and bodies of knowledge (Keller 
1985; Haraway 1999; Harding 1996; Jain 2007; Mamo & Fishman 2001). Although this 
project will not specifically investigate the production of sex and gender in the context of the 
HPV vaccine (See Casper & Carper 2008; Mamo, Nelson & Clark 2010), this project will 
speak to the ways parents draw on normative notions of sexuality, gender, and sexual 
behavior to structure their decision of whether or not to vaccinate their children, and to 
construct notions of risk. 
 The production of risk is an interactive and fluid process, making the communication 
of risk more complex than simple disclosure of technical information and the response to risk 
more complicated than mere comprehension (Nelkin 1989). As such, risk discourses, and 
correspondingly risk management as a practice, are riddled with moral, political, and cultural 
implications in addition to potential corporeal consequences (Becker & Nachtigall 1994; 
Harthorn & Oaks 2003) and have been of central interest to anthropologists studying health 
and affliction for several decades (Douglas 1970, 1992; Hayes 1992; Lupton 1993). Lupton 
(1995) stresses that current health promotion and disease prevention discourses tend to define 
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disease as a danger that places certain groups as “at-risk,” urging these groups to engage in 
harm-reducing practices, such as vaccinations, to protect their future selves from a probable 
rather than actual affliction (Cohn 2000; Gibbon & Novas 2007; Nichter 2003; Scott, Prior, 
Wood & Gray 2005). Individuals are urged to take responsibility over their own health, to 
become empowered, by engaging in “healthy” habits that will reduce the risk of harm and 
illness (Mol 2008; Nettleton 2006). Risk discourses are communicated to individuals through 
a variety of public pathways as well in the intimate spaces and relationships of everyday life. 
These discourses cannot be disconnected from larger shifts in the structure and practice of 
health in the United States. 
 
The New Public Health 
Following World War II, several factors including increased federal funding for new 
hospitals and medical schools, and the success of penicillin and other pill-based treatments, 
led to shifts in healthcare in the United States and other industrialized countries. For those 
who had access, medical care become routinized, expanding from the emergency care of 
illness or trauma to include more preventive visits to the “family doctor” (Clarke 2010:122). 
During this time, medicine became part of daily life, intensified by the simultaneous 
infiltration of visual culture via television into the homes of American families (Clarke 
2010). In the early 1980s due in large part to the development and use of computer and 
information sciences in biomedical practice, a new era emerged deemed the “era of 
biomedicalization” (Clarke 2010) or the “new paradigm of health” that calls for public health 
services to be primarily directed toward “the prevention of illness and the promotion of 
health” rather than curing illness (Moore 2010: 101). The “new public health” replaces 
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previous public health approaches that focused on contagion or sanitary control with the 
practice of health promotion (Awofeso 2004). The new public health is concerned with the 
health of the population (Peterson & Lupton 1997) and although it has brought heightened 
awareness of the external risks (e.g. pollution, climate change), it is primarily focused on the 
individual and his or her lifestyle, decisions, and behaviors. Health “problems” are often 
constructed as being caused by behavior and thus health promotion targets behavioral change 
(and environmental change to allow healthy behaviors to be “chosen”) rather than the disease 
itself (Mair 2011). These practices are also reflective of larger shifts and processes under 
which social concerns have been medicalized. 
The growth of medicalization—defined by Zola (1972) as the ongoing process by 
which social problems become characterized as medical problems—has long been of interest 
to medical anthropologists and science and technology scholars (Kleinman 1995; 
Lindenbaum & Lock 1993; Lock 2001). Drawing from insights gained from studies of 
biopower (Foucault 1990; Mamo & Fishman 2001; Ong 2003) and science and technology 
(Franklin 1995; Haraway 1999; Hacking 1999; Latour 1987, 2005; Pickering 1992), the 
concept of medicalization has been redefined as biomedicalization (Clarke et al. 2010). 
Biomedicalization encompasses the “increasingly complex, multisited, multidirectional 
processes of medicalization” as they are intensified by technoscientific innovations in 
genetics, molecular biology, and new medical technologies (Clarke et al. 2010: 47). 
According to Clarke and her colleagues (2010), biomedicalization is organized around five 
interactive processes including 1) the creation of a new biopolitical economy; 2) an 
elaboration of risk and surveillance practices in conjunction with an intensified focus on 
health itself; 3) the increasingly technoscientific nature of biomedical innovations and 
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practices; 4) transformations of biomedical knowledge production and consumption; and 5) 
productions of new social identities. This project will attend to these processes by 
investigating how practices and claims of parents are reconfiguring the production, 
consumption, and boundaries of biomedical knowledge. In addition, this research will 
consider HPV vaccination—as self-regulated practices of biopower—are embedded in the 
new era of health promotion (Foucault 1990). 
This new paradigm urges individuals to take responsibility over their own health, to 
become empowered, by engaging in “healthy” habits that will reduce the risk of harm and 
illness (Mol 2008; Nettleton 2006) and achieve the goals of the state (Foucault 1979, 1990). 
The body is the site where citizens are supposed to “work” on themselves to become 
productive members of society—the self has become somatic (Novas & Rose 2000). This 
paradigm is inextricably linked to the increase in public access, largely through the Internet 
and health information websites, to biomedical knowledge once reserved for health 
professionals (Clarke et al. 2011, and to the proliferation of health promotion and disease 
prevention discourses (Lupton 1995). 
 
Health Promotion as Practice 
Early conceptualizations of health promotion, defined initially as “the art and science 
of helping people change their lifestyle to move toward a state of optimal health” (O’Donnell 
cited in Minkler 1989), rested on two central assumptions: 1) the individual has significant 
influence and power over the decisions he or she makes regarding diet, physical activity, and 
other lifestyle behaviors and 2) these decisions have significant effects on health outcomes 
(Minkler 1989). Although early government doctrines in the United States (e.g. Healthy 
12 
 
People Objectives) regarding this new focus in public health did include environmental 
influences, early programs and interventions tended to focus solely on changing individual 
behavior, rather than addressing the context or determinants of health broadly defined 
(Minkler 1989). The 1986 Ottawa Charter formalized current health promotion definitions as 
“the process of enabling people to increase control over and to improve their health” (WHO 
1986; Kickbusch 2003). The World Health Organization (WHO) stresses that health 
promotion embraces actions directed at both “strengthening the skills and capabilities of 
individuals” but also actions directed at changing the social environment to allow for healthy 
behaviors (WHO 1998). The concept of empowerment, at both the individual and community 
level, is central to these formulations. Empowerment emphasizes the individual or 
community’s “ability to make decisions and have control over their personal life” and over 
the determinants of health in their community (WHO 1998). The corresponding notion of 
social capital has also become central to the practice of health promotion (Hawe & Shiell 
2000).  
Programs or interventions in health promotion range in scale from local efforts to 
increase fresh produce consumption to mass media campaigns to encourage condom use 
(Cattrell, Girvan & McKenzie 2009). The target of health promotion has expanded from just 
the individual to include the community, the population, and the organization (Minkler 
2006). Although health promotion practitioners and researchers have become increasingly 
aware of how the environment—including social, political, and economic factors—affects 
the (perceived or structural) ability for individuals to make healthy decisions, the individual 
and his or her “lifestyle” or behavioral decisions remains central (Glanz, Rimer & Viswanath 
2008). Health behavior theory guides most health promotion practice and research, supported 
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by the assumption that the “most prominent contributors to death and disease in the United 
States and globally are behavioral factors” (Glanz & Bishop 2010). This assumption is linked 
to Westernized notions of the individual and decision-making, which will be discussed (Mol 
2008); however, it is first important to outline the major theoretical foundations guiding 
contemporary health promotion practice and research.  
 
Theoretical Foundations of Health Promotion Research and Practice 
 Based on published articles in the past two decades, Glanz and Bishop (2010) identify 
four central behavioral theories guiding health promotion research and practice: Health 
Belief Model, Transtheoretical Model, Social Cognitive Theory, and Social Ecological 
Model. The Health Belief Model (HBM), developed originally to understand why people 
decided (or not) to use public health services in the 1950s, theorizes that people’s beliefs 
about their risk for a certain disease, and their perception of the benefits of acting to reduce 
risk, influence whether or not they take action (Hochbaum 1958; Rosenstock 1974). The key 
constructs of HBM are perceived susceptibility/risk, perceived benefits and perceived 
barriers, cues to action, and the recently added self-efficacy (Rosenstock, Strecher & Becker 
1988).). This model is often applied to health concerns that are prevention-related (e.g. early 
cancer detection or vaccination) and health promotion practices that seek to reduce risk 
factors (e.g. diet and sexual behavior) linked to disease (Glanz & Bishop 2010). 
Transtheoretical Model (TTM) adds the dimension of stages of change to health behavior 
change, whereby individuals are understood as having different levels of readiness to adopt 




 Social cognitive theory (SCT), often used in counseling sessions for disease 
management, explains human behavior as dynamic, continuous interaction between personal 
factors, environmental influences, and behavior (McAlister, Perry & Parcel 2008). A basic 
premise of SCT is that people learn through their experiences, and from observing the actions 
(and results) of others’ experiences (Bandura 1986). Social Ecological Model argue that 
multiple levels (including individual, interpersonal, organizational, community, and public 
policy) of the social environment affect health and also indicate that behaviors both shape 
and are shaped by the environment (McLeroy, Bibeau, Steckler, & Glanz 1988). Health 
promotion that uses a social ecological perspective target both individual and social 
environmental factors for change and have been used to understand health disparities at the 
population level as well (Krieger 2001). 
 Health promotion interventions designed with an explicit theoretical foundation(s) 
may be more effective than those without a theoretical base (Noar, Benac & Harris 2007; 
Glanz & Bishop 2010). However, health promotion and health behavior theories are 
predicated upon a series of assumptions that scholars in the fields critical public health, 
medical anthropology and sociology, and science and technology studies have called into 
question as potentially contributing to health inequalities or at least perpetuating a view of 
health that may be disconnected from the practices of everyday living (Mykhalovskiy 2008; 
Lindsay 2010).   
 
Investigating Assumptions: Critiques and Reconfigurations 
Critical public health researchers have considered the assumptions at play in health 
promotion and the ways certain conditions such as alcohol, tobacco use, and obesity have 
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become categorized as “problems” since the emergence of the new public health (Bell, 
Salmon & McNaughton 2011; LeBesco 2011). The language of these “epidemics” are 
scientific not moral; however, many argue that they have become the “new morality” urging 
individuals’ to choose health and sanctioning those who choose “risky” behaviors (Metzl & 
Kirkland 2010; Brandt & Rosin 1997).“Health is term replete with value judgments, 
hierarchies, and blind assumptions that speak as much about power and privilege as they do 
about well-being. Health is a desired state, but it is also a prescribed state and an ideological 
position” (Metzl 2010:1). The goal of these critiques is not to reject health or deny the ways 
health promotion has improved the lives of many, but to unpack the assumptions and 
proscriptions that accompany it.  
Health promotion as a practice is based upon a series of assumptions—including the 
assumption that “all that is needed to change people’s behavior is better education regarding 
the risks of certain lifestyle choices” (Thompson & Kumar 2011:106). Increasing people’s 
health literacy—defined as “the degree to which an individual has the capacity to obtain, 
process, and understand basic health information and services needed to make appropriate 
health decisions” is believed to be a way to increase the likelihood of healthy lifestyle 
choices (Liechty 2011:99). In addition to constructing biomedical knowledge as neutral, 
these assumptions are embedded in a Westernized view of the rational, decision-making 
individual and his or her relationship to the state (LeBesco 2011). However, the daily lives of 
people, particularly marginalized groups, are often disconnected from these guidelines 
(Lindsay 2010). 
 Thompson & Kumar (2011) argue that in marginalized groups health promotion may 
be viewed as proscriptive, resulting in resistance (framed often as “non-compliance”), and 
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result in the continuation of health inequalities. For impoverished individuals whose lives are 
already inundated with relationships with state agencies (including interactions with social 
workers), biomedical expertise and information may be seen as a form of regulation rather 
than neutral information from which to make autonomous decisions (Mykhalovskiy 2008). 
“From the sites of their healthwork, biomedical reason does not operate to ‘‘empower’’ them 
to make decisions, but is continuous with more coercive institutional relations of ruling” 
(Mykhalovskiy 2008). In the choice model, the everyday work of individuals to care for 
themselves is lost. Challenging the underlying logic of choice, perhaps by purposing a new 
logic of care, may help eliminate these disparities (Henwood, Harris & Spoel 2011; Mol 
2008).  
In the context of HPV vaccination, the promotion of the vaccine has been constructed 
as a moral mandate, by which “choosing” to vaccinate is articulated as a way to ensure the 
future health of your child and potentially his or her future partners. As such, the act is 
reflective of not only notions of responsible citizenship, but responsible parenthood. For 
those parents who “choose” not to vaccinate, much of the literature has approached this 
choice from a deficit or barrier perspective—meaning the choice is positioned as the result of 
a not having access to either a structural, social, or individual need (that would result in 
making the healthful—“right”—choice to vaccinate) (Holman et al. 2014). Lack of 
knowledge or desire to have more information regarding HPV and HPV vaccination among 
parents and providers are cited as one of the top barriers to vaccination among all groups in 
the United States, including educated parents, ethnic minorities, low-income parents, and 
geographically diverse populations (Dorrell, Yankey & Strasser 2009; Laz, Rahman & 
Berenson 2012; Luque, Raychowdhury & Weaver 2012; Perkins & Clark 2012; Wilson, 
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Brown, Booth & Harris 2013; Hamlish, Clarke & Alexander 2012).  
Additionally, parental attitudes, concerns or beliefs—often but not always framed as 
cultural beliefs among ethnic minorities but attitudes or concerns among Non-Hispanic 
White or educated populations—have also been identified as a barrier to HPV vaccination 
(Holman et al. 2014). These include parental concerns regarding the safety or efficacy of the 
HPV vaccine, belief that child is too young to receive the vaccine, perceived risk of HPV and 
HPV-related diseases, and influence of social norms (Allen et al. 2010; Holman et al. 2014; 
Luque, Raychowdhury & Weaver 2012; Reimer et al. 2012; Wilson, Brown, Boothe & 
Harris 2013). Beyond individual- or group-level factors, structural barriers such as lack of 
health insurance, lack of receipt of healthcare provider recommendation to vaccinate, and 
lack of long term relationship with provider (or “medical home”) have also been identified as 
barriers to HPV vaccination, particularly among underserved or disadvantaged populations 
(Dorell et al. 2012; Holman et al. 2014; Kester et al. 2013; Schluterman et al. 2011; Tsui et 
al. 2013; Ylitalo, Lee & Mehta 2012). The assumption underlying much of the literature is 
that if these barriers were removed—whether they are structural or individual—parents 
would choose to vaccinate their child, and in many cases, parents would. However, these 
assumptions are based on certain notions of what it means to both care and choose in the 
United States, which may not always prioritize the needs of patients in all contexts.  
In response to a growing trend toward patient choice and autonomy in health care, 
Annemarie Mol (2008) claims that ‘care’ and ‘choice’ operate under two distinct sets of 
logic, and thus advocating for choice may not always result in good care for patients. Rather 
health care needs to be improved on its own terms—terms that operate under the logic of 
care. Drawing from ethnographic data on people living with diabetes in a Dutch hospital, 
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Mol considers what constitutes the logic of care and the logic of choice by examining the 
practice of care, which includes all material and non-material actors. Mol contends that the 
logic of choice is tied to the western assumption of the rational, autonomous individual 
operating under the illusion of free choice. In practice, this does not correspond to the needs 
of the patients, whose care is dependent upon the actions of others and of themselves. Mol 
claims that patients of care are not passive beings who are subjected to the will of the 
paternalistic doctor, but active members of the care team. Mol encourages readers and 
practitioners not to be taken in by the “magic” of choice, but instead look at the specific, 
unpredictable practices of care to improve the lives of individuals living with chronic 
disease. In this dissertation, by examining the decision to vaccinate and not to vaccinate as an 
act of care, I will attempt to critically engage with the notions and practices of care, not only 
as a didactic practice between parents and children, but also interwoven set of practices 
between individuals, material resources, values, and conceptualizations of citizenship in 
specific contexts. 
Furthermore, Metzl and Hansen (2014) argue that beyond individual health practices 
and choices—as a focus of health interventions and medical care practice—structural 
conditions must be addressed that result in individual health outcomes. “Clinical 
presentations of persons at both ends of the economic spectrum are shaped by “cultural” 
variables, and also by the economic and political conditions that produce and racialize 
inequalities in health” (Metzl & Hansen 2014:127). In medical care and health promotion, 
“cultural variables” often include race, class, gender and ethnicity—variables that have been 
(attempted to be) attended to in the U.S. healthcare system through “cultural competency” 
(Metzl & Hansen 2014). Cultural competency education and practice are constructed as a 
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way to mitigate tensions between patients and physicians of different cultural backgrounds, 
and thus reduce marginalization of patients based on race, ethnicity, language or other points 
of difference. However, while cultural competency as a practice and basis for individual-
level interventions has helped to reduce stigma and disparities based on difference in some 
ways (Metzl 2013), Metzl and Hansen (2014) argue the moment has come to rethink cultural 
competency as a way to help patients clinically, and shift focus onto the structural institutions 
and practices above individual interactions that influence health outcomes. This new 
paradigm, deemed “structural competency”, is grounded in both a practical—at the level of 
medical education—and a conceptual shift—at the level of theory, intervention design, and 
the way we think about health promotion (Metzl 2010).  
Central to [structural competency] is the belief that, just as stigma in clinical 
encounters must be addressed structurally, so too must inequalities in health be 
conceptualized in relation to the institutions and social conditions that determine 
health related resources. We contend that medical education needs to more 
systematically train health-care professionals to think about how such variables as 
race, class, gender, and ethnicity are shaped both by the interactions of two persons 
in a room, and by the larger structural contexts in which their interactions take place. 
And, that as such, clinicians require skills that help them treat persons that come to 
clinics as patients, and at the same time recognize how social and economic 
determinants, biases, inequities, and blind spots shape health and illness long before 
doctors or patients enter examination rooms (Metzl & Hansen 2014:127). 
 
In the context of HPV vaccination, disparities regarding vaccination completion (three-dose 
series) based on race, ethnicity, class, and education have been documented; however, as 
noted, in close review, the majority of these disparities are based on structural factors, such 
as access to care, access to education, or access to quality healthcare. Historically, disparities 
have been based on what are formulated as “cultural variables” at the individual level, but as 
Metzl and Hansen (2014) argue these individual-level variables are often the result of 
“economic and political conditions that produce and racialize inequalities in health in the first 
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place” (127). By placing these differences in the context of individual “choice”—or as 
barriers to be overcome to ensure individuals can engage in such choice—structural factors 
are not directly targeted or understood. These conditions do not only influence the health of 
those marked with difference or lacking access to structural equality, but also those in power 
with access to economic, social, and material resources. In this dissertation, I will attempt to 
critically examine how parental notions—often constructed as beliefs or attitudes—of risk, 
sexuality, and safety shape vaccination decisions, and consider how these reflect both 
conditions of power and potential need for intervention. 
  
Promoting Health in the Information and Digital Age 
 There is significant debate over the connections between health status, frequency of 
using the Internet to seek for health information, and health behavior changes (Ayers & 
Kronenfeld 2007). However, on any given day more Americans use the Internet to search for 
health information than visit a health professional (Fox & Jones 2009) and youth may be 
using this technology to learn about sexual health (Bleakley, Merzel, VanDevanter, & 
Messerti 2004). Health promotion researchers and practitioners are hopeful for the potential 
of new communication technologies to engage and entertain the audience and consequently 
have greater impact (Crilly, Keefe, & Volpe 2011; Glanz & Bishop 2010); however, there is 
concern that these technologies may deepen the “digital divide” between those who have 
access to computer technologies and those who do not furthering health inequities (Berland, 
Elliott, Morales et al. 2001; Sorensen 2001). Although, with the development and 
proliferation of mobile communication, some argue that minority populations in the United 
States and other countries not only have access to using mobile devices but also are using 
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them more than Whites, and thus health promotion using these technologies has great 
potential to address health disparities (Smith 2010). 
A key strategy of health promotion is mass media marketing (Lupton 1995) and is 
deployed as a means to convey and communicate selective information about a disease to the 
public.  Mass media has the ability to influence health behavior and choices, particularly in 
areas where preventive care from medical professionals is not readily available or used by 
community members. The media, particularly the Internet and television, has been shown to 
have significant effects on the personal attitudes and uptake of the HPV vaccine (Habel, 
Liddon, & Stryker 2009). Text message reminders are increasingly used in sexual health 
prevention efforts and have shown to be effective in increasing on-time receipt of the second 
and third doses of the HPV vaccine (Kharbanda et al. 2011). Experts in the field of 
technology-based health promotion are cautiously optimistic about the use of digital media 
and electronic technologies to both research and promote sexual health among youth (Gilliam 
et al. 2011; Levine 2011), particularly in its potential to improve health outcomes among 
youth and individuals unconnected to the formal health care system (Crilly, Keefe, & Volpe 
2011).  
Pharmaceutical advertising also highlights the connections between capitalism and 
biomedicine in the United States, often creating discomfort and debate among individuals 
who believe medicine is or should be neutral and apolitical.  The domaining of the medical 
from the social has significant political and cultural implications (Gordon 1988), and is a 
constructed boundary that serves to perpetuate health inequalities (Comaroff 1985).  A 
significant amount of anthropological research examines the production and use of 
pharmaceuticals (Petryna, Lakoff, & Kleinman 2006; van der Geest, Whyte, & Hardon 
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1996), medical technologies (Inhorn 2003; Oudshoorn & Pinch 2003), and mass media 
(Ginsburg, Abu-Lughod, & Larkin 2002; Spitulnik 1993).  This project seeks to contribute to 
these discussions by considering how the marketing of the HPV vaccine shaped parents' 
vaccination decisions and constructions of risk. 
Scholars in STS have theorized that although electronic technologies and the 
associated proliferation of information may not change health inequities, they will have a 
cultural impact and possibly create a new world view that Nettleton & Burrows (2003) have 
deemed “E-scaped medicine” (See also Nettleton 2004). The information age has impacted 
biomedical knowledge in significant ways, most notably: “medical knowledge has escaped 
and is thus no longer something that can be accessed and, more importantly perhaps, 
produced and regulated by medical experts” (Nettleton & Burrows 2003: 78). The 
demarcation between producers and users of knowledge is being dismantled, and medical 
professionals may view online support groups and other electronic sites potentially as threats 
to their expertise (Broom 2005) leading to attempts to define “proper use” by citizens 
(Oravec 2001). Biotechnologies are not neutral objects to be applied but greatly impact 
understandings of the self (Novas & Rose 2000; Rose 2001), the foundations of knowledge 
(Haraway 1999), and potentially worldviews (Nettleton & Burrows 2003) in unpredictable 
ways. This dissertation project seeks to contribute to these studies by investigating how 
health promotion in the information age may be reconfiguring health, risk, and biomedical 






Changes in Healthcare Technology, Changes in Health Social Work 
Increasingly, social work health interventions rely on the evidence-based, medical 
model to guide practice and research (Lohr, Eleazer, & Mauskopf 1998; Vourlekis, Ell, & 
Padgett 2005).  There are important and legitimate debates about the benefits and scope of 
evidence-based approaches in social work (Gambrill 1999; Howard & Jenson 1999; Richey 
& Roffman 1999).  One potential benefit of evidence-based practice is that it may provide 
health services and clinical decisions based on the “best available research evidence” 
standardized through “empirically supported practice and program guidelines” (Vourlekis et 
al. 2005); however, a significant drawback is that these standardized programs and practices 
do not allow for the diversity of clients to be recognized.  Application of external models 
often ignores the complexities of the local situation and practices that worked in a different 
setting may be ineffective in another.  Evidence-based practice also supports the separation 
of the medical from the social and positions science as external to cultural and social 
ideologies (Wendland 2007).   
The systems under which social workers are engaging in health care settings are 
constantly in flux and effective social work practice requires flexibility and ability to work in 
multidisciplinary teams (Abramson & Mizrahi 2003; Dhooper 1997).  The disease 
management model that has come to dominate many hospital and health care settings has 
forced social workers to become “disease managers” of sorts (Claiborne & Vandenburg 
2001).  The disease management model is a “coordinated, proactive approach that maximizes 
the effectiveness of patient care for specific chronic diseases over time” (Claiborne & 
Vandenburg 2001: 217).  The model relied on a case manager to provide care coordination 
between the patient, primary care physician and interdisciplinary team.  The care is guided by 
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standards, or evidence-based practice, which are established through population health 
research and primarily quantitative data collection.  Patient feedback and continuous quality 
improvement is essential to this model (Clairborne & Vandeburg 2001).  Evidence-based 
approaches rely greatly on the evaluation of physical, psychological and social risks.  
Social work within health care service is often described as secondary to medical or 
nursing care, and thus may not have the same degree of control over care.  It is often subject 
to the medical model and organizational context (Browne 2005).  Understanding how the 
organizational context affects social work practice is important to many realms of social 
work, but is especially important in social work in health settings.  Browne (2005) highlights 
four areas within the context of the medical model that may raise issues for social work 
practice: 1) technology and associated patient care issues; 2) dynamic face of affliction, 
demographic changes, and the increased medicalization of social phenomena; 3) funding for 
costly technological services; and 4) ethical dilemmas spurred by this factors.  Technological 
advances have brought significant benefits to the lives of patients and those social workers 
have aimed to help; however, they have also brought potentially negative effects as well.  
The length of time that patients stay in hospitals have shorten greatly making social workers 
have to intervene quickly to ensure patients will be released into a safe environment and 
address any practical or emotional needs of the client (Browne 2005).  “Social work 
intervention becomes one of crisis management, and hospital social workers know that they 
must refer their patients elsewhere for more long-term support and counseling” (Browne 
2005: 111).  In terms of social justice, this creates significant issues as community support 
may be minimal or non-existent and thus clients in need are disproportionately affected.  In 
addition, the increasingly specialized model in health care adds difficulty to a social worker’s 
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job as he or she must try to help navigate clients through a dispersed and segmented system.  
The holistic approach of social work is challenged by the medical model, which may only see 
the person as a “heart case” rather than a whole human being—with physical, emotional, and 
social needs.   
Kerson (1997) clearly outlined a framework to health care social work in practice that 
places context in a place of central importance; thus it is labeled “practice in context” (15).  
Context is “a set of circumstances or facts that surround and constrain a particular event or 
situation” (Kerson 1997:1).  The author proceeds to breakdown context into three central 
elements in the field of health care that help or hinder the “helping relationship” between a 
social worker and his or her client: Policy, Technology, and Organization.  “Policy refers 
particularly to laws; technology, to means for diagnosis, treatment, and monitoring; and 
organization, to systems involved in the delivery of health services” (1).  Organization for 
Kerson are defined as “a body of persons brought together to accomplish some end or work, 
or the personnel or apparatus of an agency, business, or institution” (1997: 5), often guided 
by a particular ethos, of which social workers should be aware.  The relationship between 
social worker and client is the primary subject of the framework.  Borrowing from 
Goffman’s notion of the encounter and Bateson’s notion of the interaction, Kerson purports a 
view of the ‘relationship” as situational and imbedded in the context of the relationship.  This 
structural view of the relationship is supported with psychological dimensions of “purposive, 
feeling, catalytic, and enabling dimensions” (17).  Two basic elements of this relationship are 
the context and the practice decisions.  Kerson selects policy, technology, and organization as 
the three central affecting elements of context, but acknowledges others have called other 
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elements to be central in the field of health social work (See Germain & Gitterman 1996; 
Strauss et al. 1985).   
These three elements are considered most important because of the ways in 
which each contributes to the structure of the social worker/client 
relationship.  Policies increasingly provide rules specifying the services 
clients may receive, and under what conditions.  Organizations are also rule 
makers, defining the nature of service often at the behest of policymakers.  
Finally, in the cases of many illness and traumatic situations, dependence on 
technological intervention has contributed to the conditions of relations 
(Kerson 1997: 18). 
 
Technological advances have changed the face of medical social work drastically in recent 
years particularly surrounding women’s sexual and reproductive health.  Kerson (1997) 
defines technology “is the sum of the ways in which social groups provide themselves with 
the material objects of their civilization. It is the branch of knowledge that deals with applied 
science” (4).  Reproductive technologies such as the ultrasound have caused increased 
concern over the rights of the women-fetus, which is directly tied to notions of personhood 
and autonomy (Figueira-McDonough 1990).  Genetic testing, particularly prenatal genetic 
testing and chromosomal abnormalities have increased the need for counseling (Fertel & 
Reiss 1997), but have also raised concerns over selective abortion and the rights of disabled 
individuals (Ginsburg & Rapp 2013).  Health Social Work is not limited to the clinical 
encounter, but the clinical encounter often guides the larger health social movements and 
advocacy social workers engage in.   
Health social work is also a bit paradoxical as the majority of medical social work 
occurs in circumstances where no cure is available (such as in oncology care). After 
technological advances occur which assist in curing or preventing the affliction, such as 
vaccines, the role of social workers is reduced or eliminated entirely. “The absence of a 
technological solution is also important for social work because our services are often valued 
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more in those situations where there is no effective medical treatment” (Kerson 1997:4).  The 
example of tuberculosis highlights this as before the discovery of penicillin, social workers 
played a central role “to ensure that patients returned for prolonged outpatient treatment and 
to educate patients and others in their social circles that might have been infected” (Kerson 
1997:23).  Now the role is purely epidemiological or educational.  However, in this 
dissertation, I will explore how technological and legislative shifts are creating new 
opportunities for health social workers to not only engage in health promotion, but directly in 
preventive healthcare delivery (Pecukonis, Cornelius & Parrish 2003).  
As Metzl and Hansen (2014) note, achieving structural competency within the clinical 
encounter and beyond relies upon incorporation of insight from various disciplines in 
medical education, including anthropology, economy, and public health, that have been 
critically engaging with contextual factors—beyond the individual—for quite some time. In 
many ways, social workers have been arguing for structural competency outside the clinical 
encounter since their inception as a field, engaging in such activities as community-based and 
policy-based interventions to establish healthful food and play options in impoverished areas 
that will complement structural competency efforts in the clinical encounter.  In this 
dissertation, I will argue in addition to continuing to work on reducing structural inequalities 
outside the clinic, social workers also have a direct role to play within the clinical setting, 
particularly in eliciting and communicating with patients regarding the structural factors, 
such as transportation or workplace limitation, that shape (or limit) their healthcare decisions 
and practices.  This in turn can assist physicians to practice structural competency in the 
clinical encounter by considering how to tailor recommendations to align with the lived 




III. RESEARCH DESIGN 
 
Primary Research Questions 
 This project was guided by two central research questions: 1) How are different 
actors constructing risk in the context of the HPV vaccine, and in what ways are parents 
made to be responsible for protecting their children against this risk? and 2) What norms, 
values, and practices do parents invoke in order to structure and support their decision to 
vaccinate or not to vaccinate their children? In order to answer the first research question, I 
aimed to conduct the following activities: 1) document the multiple ways different actors are 
constructing the risks and benefits of HPV vaccination by systematically collecting 
information related to HPV vaccination in scientific journals, newspapers, and popular 
magazines; and, 2) trace the pathways by which parents learn about the HPV vaccine by 
asking parents directly about information sources through qualitative interviews. In order to 
answer my second research question, I aimed to conduct the following activities: 1) collect 
narrative evidence of the specific norms, values, and practices parents use to guide and 
support their decision to vaccinate or not to vaccinate their children by conducting qualitative 
interviews with parents; 2) collect quantitative data to identify patterns across parents; and, 3) 
collect ethnographic data on the interactions between parents and health professionals by 
conducting participant-observation at immunization classes designed to discuss HPV 
vaccination4. Supported by funding by the Wenner-Gren Foundation and Rackham Graduate 
                                                        
4 Unfortunately, during my time in the field, the proposed immunizations classes only occurred twice due to 




School at the University of Michigan, I conducted these activities over 12 months, September 
2012-August 2013. All activities involving human subjects were approved by the University 
of Michigan Institutional Review Board prior to commencement. 
 
Research Sites 
 Increasingly, the feasibility of ethnography as traditionally conceived has been 
challenged, urging anthropologists to rethink the construction of the “field” and the 
methodological approaches used to capture the amorphous flow and influence of phenomena 
like mass media and biomedicine (Gupta & Ferguson 1997). In this vein, the boundaries of 
my field site are flexible—loosely defined by the geographic limits of the San Francisco Bay 
Area—and include multiple sites of production and consumption of health media (See Ong 
2003 and Dávila 2001 for examples of similar approaches). Primarily, I conducted research 
in three different cities in the region that are ethnically, economically, and culturally quite 
distinct: San Francisco, Oakland, and Palo Alto. San Francisco is considered the center of the 
Bay Area due in part to its dense and large population. According to the 2008-2012 
American Community Survey (US Census Bureau 2013) estimates, the median household 
income is high ($73,802) and the city has a poverty rate among individuals (13.2 percent) 
that is lower than the national average of 14.9 percent. The topographically variegated layout 
of the city has created a multitude of enclaves that are climatically and ethnically quite 
distinct. The majority of the population identifies as Non-Hispanic White (52.3 percent); 
however, there is a large Asian community (35.8 percent) as well (US Census Bureau 2010). 
15.1 percent identify as Hispanic or Latino. San Francisco is also home to the highest 
percentage of gay and lesbian individuals in the United States (15.4 percent).   
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 Palo Alto and Oakland sit on opposite ends of San Francisco in many ways. Palo Alto 
located about 35 miles south of San Francisco, has an extremely high median income 
($122,482) and almost negligible poverty rate (4.9 percent) among individuals (US Census 
Bureau 2013). The inhabitants are primarily Non-Hispanic White (68 percent), followed by a 
smaller population of Asian individuals (30.3 percent) and only 2.4 percent of individuals 
identify as African American (US Census Bureau 2013). Oakland, in contrast, has a median 
income that is much lower than both cities ($51,683), and has a significantly higher poverty 
rate among individuals (20.3 percent) than Palo Alto, San Francisco, and the United States. 
While the largest percentage of the population living in Oakland still identifies as Non-
Hispanic White (38.7 percent), the city has a significantly larger portion of African 
Americans living there (30.5 percent) than in other regions and 25.4 percent identify as 
Hispanic or Latino (U.S. Census Bureau 2010). The diversity of these three cities allow for a 
broad understanding of parental negotiations regarding HPV vaccination.   
 The San Francisco Bay Area is also a well-suited research site due to recent 
developments regarding vaccination rates and practices across the region. Following an 
outbreak of nearly 9,000 pertussis (“whooping cough”) cases in 2010 in California—with the 
second highest incidence rate occurring in Marin county (137.66 per 100,000 in comparison 
to state incidence rate of 21.425), California passed Assembly Bill 354, which required 
students in 7th through 12th grade to receive a pertussis booster. In conjunction with this bill, 
the state public health department created a promotional campaign (“Preteen Vaccine 
Week”) to encourage awareness of the need to receive the pertussis booster (‘Tdap’) and 
encourage uptake of other adolescent vaccines, including the HPV and Meningococcal-4 




vaccine. After implementation of AB 354, vaccination rates for Tdap increased to 97.2 
percent across the state and nearly 97 percent in Marin County, which had one of the lowest 
vaccination rates before the legislation. However, HPV rates have not seen similar 
increases6. NIS-Teen 2012 survey estimates that 35.8 percent of adolescents aged 13-17 have 
completed the three-dose HPV vaccine series in California, which is slightly higher than the 
national average of 33.4, but significantly lower than other adolescent vaccines.  
Furthermore, although childhood vaccination rates across the United States (for 
vaccines other than HPV) are relatively high (for example, 2012-2013 vaccination coverage 
medians for measles, mumps, rubella vaccination are estimated to be 94.5 percent), certain 
counties in California have lower (although still relatively high) percentages of 
kindergarteners who are fully immunization upon school entry. Alameda County (which 
includes Berkeley and Oakland) reported that 87.23 percent of kindergartens were fully 
immunized in 2012-2013. Marin Country (which includes San Raphael, Sausalito, Mill 
Valley) reported 82.02 percent of kindergartens as fully immunized, and both counties are 
among the lowest in the state. Furthermore, certain communities—notably families who 
attend certain schools—have higher rates of immunization exemptions and resistance, and 
also reported higher rates of pertussis outbreaks in 20107. 
 
Recruitment Methods 
 In order to recruit potential interview participants, I primarily used local parenting 
networks throughout the San Francisco Bay to distribute recruitment flyers either physically 
                                                        
6 The California Department of Public Health does not currently collect HPV vaccination rates by county, and 




at community locations where parents frequently visited (e.g. community centers, parks) or 
electronically through parenting list-servs provided by the local parenting groups. I also used 
respondent-driven sampling (Bernard 2006), encouraging enrolled study participants to share 
my contact information with friends or family they thought might be interested in the study. 
To gather a broad range of perspectives, I purposively targeted parenting groups in different 
regions through the bay area including: East Bay (Oakland, Berkeley, San Leandro, Castro 
Valley); North Bay (Mill Valley, Sausalito, San Rafael); City of San Francisco; and 
Peninsula (Redwood City, San Mateo, Palo Alto). In each region, I identified local networks 
and when appropriate, gained permission from network leaders to recruit using extant 
communication channels. In addition to parenting networks, I also placed flyers on public 
community boards throughout the regions, and also on the local craigslist. All participants 
were self-referred. 
 The approved study flyer included study information and contact information. The 
electronic flyer also included a link to an online screening questionnaire (managed by secure 
online survey software, Qualtrics, provided by the University of Michigan). Individuals aged 
18 or older were eligible to participate in the study if a) they had at least one child between 
the ages of 7-17; b) had at least heard of HPV and the HPV vaccine; and c) were able to 
speak and read English. At the completion of the screening questionnaire, study participants 
were offered the option to provide their contact information or to contact me directly via 
email or phone.  
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 Between October 2012 and February 2013, a total of 88 screening questionnaires 
were started online, and 69 questionnaires were completed8. Of those who completed the 
screening questionnaire, 59 provided their contact information (56 provided email and phone 
number, while three provided their email only). For those who provided their contact 
information, I contacted each potential participant via email or phone within one week to 
further describe the study, assess interest, and schedule an in-person interview if interested. 
In addition to those who provided contact information in the online screening questionnaire, 
an additional six individuals contacted me either by phone or email directly to indicate 
interest in the study. Of these 65 parents who expressed interest, 50 participants enrolled in 
the study.  
 
IV. DATA COLLECTION AND ANALYSIS 
 
Semi-structured Interviews 
 Drawing from ethnographies that use in-depth interviews as a guiding framework 
(See Rapp 1999), I conducted 50 semi-structured interviews with parents considering HPV 
vaccination for their sons or daughters to answer my research questions. I designed the 
interview guide to investigate the following five intersecting themes: 1) the communicative 
and technological pathways by which parents learned about the HPV vaccine; 2) personal 
constructions of risks and benefits of HPV vaccination; 3) salient factors, including specific 
sources of information and actors, influencing the decision of whether or not to vaccinate 
their children; 4) specific norms (e.g. gender ideology) and values (e.g. moral codes) parents 
                                                        
8 The online screening questionnaire did not require individuals to provide identifying information (e.g. email 




call upon when discussing the HPV vaccine and their decision to vaccinate or not to 
vaccinate their children; and 5) interpretations of the responsibility and role of parents in 
protecting their children and their children’s future sexual partners against HPV. (See 
Appendix B for full interview guide).  
I conducted interviews at a variety of locations, including libraries, offices, coffee 
shops, and parks. Interviews lasted between 45 and 120 minutes. Unless requested otherwise 
by the participants9, each interview was digitally recorded. In addition, following the 
interview, I took field notes of my impressions and memorable themes to begin the analytic 
process while collecting data. Each audio recording was transcribed and all identifying 
information was redacted during transcription.  
 I analyzed transcribed interview data using a multiple stage approach, drawing from 
open coding techniques (Emerson, Fretz, & Shaw 1995) and tenants of grounded theory and 
the constant comparative method (Clarke 2005; Strauss & Corbin 1998). First, I read through 
ten interviews to identify common themes and experiences across participants (open coding). 
Using the themes I identified, I created a list of codes and drafted definitions for each, 
resulting in a draft coding dictionary. I then applied the coding dictionary to an additional 
five interview transcripts to clarify the coding dictionary further. The revision process 
resulted in a finalized coding dictionary consisting of 152 unique codes (See Appendix C for 
full coding dictionary).   
 Using qualitative data analysis software (Atlas.ti 7.0), I reviewed each interview 
transcript, and applied specific codes to text that exemplified the definition of the code. 
Following application of codes, I extracted and reviewed summary reports of each code to 
                                                        
9 Two participants expressed desire against audio-recording the interview. For these, I took extensive notes to 
capture their thoughts and experiences. 
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identify major themes by frequency and intensity across participants. In addition to 
identification of patterns, I reviewed themes across each participant to understand the 
complexities of individual experience and understanding.  
 
Questionnaire 
In addition to completing the in-person interview, 44 participants also completed an 
in-person, written questionnaire10. The written questionnaire included several items 
previously used in large-scale surveys on HPV vaccination (McRee et al. 2010), social 
attitudes (Pew Research Center 2012), information-seeking behaviors (Kelly et al. 2010), and 
risk perception (Lerman et al. 1991). I included the questionnaire to supplement, rather than 
center, my research, and thus only simple statistical analysis was conducted (See Appendix D 
for full questionnaire). Descriptive statistics (e.g. frequencies, means, and standard 
deviations) were analyzed across all participants using IBM SPSS Statistics 21. Additionally, 
for those domains of particular interest to the project design—specifically, political and 
public controversies—I conducted independent sample t tests and chi square analysis to 
compare parents who had vaccinated at least one child and parents who had not vaccinated. 
For this analysis, I only included parents who at least one child 11 years or older. Due to the 
small sample size, any conclusions based on statistical analysis should be tempered, and 
further research is needed to test these preliminary findings in a larger sample. However, 
coupled with the rich qualitative data, these findings give insight into the multitude of factors 
shaping HPV vaccination decisions.  
                                                        
10 I decided to add the written questionnaire after receiving initial IRB approval, and had to resubmit for 
additional approval after I begin scheduling initial interviews. Thus, six interviews occurred before having 
approval; however, I did ask some questionnaire questions verbally, and this data is included in statistical 




Systematic Collection of Information 
 Throughout my time in the field (and several years before), I collected and filed 
public sources of information, including scientific and popular journal articles, public health 
awareness campaigns, and pharmaceutical marketing, that described and centered on the 
risks, benefits and controversies of HPV vaccination. From sifting through magazines in 
waiting rooms to spending hours reading and reviewing online forums, blogs, and articles, I 
sought to find how—and through what means—parents, scientists, and others were talking 
about the HPV vaccine. Only a slight sliver of the data I collected is presented in this 
dissertation, but it serves to give an overview of the complex information landscape. The 
tracking of public information also allows me to situate the local deliberations of parents and 
decisions of parents within the hierarchical and heterogeneous assemblages of actors, objects, 




This study is limited in several ways. First, study participants overall are highly 
educated and affluent, and live in a geographic region that while ethnically and racially 
diverse is predominately liberal in its political views. Thus, results are not generalizable 
across all populations. Additionally, further research is needed to example the experiences of 
parents living in other geographic regions (rural and urban), parents of lower-income and 
                                                        
11 In addition to these efforts, I also conducted a systematic collection of local and national newspaper coverage 
of HPV vaccination, resulting in over 900 unique articles. In my future research, using content analysis 
framework, I will compare the content and presentation of risk in these sources; however, these efforts are 
beyond the original scope of the dissertation. 
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lower education status, and parents without access to healthcare to contrast and compare the 
experiences of these parents. Second, the study did not collect any observational data of 
communication between parents and providers, and parents and children. The perspective of 
providers and adolescents is needed to more fully gather the perspectives of all actors 
involved in HPV vaccination decisions. Lastly, from a qualitative perspective, the sample is 
sufficient; however, statistical results presented in this dissertation should not be viewed as 
conclusive due to the smaller sample size of 50.  
 
V. OUTLINE OF CHAPTERS 
 In the following chapter (Chapter Two), I present an overview of my findings—a 
survey chapter of sorts—to set up themes and discussions that I will elaborate upon in 
subsequent chapters. It also is my attempt to speak to the growing literature in the fields of 
health services, public health, and biomedicine on parental decision-making and HPV 
vaccination in the United States by identifying patterns. Although by nature reductionist, 
identification of patterns is helpful to begin to understand shared themes across participants, 
and to begin to identify ways in which interventions—whether at the level of health 
promotion efforts or healthcare provider education—may be needed to reduce structural 
barriers to care. However, patterns often miss the complexities and ambiguities that exist in 
the details and lived experiences of individual people. As such, drawing from the work of 
Biehl and Locke (2010) on subjectivity, desire, and becoming, I conclude the chapter by 
detailing the stories and decisions of three parents to identify how desires to care—and 
systems of power—came to bear on HPV vaccination decisions.  
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In Chapter Three, I explore the media, pharmaceutical marketing, and controversies 
regarding HPV vaccination in the United States. I first provide detailed analysis and 
documentation of the initial “One Less” marketing campaign employed by the 
pharmaceutical company, arguing that the initial campaign utilized a feminist empowerment 
model in an attempt to advert cultural backlash. Following, I trace larger political and 
cultural debates regarding HPV vaccination in the United States, including those regarding 
Congresswoman Michele Bachmann, and Governor Rick Perry. I then situate these broader 
discussions in the thoughts and decisions of parents with whom I spoke, drawing from Emily 
Martin’s work on ambivalence and meaning making in pharmaceutical practices. I also 
consider the “pharmaceuticalization of public health” to highlight how vaccination decisions 
are scripted with and come to reflect political and economic values and practices in the 
United States. Lastly, amid recent shifts in the healthcare system in the United States toward 
patient engagement, I explore new opportunities for social workers to engage in primary care 
settings and assist in eliciting details from patients’ lives—beyond cultural variables—that 
may shape their healthcare outcomes.  
In Chapter Four, merging theoretical and practical considerations, I explore the ways 
in which my findings may help to explain current resistance to HPV vaccination in the 
United States. Using fundamental cause theory (FCT) as a guiding framework, I consider 
how the theoretical concept of countervailing mechanisms may help to explain HPV 
vaccination patterns that document both disparities by race and socioeconomic status, and 
low uptake among high-resource populations (Link & Phelan 1995). Additionally, drawing 
from anthropological work on temporality, risk and potentiality, I consider how cultural 
mechanisms—specifically sexual norms regarding teenage sexuality (particularly among 
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young girls) and lay challenges to scientific and expert knowledge—may be contributing to 
low and stagnating vaccination rates among resource-laden populations acting as 
countervailing mechanisms against (arguably) beneficial health behaviors. Specifically, I will 
contend that parents are challenging expert knowledge and the universalizing assertions of 
public health through desires to delay vaccinate to an age that they feel is more appropriate. 
To defend their desire to delay vaccination, parents often invoked claims to experiential 
evidence validated by a sense of knowing their child and his or her sexual and emotional 
development—attempting to redraw the lines of power based on their claim to parental 
knowledge that no "expert" can possess (Gieryn 1983; Nader 1996). Entangled within these 
claims (or acts of boundary work) are temporal assessments of risk—whereby parents 
weighed their child’s (perceived) present risk of HPV exposure against the unknown risks of 
the vaccine itself.  
In Chapter Five, I will examine how tensions between individual rights, collective 
good and moral obligation—often scripted through political and social values—emerged in 
my discussions with parents. I will contextualize these tensions within the broader political 
shifts occurring in the United States. Within these discussions, I consider how notions of 
responsibility, obligation, and care as both a parent and member of society guided HPV 
vaccination decisions, and how these notions reflected not only relationships between parents 
and children, but between the individual and the collective. In these ways, the act of 
vaccinating (or not vaccinating) gained meaning as an ethical act, or an act that at the core is 
concerned with questions of how we choose to live (Lakoff & Collier 2004). In conclusion, I 
consider the ways in which parents constructed the HPV vaccine as distinct from other 
childhood vaccinations based the manner in which it is transmitted. Beyond epidemiological 
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understandings, these discussions reveal how normative discourses that stigmatize certain 
behaviors—and bodies—are remade amid medical and technological change. 
 
VI. RESEARCH IMPLICATIONS  
 
Contribution to Anthropological Theory 
 By studying the ethical reflections of parents considering HPV vaccination for their 
children, my dissertation contributes to central theories in four key fields of anthropological 
inquiry that have not been often connected: medical anthropology, science and technology 
studies, media anthropology, and anthropology of ethics. Research in medical anthropology 
has demonstrated how political and economic factors at the structural level directly affect 
localized experiences of health and affliction (Farmer 1992, 2005; Horn 1994; Inhorn 2003; 
Nguyen & Peschard 2003; Ong 2003; Petryna 2002), yet this research often places the media 
as a secondary or non-existent actor (See Martin 1994 and Jain 2007 for notable exceptions). 
Science and technology studies have shown how the ostensibly objective act of scientific 
innovation is based on situated views and practices (Clarke & Olesen 1999; Fausto-Sterling 
2005, Haraway 1999, 1997; Harding 1996; Keller 1996; Martin 1991; Worthman 1995), but 
has not often extended this approach to understanding how the uncertainty of medical 
information is understood and negotiated by parents considering health decisions for their 
children. Scholars of media anthropology have dissected the underlying assumptions of 
images projected and produced in the media (Askew & Wilk 2002; Dávila 2001; Ginsburg, 
Abu-Lughold & Larkin 2002; Ortner 1998, Shryock 2004; Spitulnik 1993), yet have not 
often used health media campaigns and pharmaceutical marketing as direct objects for 
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investigation. Anthropology of ethics have examined the ways individuals and collectives 
construct notions of good (Collier & Ong 2005; Faubion 2011; Foucault 1997; Rabinow 
2003; ), but have not often focused on personal constructions of risk as a ethical practice in 
the context of medical uncertainty. 
 My research connects and expands upon the central approaches of these fields by 
detailing the personal reflections of parents as they negotiate various conflicting sources of 
information with notions of how best to protect their children. Additionally, by taking 
seriously the uncertainty that exists within the public and scientific realm (Braun & Phoun 
2010), this project constitutes HPV vaccination as an anthropological and ethical problem, 
rather than simply a medical decision, whereby the decision of whether or not to vaccinate is 
entangled with questions of how one should live—and parents—amid technological 
transformations (Collier & Ong 2005; Lakoff & Collier 2004; Rabinow 2003). In these ways, 
this project contributes to not only the subfield of medical anthropology, but the wider 
anthropological discipline. 
 
Contribution to Social Work Research and Practice 
 By examining how economic, political and social factors as well as parental notions 
of risk and responsibility guide vaccination behaviors and practices, this dissertation 
contributes to a large body of social work research focused on promoting and improving 
health of the population through equitable access to not only healthcare. As will be discussed 
in Chapter Four, national patterns of HPV vaccination by race and socioeconomic status are 
surprising, as initiation rates are actually higher among adolescents living under the poverty 
line and among certain minority groups. However, completion rates of the three-dose series 
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are lower among underserved groups—although more recent data is showing shifts in these 
rates. Moreover, other studies have shown disparities by race and socioeconomic status—
often stemming from gaps in HPV-related knowledge, access to healthcare, or receipt of 
healthcare provider recommendation.  
My findings suggest that in addition to structural factors, collective beliefs and 
practices, including sexual norms, may help explain these patterns. Additionally, beyond 
receipt of healthcare provider recommendation, the specific content (and quality) of provider 
communication may also impact communication of information in an equitable way. 
Although further research is needed, my results suggest that public health interventions must 
address not only structural inequities, but also parental concerns regarding the safety and 
potential risk of the HPV vaccine in relation to other vaccines and the timing of the vaccine 
in relation to sexual behavior and immunogenic evidence. Also, my findings support the 
importance of not only having access to preventive health care, but the subtle ways structural, 
political, and economic factors shape health outcomes. Furthermore, as I will contend, social 
workers are uniquely qualified to help clinical efforts to achieve structural competency—and 
support recent legislative and structural efforts to elicit and incorporate patient values and 
circumstances into preventive and acute care.  
 
 VII. FUTURE DIRECTIONS AND OPPORTUNITIES IN U.S. HEALTHCARE 
In the late 1990s, a buzz began to grow in the edges of the medical community about 
a novel way to approach patient care. First defined by Charles, Gafni & Whelan (1997), the 
term "shared decision-making" (SDM) represented a pendulum swing back from the earlier 
patient autonomy movement. This movement also reflects a resistance to the historically 
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paternalistic model of healthcare that dominated the patient-provider relationship. In contrast 
to patient autonomy, which stressed the individual autonomy of the patient, shared decision 
making envisioned a collaborative state by which patients and providers were placed on the 
same level, each bringing their own expertise to the table. The infamous saying, "it takes two 
to tango" emerged as the way to address inequities in the doctor-patient relationship and 
improve patient care (Charles, Gafni & Whelan 1997).  
In some circles, this term became infectious, constructed as a panacea to rid the world 
of the ills of healthcare practice. Over years of research and clinical trials, SDM proved to be 
efficacious at improving patient knowledge, improving decision quality, and even improve 
health outcomes in certain cases (Légare et al 2012; Stacey et al. 2011). Patients even elected 
less invasive (read: less expensive) treatment believed to reduce potential harms caused by 
undergoing more aggressive procedures, while also only decreasing extraneous costs on an 
already taxed health care system.    
Decision aids—in the form of brochures, videos, or interactive websites—have been 
proffered as the tool to facilitate these shared discussions between doctors and patients, 
allowing for the patient to have access to the risks and benefits of different treatment options. 
An underlying concept is the notion of equipoise—or acknowledging that in many cases in 
medical treatment, there is no one best way to treat the patient (Elwyn et al. 2000; Elywn, 
Frosch & Rollnick 2009). Rather there are multiple options, with varying (often uncertain) 
risks and benefits, which should be selected based on patient's preferences. These 
"preference-sensitive" decisions have been the primary focus of shared decision-making 
efforts; however, some have argued SDM should apply to other medical decisions, including 
those where clinical evidence is low (Politi, Lewis & Frosch 2013).  
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Returning to the question posed by Biehl at the opening of this chapter, in some ways, 
this movement (more recently expanded to notions of patient engagement) aims to create a 
more informed debate (or at least open conversation) about the uncertainties and 
subjectivities of medical knowledge, acknowledging simultaneously that patient's 
preferences—beyond morbidity and mortality—matter and there are limits to medical 
knowledge. In the case of HPV vaccination, decision aids have been presented to help inform 
parents, and dispel misinformation floating in the public (Fiks et al 2013; Mayne et al. 2012); 
however, like other decision aids, beyond the realm of clinical trials, their impact has been 
limited, in part to the difficulties incorporating into clinical care (Lin et al. 2013) and 
potentially more due to mediating, structural factors guiding healthcare practices across 
different populations. Even when they do manage to find the hands of patients, the larger 
cultural ethos underlying health care in the United States—from medical schools to 
evaluation measures—has not shifted greatly to respond to cultural shifts. With the 
implementation of the Affordable Care Act, some structural aspects have been put into place 
to help encourage this cultural change, mostly in the form of reimbursement rates from 
insurance companies being linked to patient-centered metrics and preventive care, but it 
remains to be seen what impact they will have on patient experiences and outcomes.  
Additionally, as will be discussed in this dissertation, underlying cultural beliefs, 
constructions, and experiences come to bear on medical decisions in unanticipated ways. 
When I turned the recorder off, most if not all of the parents with whom I spoke asked me 
what I thought about HPV vaccination, and while careful not to offer any medical advice, I 
told them that at the core, the uncertainty they felt made the topic not only of anthropological 
interest, but interest to the practice and promotion of health. In the digital information age, 
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facts are made and unmade and made again in a matter of seconds, and it seems that 
uncertainties are on the rise. In these moments of uncertainty, parents fall back upon the 
values, norms, and experiences they trust—to make sense and decide how best to care for 





























CHAPTER TWO: MAKING AND UNMAKING PATTERNS 
Vaccines represent one of the most successful public health interventions in modern 
medicine. Despite successes, cultural anxieties over vaccine safety and necessity have existed 
in the United States since the development of the polio vaccine and continue today in the 
context of the human papillomavirus (HPV) vaccine. Politically charged discussions of the 
influence of pharmaceutical companies on HPV vaccination policies, and fears that HPV 
vaccination may lead to riskier sexual behavior have exacerbated existing cultural anxieties. 
Additionally, there has been some medical uncertainty over the vaccine, including debates 
over the cost and benefit of widespread vaccination, and limited evidence of the long-term 
effectiveness regarding cervical cancer prevention. While these uncertainties continue today, 
little is known about the impact these uncertainties have on parents’ decisions regarding HPV 
vaccination for their sons and daughters.   
 In this chapter, I will first provide a brief summary of health sciences literature 
examining parental decision-making and HPV vaccination in the United States. Then, I will 
present an overview of the major factors and patterns underlying HPV vaccination decisions 
among parents with whom I spoke, using both qualitative interview data and quantitative 
questionnaire data. In subsequent chapters, I explore these themes further, drawing from 
theories in health disparities, social work, and medical anthropology, to position these 
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decisions in relation to the network of scientific, political, and individual actors that give 
meaning and resistance to these acts.  
Although by nature reductionist, identification of patterns is helpful to begin to 
understand shared themes across participants, and to situate my findings within the larger 
research literature. However, patterns often miss the complexities and ambiguities that exist 
in the details and lived experiences of individual people. As such, drawing from the work of 
Biehl and Locke (2010) on subjectivity, desire, and becoming, I will end the chapter by 
detailing the stories and decisions of three parents, all mothers, to identify how desires to 
care came to bear on HPV vaccination decisions, and locate people amid the patterns.  
 
I. PARENTAL DECISION-MAKING AND HPV VACCINATION IN THE UNITED STATES  
 The majority of research that has examined why and how parents decide whether or 
not to vaccinate their children against HPV has been conducted by health scientists, including 
biomedical, public health, and health services researchers, and is often funded in part by 
pharmaceutical companies themselves. These studies also frequently rely upon the results of 
national survey data examining immunization and other health practices in the United States, 
including the Health Information Trends Survey (HINTS) and National Immunization Survey 
(NIS). Self-reported responses regarding health behaviors, attitudes, and outcomes (which 
may or may not be confirmed by medical record data) are analyzed to identify factors that are 
associated with or possibly predicative of HPV vaccination uptake. While not exhaustive, I 




 Prior to and following initial 2006 licensure of the quadrivalent HPV vaccine 
(Gardasil) in the United States, a number of studies examined level of HPV awareness and 
HPV-related beliefs in different populations to assess their acceptance or intention to 
vaccinate if a HPV vaccine became available (Allen et al. 2010a). Generally, these studies 
found that parents and young adult females knew very little about the virus (HPV) itself and 
its relationship to cancer (Brewer & Fazekas 2007; Gerend & Magloire 2008). Lower levels 
of knowledge have also been found among disadvantaged groups, including ethnic minority 
parents, parents with lower income or lower education levels (Cates et al. 2009). More recent 
studies, however, have not demonstrated a link between HPV knowledge and uptake (Lai, 
Tinker & Cheung 2013).  
 Beyond awareness, early studies also looked at how HPV-related beliefs, including 
perceived risk of developing cervical cancer, perceived benefit from vaccination, and 
perceived barriers to vaccination, impacted parental intention to vaccinate (Allen et al. 
2010b; Caskey et al. 2009).  Some studies examined parental attitudes regarding sexual 
disinhibition—or beliefs that vaccination would lead to riskier or earlier sexual activity, and 
in general, found very few parents held these beliefs, and thus did not greatly impact 
vaccination practices (Schuler et al. 2011).  
 More recent studies have examined factors associated with actual HPV vaccination 
initiation (receipt of at least one dose) and vaccination completion (receipt of all three doses), 
and found supporting evidence for disparities based on socioeconomic status, race, parental 
knowledge, and geographic location (Downs et al. 2010; Moss et al. 2012; Niccolai et al. 
2011); however, not all studies or data have shown these gaps12. Other factors including 
                                                        
12 I will discuss the mixed findings on racial and socioeconomic disparities regarding HPV vaccination 
initiation and completion in a subsequent chapter. 
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health insurance status, perceived safety of the vaccine, parental medical history, media use 
and exposure, and recommendation of the healthcare provider have also been related to HPV 
vaccination practices (Hughes et al. 2009; Kessels et al. 2012; Reiter et al. 2001).  
 
Anthropological Perspectives 
 When I first started examining the marketing of the HPV vaccine in 2007, very little 
work had been published in the field of anthropology and sociology on the HPV vaccine (See 
Casper & Carpenter (2008) for notable exception). Since this time, a collection of essays with 
work from Steven Epstein, Robert Aronowitz, Laura Mamo and numerous other social 
scientists has been published, providing key insight into how the manufacturing and 
marketing of the HPV vaccine reflects larger societal, biomedical, and political practices in 
the United States (Wailoo et al. 2010). More recently, ethnographic investigations of HPV 
vaccination in the United States (Gottlieb 2013) and worldwide (Towghi 2013) have started 
to emerge. These insights complement large-scale health sciences research by providing a 
critical perspective on the biopolitics of the HPV vaccine. However, more research is needed 
to understand both the marketing and reception of HPV vaccination from the users 
themselves. By examining parental ethical and medical considerations regarding HPV 
vaccination in relation to broader articulations of health promotion and practice in the United 
States, my dissertation research contributes to theoretical discussions in the fields of medical 
anthropology, public health, and social work, and provides practical insight into how 
structural factors—either limiting or enabling—may result in not only perpetuation of health 




II. REVIEW OF DISSERTATION FINDINGS 
Demographics 
 Between August 2012 and March 2013, I interviewed 50 parents living throughout 
the greater San Francisco Bay Area. Of these 50 parents, 44 also completed a written 
questionnaire at the time of the interview. The majority of the parents I spoke with identified 
as White or Asian/Asian-American and female. Eight parents were first generation 
immigrants, coming from a range of countries including United Kingdom, India, and China, 
and 16 parents were second-generation immigrants. Most of the parents reported high income 
based on national standards, but considered themselves middle-class, partly due to the high 
of cost of living in the bay area. Of particular note is the high level of education of most of 
the parents with whom I spoke, with 52 percent earning a doctorate level degree, and 42 
percent earning a bachelor's degree. While occupational fields varied from business to 
computer sciences to art, nine (18 percent) parents worked in the field of law, which may be 
representative of the area in which I recruited or potentially the topic of study. Table 1 below 
includes the complete demographics for those parents interviewed. 
Table 1: Interview Participant Characteristics (n=50) 
HPV Vaccination Decision  
Already vaccinated at least one child 23 (46%) 
Planning to vaccinate 9 (18%) 
Not planning to vaccinate 5 (10%) 
Unsure 13 (26%) 
Gender   
Female 46 (92%) 
Male 4 (8%) 
Age: Range 38-58 Mean: 48.8; SD = 9.96 
Number of Children: Range 1-5 Mean: 2.16; SD = 1.02 
Ethnicity/Race   
American Indian/Alaskan Native 2 (4%) 
Asian/Asian American 10 (20%) 
Black/African-American 2 (4%) 
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Table 1 Continued 
Latino/Hispanic 2 (4%) 
White 34 (68%) 
Relationship Status 
 Married or Living as Married 42 (84%) 
No steady partner 8 (16%) 
Social Class (Missing = 3) 
 Lower or Working Class 4 (8%) 
Middle Class 37 (74%) 
Upper Class 6 (12%) 
Income (Missing or Decline to Answer = 10) 
 20,000-49,999 4 (8%) 
50,000-79,999 6 (12%) 
80,000-119,999 8 (16%) 
120,000 or more 22 (44%) 
Employment Status 
 Working full or part time 36 (72%) 
Homemaker 9 (18%) 
Self-employed 3 (6%) 
Unemployed or disabled 2 (4%) 
Highest Education Completed  
HS Diploma/GED 1 (2%) 
Technical Cert or Associate’s Degree 2 (4%) 
Bachelor’s Degree 21 (42%) 
Master’s Degree 15 (30%) 
Doctorate/Jurisdoctorate 11 (22%) 
Children’s Insurance Status (Missing = 4)  
Private or Employer-based Plan 44 (88%) 
SCHIP 2 (4%) 
Political Party Affiliation (Missing = 4)  
Democratic 35 (70%) 
Republican 6 (12%) 
Other (Independent, Libertarian, Green) 5 (10%) 
Religious Affiliation (Missing = 3)  
Catholic 8 (16%) 
Jewish 9 (18%) 
Mormon 1 (2%) 
Muslim 1 (2%) 
Christian (Protestant, Episcopalian, Quaker, & Unitarian 
Universalist)  11 (22%) 




HPV Vaccination Decisions 
 Of these 50, 23 parents (46%) had already vaccinated at least one of their children at 
the time of the interview. Of the remaining parents, nine (18%) reported that they planned to 
vaccinate their children in the future, five (10%) reported that they did not plan to vaccinate, 
and 13 (26%) reported they were uncertain if they would vaccinate their child or children. In 
interviews, I learned that most parents expressed the desire to delay vaccination, rather than 
refuse, but desired to wait until either their child is older than the recommended age of 11 
and/or until more evidence regarding the safety and benefit of the vaccine has been 
documented. I will discuss these factors in more detail throughout my dissertation. 
 
Children of Enrolled Parents 
 On average, parents who I interviewed had two children; however, some had as many 
of five. Children ranged in age from toddler to grown adult with children of their own. In our 
discussions, parents elaborated on the diverse ways they came to be parents beyond 
normative biological pathways, including tales of sifting through numerous sperm donor 
profiles with their partners, overcoming challenges of international adoptions, and unique 
parental relationships born from second and third marriages. They also gave detailed 
descriptions of differences and similarities between children, often through the lens of how 







Unvaccinated and Vaccinated Children  
 The majority (70.3 percent) of the 74 children eligible for vaccination13 were female; 
however, there was no significant relationship between gender and vaccination status, X2 (1, 
N=74) = 0.092, p=0.762. However, when looking at age, there was a significant difference 
between unvaccinated (M=13.51, SD=2.267) and vaccinated (M=15.77, SD=2.433); t(72)=-
4.111, p=0.000, CI [-3.348, -1.161]. Based on these results, older children were more likely 
to be vaccinated, with only 27.6 percent of children 13 and under vaccinated, and 47.7 
percent of children 17 and under vaccinated (See Figure 1).  
Recommended timing of the vaccine emerged as a pressing concern for parents 
during interviews, entangled with parental uncertainties regarding the safety of the vaccine 
and temporal assessments of when their child might become sexually active. In the next 
                                                        
13 For purposes of examining those children vaccinated with those unvaccinated, I only included children older 
than the age of 11 (the recommended age for vaccination initiation) at the time of the interview. I also limited 
analysis to children to those who would still have been under 18 (and under medical care of their parents) when 





section, I will give an overview of how these factors and others influenced parents' decision 
over when and if to vaccinate, and elaborate further in subsequent chapters.  
 
III. IMPACT OF PUBLIC CONTROVERSIES AND CULTURAL ANXIETIES   
 One of the primary research questions of my project was to examine how evolving 
public controversies and cultural anxieties over the HPV vaccine impacted what parents think 
and decide about HPV vaccination for their own children. While the controversies have been 
numerous, for purposes of my research project, I categorized them in the following ways: 1) 
fears that HPV vaccination will lead to risky or earlier sexual behavior; 2) concerns that HPV 
vaccination is being pushed for pharmaceutical profit; and 3) uncertainties regarding the 
corporeal risks of HPV vaccination. I also asked parents generally about what they had heard 
regarding the HPV vaccine from media sources as well as friends, family members, and 













Risky Sexual Behavior 
 
 
 Overwhelming, parents did not report that they believed HPV vaccination would lead 
to increased sexual behavior or earlier sexual debut, and as such, this belief did not influence 
their decision whether or not to vaccinate their child (See Figure 2).  An independent samples 
t-test was conducted to compare parental belief that the HPV vaccine may cause children to 
have sex at an earlier age in parents who had vaccinated and not vaccinated at least one child 
aged 11 or above. There was not a significant difference between the scores in unvaccinated 
parents (M=4.37, SD=0.895) and vaccinated (M=4.43, SD=0.590); t(40)=-0.288, p = 0.775. 
This is not surprising as only one parent reported believing these claims to be true. 




  When I asked parents during interviews if they had heard anything regarding the 
controversies, many had heard of the parental concerns regarding the potential to increase 
sexual activity, but most expressed that they did not believe it. Stating it bluntly, Alice, a 
mother of an unvaccinated 12-year old daughter, described these rumors as "a crock of crap." 
The following quotes highlight other parents’ general disbelief as well: 
Antonia: I haven’t paid attention to any controversies. I understand there are 
controversies...I kind of have heard that it might encourage your kids to be more 
sexually active, but I don’t believe that (Mother of two unvaccinated daughters, aged 
11 and 19). 
--- 
Betsy: People think that [the HPV vaccine] was giving kids carte blanche to start 
having sex, and that it was interfering with the parent and child relationship – and 
dictating morals to kids.   
 
Kate: What did you think of that? 
 
Betsy: Ridiculous. The logic that you vaccinate them before they become sexually 
active, that makes sense. And for some kids that may be 11-12, others it might be 14, 
15, 16—hopefully later than that (Mother of vaccinated twin 13-year old daughter 
and son, and 17-year old son). 
 
Although parents did not report that sexual anxieties regarding potential promiscuity or 
earlier sexual debut influenced their decisions, some parents did describe hearing it from 
other parents. Cristina, an early education teacher and married mother of a 13-year old 
daughter, described one surprising interaction she had with of a parent that she had known 
for nearly 10 years:  
Cristina: I was very surprised one day when a friend had come over after school with 
my daughter, and the mother came to pick her up, and we were just chatting on my 
front porch. And she said something about how she was just shocked that her doctor 
had suggested [the HPV vaccine], and what was I going to do? I was sort of a deer in 
the headlights in that moment because I really hadn’t ever been looking at it as a bad, 
negative kind of choice. I only really was looking at it as a medically bad choice—like 
that there could be a harmful effect from a vaccine or something. I never, ever was 
looking at it as any kind of moral factor—like that my daughter having this shot 
would make her feel free to go and be promiscuous or something. That just didn’t 
even, sorry, that just didn’t even cross my mind.  So then when this Mom was saying 
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that she was shocked, it became clear to me that that was what she felt. That the 
doctor was making some kind of statement about what his expectations were of her 
child or something. It was clear that that’s how it made her feel.  So I was 
uncomfortable because I pretty much already made up my mind at that point that I 
was going to pursue this.  So it felt a little bit awkward for me and I don’t think I said 
a whole lot, but I did say that yes, I knew about it and I hadn’t thought…that it was 
gonna make my kid run around and have sex at age twelve.  She just really was not 
happy about it.  
 
Although Cristina had not yet vaccinated her daughter, drawing in large part from 
conversations she had with her sister, a mother of slightly older teenage daughters, and to 
whom she often deferred to for parenting advice, she did not feel comfortable telling this 
mother that she planned to vaccinate. I asked if she had any follow up conversations with this 
mother after she made her own vaccination decision, and she noted: 
Cristina: I avoided it like the plague, just because—I know it sounds silly, like I can’t 
stand up for my own decision, but I didn’t want to make her feel uncomfortable. I 
didn’t want to make me feel uncomfortable. That’s a choice she has to make for her 
family, so I didn’t go there.   
 
This resistance to discuss or approach parents who chose not to vaccinate, even among 
parents who strongly endorsed childhood immunizations, emerged again and again in my 
conversations, reflecting in part the tensions between values regarding individual parental 
rights, and collective societal obligation to promote health and protect against known harms. 
In a later chapter, I will explore these tensions further. 
 
Pharmaceutical Distrust 
 In my dissertation, I also aimed to understand how beliefs regarding the 
pharmaceutical industry in general and more specifically opinions regarding their perceived 
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role in public health policies14 impacted parents’ vaccination decisions. In the written 
questionnaire, parents were asked how much they agreed or disagree with the following 
statement: The HPV vaccine is being pushed to make money for drug companies. An 
independent samples t-test was conducted to compare item responses between parents who 
had vaccinated and not vaccinated at least one child aged 11 or above. There was a 
significant difference between the scores in unvaccinated (M=3.16, SD=1.167) and 
vaccinated parents (M=3.96, SD=0.706); t(40)= - 2.735, p = 0.009, CI (95%) -1.424, -0.173. 
These results suggest that parents who had a stronger belief that HPV vaccination is being 
pushed to make profits for pharmaceutical companies were less likely to have vaccinated 
their child (See Figure 3). 
 
                                                        
14 This interest arose out of early and continued controversies regarding Governor Rick Perry of Texas and the 
influence of lobbying by Merck on state initiatives to require HPV vaccination, which I will explore and 




Although quantitatively there is evidence of an association between perceived belief 
regarding pharmaceutical motives and vaccination status, in the conversations I had with 
parents, the connection seems much more complicated and nuanced, whereby some parents 
who expressed strong distrust had vaccinated their children, while others who expressed 
generally positive views had not. For instance, Sadie, who had vaccinated her 17-year old 
daughter and intended to vaccinate her 19-year old son, stated her distrust bluntly: “I think 
[pharmaceutical companies] are out for the money, never for the good of society.”  
Latrice, a mother of a nine-year old son, also held a very strong and negative opinion 
of the pharmaceutical industry, but planned to vaccinate her son as soon as he turned 11. As 
she explained: 
Latrice: I have a very negative opinion of [pharmaceutical companies] cause I’ve 
taken classes on health education and I’m very skeptical. I think of them as fortune 
500 companies—the big corporations. I think it’s all about money with them, and I 




think they’re affiliated with the doctors, and the doctors, instead of treating you or 
trying to take tests to see what’s wrong—oh, let me give you a pill.  Your toe hurts, let 
me give you a pill.  It’s just like they’re trying to make the pharmaceutical companies 
rich. They’re all in connection with the low income community clinics, and I think 
they’re full of crap, I really do. I think they’re dishonest and they’re always trying to 
push the medicine on you when it might not even be medicine. 
 
In contrast, Lorraine, mother of two adopted daughters, who also expressed distrust, did not 
plan to vaccinate her daughters. 
Lorraine: I do think [pharmaceutical companies] influence the picture a lot, that 
doctors do get samples and make them available to people and that doctors. They’re 
human too, and they’re gonna get lots of perks and stuff from the pharmaceutical 
companies.  I don’t trust them completely to have our interests. I think we’ve learned 
over the years that lots of times people say something is safe and it is not. We’ve got 
evidence of that. And I think whenever there’s that much money involved—it’s a ton 
of money—that decisions are going to be made that aren’t necessarily in our best 
interest.   
 
Most parents, including those who had vaccinated and not vaccinated their children, 
expressed ambivalence with regard to pharmaceutical companies, expressing concerns over 
the conflicting interests of providing collective good to society while simultaneously 
profiting from these endeavors. As Delia, a mother of an unvaccinated nine-year old son and 
12-year old daughter described: 
Delia: I know a lot of people think they’re a big boogieman. I’m pretty neutral about 
it.  Maybe I’m naïve, I mean I know that some of them, or certain drugs, are bad, but 
you’re always looking for a cure for cancer or a vaccine for this or that. And 
pharmaceutical companies are the ones who are developing those things.  They are 
working with scientists and doctors.  I know scientists and doctors.  I think they are 
working for the public good, so I think pharmaceutical companies—like I said I’m 
just pretty neutral.  So there are some horrible profit driven people, and I know some 
good scientific medical people who are trying to solve healthcare problems.   
 
In the next chapter, I will explore this ambivalence further, drawing from the work of Emily 





Corporeal Risk: Bachmann and Intellectual Disability 
 A few months before I began my fieldwork, Congresswoman and staunch Tea Party 
supporter Michele Bachmann made her now infamous statements inferring that HPV 
vaccination has "very dangerous consequences" including "mental retardation", based on a 
conversation she had with a mother outside a Republican Presidential Debate. As such, in my 
project, I hypothesized that this statement would not only be well known by parents with 
whom I spoke, but also potentially highly influential. 
 In order to assess this, using Bachmann's exact framing, I asked parents directly in the 
written questionnaire, how much they believed the following statement to be true: The HPV 
vaccine may cause mental retardation. An independent samples t-test was conducted to 
compare item responses between parents who had vaccinated and not vaccinated at least one 
child aged 11 or above. There was not a significant difference between the scores in 
unvaccinated (M=3.95, SD=0.705) and vaccinated parents (M=3.91, SD=.733); t(40)= 0.154, 
p = 0.879, CI (95%) -.416, .484. This is not surprising as no one reported believing that HPV 
vaccination may lead to intellectual disability, although several parents (12) reported that 
they were unsure (See Figure 4). 
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 In conversations with parents, I learned that the general disregard of Bachmann's 
statements representing more a disregard of the politician who spoke these words than 
general disbelief in the potential for corporeal harm from the vaccine. As these two parents 
explained: 
Ruth: I don’t remember if she said that [the vaccine] was linked to autism or mental 
retardation, but something weird.  And Michele Bachmann chimed in and honestly at 
that point I turned the radio off because, that’s showing my bias, but I can’t listen to 
such inflammatory information. Now if the surgeon general came out and said, ‘You 
know, there’s some concern,’ I’d probably listen. But from that kind of quarter, I’m 




Kate: Did you hear about the debate between Rick Perry and Michele Bachmann? 
 
Kelsey: Both of whom are incredibly stupid. 
 
Kate: Do you remember any of specifics? 
 
Kelsey: Yeah, I follow presidential politics.  I think she was saying that [HPV 
Figure 4: Parental responses to “The HPV vaccine may cause mental retardation” by vaccination status 
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vaccination] was a bad idea because it will send a message that will encourage sex 
before marriage and young girls to be sexually active.  I expect there was some 
paranoia about the government in there too.  I think Rick Perry favored it…I think he 
came down on the side I could agree with there.  It’s nice when you can find some 
areas with people you don’t respect that you can agree on.  She’s a wing nut though – 
sorry.  Great cheek bones!  There’s probably the main thing going for her!  Sorry! 
(Mother of 12-year old unvaccinated son). 
 
While these comments may not be surprising (or entirely reflective of the actual debate) due 
to the political climate of the area in which I conducted research, even among those who 
considered themselves Republican, these statements were generally disregarded. As Krista, 
mother of two vaccinated 14- and 16-year old daughters, explained: 
Krista: Poor Rick Perry.  I’m a Republican and I really thought he would be a great 
candidate, and that issue was one of the reasons he didn’t get the nomination.  There 
were other reasons, and that made me sad.  I mean, I’m very much on the fence about 
whether the government should force certain things on people…so I don’t know how I 
feel, but I certainly would have not voted for him because of what he did. 
 
Kate: So are you’re talking about that he passed the mandatory law? 
 
Krista: He passed something. I don’t even think it was mandatory. I’m trying to 
remember the details. Because it was about sex people flipped out the way I 
remember it. 
 
Kate: Do you remember Michele Bachmann’s involvement in it? 
 
Krista: Oh no!  She’s the one that says that it causes retardation; I do remember this, 
oh my God!  She was saying a bunch of crazy things, so everybody knew that was just 
one of them…It’s really bad for someone in that position to scare people 
 
Contrary to what I had hypothesized, not only did parents not believe these statements, many 
did not recall hearing about them. As Maggie, a mother of a 17-year old vaccinated daughter, 
noted: 
Maggie: No I haven’t heard anything about it.  I don’t usually tie politics and health 
at all.  I don’t value what their opinion is about my healthcare—about any politician.  
I already know how they lobby to gain and how unions buy their votes, so I’ve 
already been part of that process personally.  I don’t think they have any business in 
my healthcare.  I think about the only laws they should be involved in is the insurance 




Throughout the interviews, parents described a variety of sources—human or otherwise—
from which they actively sought information or advice regarding HPV vaccination. They also 
described sources from which they heard information without actively seeking it. Depending 
on the source, they may have disregarded it or taken it with great value. Although most 
disregarded the claims of Bachmann and other politicians, parents did express great 
uncertainty regarding the safety of the vaccine, and in some cases, this uncertainty was 
increased by hearing—even if secondhand—the story of Jenny Tetlock. 
 
IV. THE STORY OF JENNY TETLOCK 
Lorraine: I just remembered the family’s name is Tetlock. Phil Tetlock was the father 
and Jenny Tetlock, I think she was fifteen when she died and she had her first—I 
guess you get a series of these—she was getting a series of three.  So I think she may 
have been thirteen or so when she first got sick and had a very rapid decline.  She 
went to a school that was near us so we heard a lot about it.  Other kids that I knew 
went to the same school with her, and although I’m not close to the family, I had met 
them and I had met her.  So just hearing a story like that makes you wonder. 
 
I first heard of Jenny Tetlock from Lorraine, an East Bay mother who had met her parents—
both professors at a local university—through her spouse—also a professor. Jenny developed 
a rapidly degenerative motor neuron disease15 at age 13, shortly after receiving her third shot 
Gardasil in 2007. After battling the disease for nearly two years, Jenny passed away on 
March 15, 2009. I heard the story numerous times throughout my fieldwork, some parents 
giving specific details of the girl’s name or disease, while others only mentioning that they 
had heard of a local girl's death.  
 In searching for more information, I came across a blog page launched about a year 
                                                        
15 From the website, it seems that the parents were not given a specific diagnosis, but they believe it may have 
been a juvenile form of amyotrophic lateral sclerosis (ALS)—commonly known as Lou Gehrig’s disease. 
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after Jenny’s diagnosis by Jenny’s family16 designed to primarily aid the parents in their 
“search for comparables,” or young adults who have been diagnosed with similar 
neurological diseases, particularly those adolescents who experienced a positive impact from 
any treatments. Although across the blog postings, her parents and family members 
hypothesize that Gardasil may have contributed to their daughter’s disease, they are careful 
to communicate that this is not proven, but only one of many options. For instance, in 
response to a CBS Early Show segment on Gardasil that used their story (aired July 2008), 
the family published the following comment: 
This morning, the CBS Early Show ran a story about Gardasil, using Jenny as the 
example of a girl who may have experienced an “adverse reaction” to the vaccine. 
CBS contacted the family; we did not contact them. Family representatives 
emphasized to CBS’s producers Boxer and Bicknell that we do not want Jenny to 
become the poster child for the anti-Gardasil campaign and that it is by no means 
certain that Gardasil caused Jenny’s illness. Rather, our goal in making Jenny’s sad 
story public is to locate any possible “comparables” to Jenny, which could include 
girls (and even boys) who have not taken Gardasil, but who have experienced a rapid 
decline and paralysis that is resistant to the many kinds of treatment Jenny already 
has received.  
–Posted July 7, 2008 on jenjensfamily.blogspot.com 
 
Despite hesitation from the Tetlock family for Jenny to become the "poster child for the anti-
Gardasil campaign," the story had an impact locally and nationally. For other parents who 
had heard of Jenny Tetlock, the story of a local girl who they could have known with a name 
and a face, made a striking impact on how they constructed the potential for harm from HPV 
vaccination. Even among those parents who had not heard this case, concerns of vaccine 
safety—even if just uncertainty—emerged as a highly significant and influential factor 
underlying parental considerations and decisions regarding HPV vaccination. 
 The story of Jenny Tetlock and her parents’ desire to resist becoming a poster child 




for the anti-vaccination movement reflects what scholars have deemed as growing “vaccine 
anxieties” (Leach & Fairhead 2007) or “vaccine critical movement” (Kirkland 2012) across 
the United States and globally. Stemming in part from claims made by Andrew Wakefield, a 
British doctor who published falsified data that showed a link between the Measles, Mumps, 
Rubella (MMR) vaccine and autism, and efforts by celebrities such as Jenny McCarthy 
supporting his claims, there is a growing number of parents who are “opting out” of 
childhood vaccinations (See Appendix A). While scientific evidence has not supported this 
link, Kirkland (2012) argues vaccine critics are now targeting “the culture of mainstream 
professional medical care, dominant cultural notions of disease, and the scientific authority 
structures that undergird the honored place of vaccination in public health governance” (71) 
to state claims of legitimacy. None of the parents I spoke with in my study considered 
themselves to be anti-vaccinators, although some had adopted alternative schedules of 
vaccines, so I cannot speak directly to how anti-vaccinators construct and engage with HPV 
vaccination. However, parents did invoke tropes used by vaccine critics in their discussions 
of HPV vaccination, most notably in challenges to the safety and perceived need of HPV 
vaccination. 
 
V. VACCINE SAFETY  
 Beyond specific statements made by Bachmann and others, there has been much 
public discussion regarding evidence for the safety (and benefit) of HPV vaccination. As 
such, I hypothesized that this would be a significant factor shaping parents vaccination 
decisions. In the written questionnaire, parents were asked how much they agreed with the 
following statements: 1) The HPV vaccine is safe; and 2) There is not enough scientific 
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evidence that the HPV vaccine is safe. An independent samples t-test was conducted to 
compare item responses between parents who had vaccinated and not vaccinated at least one 
child aged 11 or above. There was a significant difference between the scores in 
unvaccinated (M=2.95, SD=.705) and vaccinated parents (M=2.13, SD=.458); t(40)= 4.527, 
p = 0.000, CI (95%) [.452, 1.182] based on reported belief regarding HPV vaccine safety 




There was also a significant difference between the scores in unvaccinated  (M=2.47, 
SD=.964) and vaccinated parents (M=3.65, SD=.832) conditions; t(40)= -4.253, p = 0.000, 
CI (95%) [-1.749, -.608] based on reported belief regarding evidence of vaccine safety (See 
Figure 5: Parental responses to “The HPV vaccine is safe” by vaccination status 
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Figure 6). Based on these results, parents who expressed a higher belief in the safety and 
evidence of safety of the HPV vaccine were significantly more likely to have vaccinated at 
least one child. In my conversations with parents, uncertainty regarding the safety (and thus 
potential risk) of vaccination surfaced as an influential factor in parents’ decision to delay or 
refuse vaccination. As Kendra, mother of an unvaccinated 13-year old daughter, explained: 
Kendra: So what’s my plan for [vaccination]? If don’t know. I guess I’m not against 
her getting it later. If it turns out that there’s a lot of good data that it’s safe. I think 
safety would be my main reason for not getting it—safety of the vaccine.  If it’s not 
looking very safe—cause even if it reduces the risk a little, I don’t need the risk 
reduction to be huge, I just need the safety to be huge. ‘Cause you know all the 
vaccines—she’s not going to die from the measles, the mumps, chickenpox, but I get 
her all those things cause why not stay healthy. And the vaccines to me seem safe so 
that’s sort of my equation.   
 
In a subsequent chapter, I will examine how notions of sexuality and parental knowledge 
shape assessments of safety and risk. In addition, parents’ relationship with and trust 
regarding doctors also mediated these considerations. 





VI. DOCTORS KNOW BEST…SOMETIMES 
 In our conversations, parents discussed a variety of sources—friends, family 
members, websites, and media sources—from which they drew upon to inform themselves 
regarding risks and benefits of HPV vaccination. Of these sources, doctors (not surprisingly) 
emerged as having a key role in vaccination decisions, particularly among those who 
expressed trust in doctors in general.17  In the questionnaire, I asked parents to complete five-
items, adapted from Hall and colleagues' Trust in Medical Professionals scale (2002), to 
assess parents' general trust in doctors. I also summed the five items (score 5-25, lower 
scores indicating higher trust), and examined the relations between the individual items, 
summed score, and vaccination status. Internal consistency for the overall scale was high 
(Cronbach's α=0.828). Table 2 includes the results of each item: 








I trust doctors' decisions about 
which medical treatments are best. 
2.89(.809) 2.48(.665) t(40)=1.831, p=.075 -.043, 
.876 
I trust doctors to tell me all the 
risks and benefits of medical 
treatments. 
3.32(.885) 2.48(.790) t(40)=3.238, p=.002 .315, 
1.360 
I trust doctors to put the needs of 
patients before what is most 
convenient or best for them. 
2.68(.820) 2.78(.795) t(40)=-.394, p=.696 -.604, 
.407 
I trust doctors to tell me if they 
are not certain about the risks and 
benefits of a certain medical 
treatment. 
2.79(.976) 2.52(.846) t(40)=.952, p=.347 -.300, 
.836 
All in all, I trust doctors 
completely. 
3.63(.955) 3.13(.757) t(40)=1.898, p=.065 -.033, 
1.035 
Sum Score of 5-items 15.61(3.63) 13.39(2.888) t(39)=2.272, p=.029 .244, 
4.196 
                                                        
17 In interviews, I asked parents about their relationship with their child's doctor and in general, most described 
having access to consistent, quality care for their child, often stating that their child had been with the same 
pediatrician since birth. A few parents did describe lower quality of care (rushed communication, inconsistency 
in doctors seen) for their children, but still reported having access and generally good care.   




Parents who had vaccinated at least one child reported significantly higher levels of trust than 
those who had not vaccinated. Additionally one item regarding trust in doctors to tell patients 
all the risks and benefits also was independently related to vaccination status, whereby 
parents who had vaccinated were more likely to agree with this statement than those who had 
not. Beyond quantitative data, the following quotes also highlight the powerful role trust in 
medical professionals (and their expertise) had on vaccination decisions: 
 
Debra: Maybe more people might have researched it. I just kind of – I did trust what 
the doctor was telling me and went with it.  So I want to say it’s more of an easy 
going kind of way of dealing with it as opposed to – maybe if my husband would have 




Krista: I guess that to a certain extent I assume that by the time my doctor tells me 




Jessica: I think that if the doctor recommends [vaccination for my son]…either he 
would bring it up, or if I were thinking about it, I might say, ‘Is that something we 
should do?’ and if he says yes, I probably will do it (Mother of 17-year old vaccinated 




Michelle: I was persuaded by the doctor [to vaccinate]. Yeah, and I had never been 
against the vaccine before even though when they were younger, the physician was 
saying that you can either do chickenpox or not. I think it’s chickenpox; I think it’s 
that one.  Then you can let the child develop naturally…I had chickenpox when I was 
in third grade myself and then you become immune you know later on.  So that time 
the doctor was not very insisting on getting it…When now it seems so, that the doctor 
said that you still have the choice not to do it but it’s the best for you. Things like that. 
So I think for the HPV, now that I think about it, it’s because she persuaded me to do 
that (Mother of vaccinated 12- and 15-year old daughter and 11-year old 
unvaccinated daughter).  
 
 Although these patterns are informative, trust in biomedicine and its expertise is a 
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complex concept shaped by understandings of how and why we become ill (explanatory 
models), epistemological understandings of how we know (knowledge production), and lived 
experiences beyond health and affliction that cannot be easily reduced to survey 
measurement (illness narratives). In an effort to show these complexities, I will compare the 
experiences and decisions of two parents—each of which made opposite decisions than one 
might guess based on identified patterns. This is not to argue that identifying patterns is not a 
useful endeavor, and from a practical standpoint, identifying patterns might be necessary to 
begin to translate findings into structural, individual and group level interventions to improve 
public health. Rather, this is to argue as many have for why "ethnography matters" (Fassin 
2012).  
 
VII. UNMAKING MODELS 
 At the onset of our interview, Marilyn, a full-time working mother of five daughters, 
aged 11 to 21 (four of whom had been vaccinated), immediately disclosed that, "I didn't 
really investigate the risks and benefits of the vaccine because we just generally vaccinate." 
‘We’ in this case includes herself and her husband, a family practice physician who works in 
community health clinics in the Bay Area. Like Marilyn, other parents had felt the need to 
give a confessional of sorts during the interview, whereby they apologized or divulged their 
lack of knowledge regarding HPV vaccination. However, in this case, I was not surprised 
that she had not done much research and just followed the recommendations of her child's 
doctor because in this case, the doctor was her husband. What did surprise me is that during 
our conversations she also explained that she herself was a bit surprised that she did not do 
more research due to her personal experience with the potential harm of vaccines. 
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Marilyn: That’s where I feel uninformed like maybe I should have looked more into it. 
You know like the whole MMR thing, I actually have a person in my family who had a 
bad outcome with MMR, my younger brother. But I just never heard maybe much 
about Gardasil having any downside, so I just didn’t bother to even investigate that 
when the time came up. 
Kate: Did your brother have a bad reaction to the MMR shot? 
Marilyn: Well, he developed encephalitis, where he almost died actually at age 10 
and he was in a coma for 3 months. And they don’t know for sure if it’s the MMR but 
that’s the theory…He was one of those cases that you hate to hear about. So it’s just 
had different repercussions in my family, like my older sister does not vaccinate, but 
myself and my younger sister, she’s also a physician, we never hesitated to vaccinate.  
So it’s kind of like my older sister’s thinking her kids could be that one in a million 
like my brother was and end up brain damaged. And I think the rest of us are 
thinking, well that’s so unlikely and the medical reasons are overwhelming in favor, 
so let’s just do it and just trust that. 
For Marilyn, despite living through "one of those cases" where vaccination results in serious 
harm, she did not hesitate to vaccinate based on a trust in both medicine and statistical 
probability that it would not happen to her and her family. In contrast, another parents 
expressed strong resistance to vaccination, despite seeing (and expressing gratitude for) the 
positive effects of biomedical intervention. 
I met Autumn on a rainy day at a coffee shop near the local university where she 
worked as a finance administrator. Full of energy despite the gloomy day, Autumn described 
the intensity and closeness of her relationship with her two daughters (aged 15 and 17), 
stemming in part from her experience as a single mother. 
Autumn: I can read my kids, I separated from their dad when they were pretty small, 
seven and four, and had them, have them eighty percent of the time. And I’ve had 
them eighty percent of the time for the last ten years, so to read them is pretty, is 
pretty easy. And the youngest is like an open book sometimes, and when my oldest 
gets a little too chatty and that’s when I know. 
 
This closeness also came from her experience caring for her younger daughter, who was 
diagnosed with childhood leukemia at age five. Nearly 10 years later, she described her 
daughter as a "survivor" and expressed gratitude for her child's pediatrician for identifying 
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the illness and helping to care for her daughter. However, despite this positive and long-
standing relationship with her child's doctor, Autumn "fired" her doctor due to her doctor’s 
insistence to have her daughter receive the HPV vaccine. As she explained:   
Autumn: I fired their first primary care physician. Because at my soon to be twelve-
year-old’s well check or at an appointment we were at, she says, ‘Well I guess when 
she comes into her well check, we’ll be setting her up for the HPV.’ And I said, ‘No 
we won’t.’ And she says, ‘Oh sure you will.’ I said, ‘No we won’t.’ And she got really 
in my face and I said, ‘You will hear me about this. I am not interested in my child 
who doesn’t even know what sex is to be inoculated for something that is not in her 
next three year window, I assure you.’ [The doctor] wanted nothing, absolutely 
nothing to do, she basically put her hand up to me and said, ‘Fine we’ll talk about it 
later.’ And I said, ‘No we won’t.’ And I turned around, called my oncologist, and 
said, ‘Who can you recommend? Who is your PCP for your kids because I’m ready to 
fire mine.’ And I told her why and she says, ‘Wow.’ I said ‘You know, you don’t tell a 
mom, whose other kid has been shot up with every chemotherapy drug known to man 
it feels like and every drug under the sun that you’re gonna just ‘Because I said so’ 
put poison into my kids body. No you’re not...I had been hearing about [the vaccine] 
and reading about it and I thought, ‘This is ridiculous.’ They’re using little girls as 
guinea pigs. It’s that simple. 
 
Despite a personal history and use of "every chemotherapy drug known to man", she 
considers the HPV vaccine to "poison" due to novelty and initial target audience of the 
vaccine. Her resistance to the vaccine overrode her trust of—and ultimately her relationship 
with—her child's doctor.  
 In the case of both of these mothers, based on my own identified patterns, it would be 
predicted that each would have chosen a different vaccination decision. Personal experience 
of seeing the harms of vaccination would lead one to predict that this individual would be 
resistant or at least critical of new vaccines. In contrast, expressed trust and gratitude with 
doctors and personal experience of seeing the positive impact of biomedical care would be 
predicted to lead to decisions to vaccinate. In each of these cases, however, other aspects of 
life overpowered these predictors, pointing to the way in which ethnography can complicate 
and enrich health behavior and risk models. In the final section, I will examine the ways in 
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which my time in the field also unmade my own theoretical approach and understanding of 
the project.  
 
VIII. LOCATING PEOPLE AMID THEORY 
In their relentless drive to theorize, anthropologists run the danger of caricaturing 
complex realities, neglecting key realms of experience, and missing lived ironies and 
singularities that might complicate and enrich analytics. People are missing, in 
multiple senses (Biehl and Locke 2010:319). 
 
 My original framing of my dissertation built upon theories and frameworks of how 
subjects are produced through various mechanisms and practices—informed in large part by 
the work of Foucault and those speaking to his work on biopolitics, governmentality, and 
subjectification. Underlying much of this work are concerns regarding how articulations of 
power come to make (and unmake) who we are and how we engage with the world. In the 
context of HPV vaccination, I do believe these practices are at play, particularly in the realm 
of moral politics and pharmaceutical marketing. However, what I have learned from speaking 
with parents is that decisions regarding HPV vaccination are not solely a result of powerful, 
biopolitical institutions, but rather are evaluated through their desire to care and parent in 
particular ways. 
  Drawing from the philosophical work of Deleuze on desire and Foucault on power 
(and their debates), Biehl and Locke (2010) argue for an "anthropology of becoming", which 
allows for an examination of how power and knowledge guide action and existence while 
simultaneously acknowledging the complexities of lived experience that emerge during 
fieldwork. To bring these complexities to light, I will use the cases of three mothers who 
have all made different decisions regarding HPV vaccination for very distinct reasons. 
Within each case, the desire to care guides and shapes each decision. However, exactly 
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how—and for whom—this desire is articulated and mobilized is quite different, and 
highlights the role of both lived experience and power of normative constructions of risk, 
sexuality, and social obligation. 
  
Latrice 
As her nine-year old son played on a nearby playground, Latrice, a 32-year old 
African American Oakland Native, detailed the struggles of her life as a single mother who 
has worked to become educated in order to escape the poverty and crime of West Oakland. 
As a first generation college student, earning her Master’s in Education, she is remarkably 
sensitive to the challenges of escaping poverty and the impact of institutional processes on 
daily life. She laughed as she explained, “[The paperwork] depletes a lot of my time. I only 
can work part-time because I find I spent a lot of my time at the housing authority—that’s 
like my home away from home.” She is dedicated to caring for her son—by promoting 
healthy living and education—but worries that the unsafe environment where they currently 
live is contributing to her son’s obesity, high cholesterol, and borderline diabetes. “When you 
live in a bad neighborhood,” she said, “if you don’t feel safe, you know walking around the 
neighborhood, you cannot get those physical activities.”  
Although she has many other concerns, she is adamant that her son receives the HPV 
vaccine when he is of age. This persistence stems largely from her experiences with the virus 
herself that resulted in increased medical surveillance and many invasive procedures. She 
believes she contracted HPV from her son’s father—another actor who heavily influences 
how she cares for her son, but not necessarily in expected ways. In asking about her 
vaccination decision for her son, she gave great detail of her desire for her son to be 
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vaccinated so he would not spread the virus to other women. When I asked what she hoped 
her son would be like when he was an adult, she said, “Number one: Not like his father.”   
For this mother, her desire to care and subjectivity as a parent has intersected with 
institutional processes more than most. Through these experiences, she has shaped a 
particular understanding of risk and responsibility guided by personal experience with HPV, 
and the material and social realities of her daily life. For her, the decision to vaccinate her 
son is embedded within a larger desire to care for the community of women at large by 
raising a healthy and educated son.  
 
Lorraine  
I met Lorraine on an early rainy morning in Berkeley after she had just dropped off 
her two daughters at school. Her daughters hoped the rain would clear in time for soccer 
practice, but she secretly hoped the rain would stay so they could all go home and avoid the 
muddy fields. Although an older mother by national standards—in her late fifties—she very 
much fits the stereotyped profile of a Berkeley mother—liberal, educated, and very informed. 
As she put it, “I listen to public radio—I am a Berkeley person, what can I say [laughter].”   
In the case of the HPV vaccine, these desires to be informed and search for information, 
however, were trumped by a specific personal experience.  
Early on in our conversation, Lorraine disclosed, “We have a personal connection to a 
story which has certainly added to my negative views of [the vaccine]…A girl who died in 
our community…I don’t know if—and I don’t know if they know, but they certainly believe 
it was from the vaccine.” The story is one I would hear again—of a girl (Jenny Tetlock) who 
died from an autoimmune disorder that is believed by some to have been triggered by the 
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vaccine. Lorraine explained that hearing the story made her question the safety of the vaccine 
not because she lacked comprehension of probability statistics, but rather because the 
closeness of the story amplified the potential for risk. “I know the numbers are very small. 
I’m sure that the cases that might be even attributed to it must be [minute] …so I’m not like 
‘wow this is horrible, everyone’s dying”. But I do think there could be cause for concern.”  
Her experiences have placed the risk of the vaccine at a greater weight than the current risk 
of her daughter catching the virus. However, for her there is something particular about the 
HPV vaccine, which makes these risk calculations more understandable. 
 Lorraine is not anti-vaccine. As she explained: 
I think there is a certain selfishness in deciding ‘oh I’m not gonna vaccinate my kid 
because there is enough protective immunity in the rest of the community—that I 
don’t have to’ but if everyone starts to do that, then obviously that’s gonna 
breakdown. I’m sure that there are harms caused by vaccines for some people, but 
probably the bigger picture is that overall it has improved our health. But I feel the 
HPV one is different in character.  
 
When I asked her why, she responded, “Well, because we are talking about a behavior that 
leads to some diseases. And the case of chicken pox or polio or whatever, you’re talking 
about exposure and it’s just you know, you cannot avoid the diseases by avoiding behaviors.” 
The behaviors she is referring to are sexual behaviors. While it could be argued all 
communicable diseases are in some ways linked to behaviors—riding the bus, living in 
certain areas, or traveling abroad—the act of sex remains for Lorraine, and for many other 
parents, something distinct that can be avoided—or taught to be avoided—in  order to protect 
their children from HPV. 
 For this mother, the visceral experience of knowing someone who potentially died 
from receiving the vaccine, amplified and altered her construction of the risk of the vaccine. 
Additionally, the way she understood HPV as distinctly different from other communicable 
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diseases—as something that could be prevented by avoiding certain behaviors—solidified 
her calculations. For her, the more pressing risk came from the vaccine rather than from the 
virus. Although she greatly desired to care for her children by making them healthy and 
protecting them from risk, she believed she could reduce the risk of HPV transmission by 
teaching them safe sexual behaviors; whereas, the risk of the vaccine seemed uncertain and 
out of her hands. 
 
Sarah  
I met Sarah, a divorced, single mother of two teenage children, at a small café while 
her daughter attended violin lessons in a nearby school. Immediately, I was struck by her 
ability to clearly define who she was a parent, particularly in contrast to the liberal 
community around her.  “[I’m] more authoritarian. I’m the boss.” Her strictness also shaped 
her views on vaccination—or rather on those who decide not to vaccinate. As she explained, 
“Parents who are not in favor of vaccines—for me, their reasons don’t seem very sound. I 
don’t feel like they have a legitimate grievance.”  
Responsibility also seemed to hold significant meaning for how she defined herself as 
both a parent and citizen. She views herself as primarily responsible for her children’s’ 
health. As she stated, “I have been entrusted with the responsibility of keeping them 
healthy.” This very much guided her decision to have her children vaccinated against HPV. 
However, when I asked her what the primary reason was, she answered: 
You’re gonna laugh. It’s not even to protect my kids from getting sick. It’s because I 
buy into the whole subject of herd immunity so strongly I want my kids to be 
vaccinated more for the good of society. I want to be part of the legion that protects 
people who cannot get [vaccinated]…I really strongly believe that. I know the 
chances of them getting [cervical cancer] aren’t very high. But I really think the more 




For Sarah, her personal desire to protect the collective drove her decision to have her children 
vaccinated. 
However, she felt some internal conflict between her views on vaccines and her 
general political views. As she explained, “I kind of lean libertarian or moderate so therefore 
I…am in favor of a smaller government. But on the other hand, there’s a few—like the topic 
of vaccines, I feel like vaccines should be mandatory for everyone that can get them. So in 
that area, I’m more in favor of a large government. So I realized that I have an internal 
conflict there.”  While Sarah very much desired to care for her children—and viewed it as 
her responsibility, the decision to vaccinate her children was driven more by the desire to 
care for the collective societal whole.  For Sarah, the decision to not vaccinate ones children 
is not only an act of poor parenting, but bad citizenship. 
 In conclusion, as indicated by the thoughtful considerations of each of these parents, a 
consistent reason underlying their decision to vaccinate or not to vaccinate their children 
against HPV is a strong desire to care. Beyond caring for their child, the desire to care is 
reflective of relationships between a variety of actors (individual and collective) as well as 
norms, values, and assumptions. This desire may in some ways be an inescapable result of 
the powerful material, legal and moral requirements of parenthood and biological citizenship 
in the United States. However, how this desire is articulated varies significantly, and is 
shaped by the particular ways each parent constitutes risk, responsibility, gender, and 
sexuality. Lived experiences such as Latrice’s experience with HPV and her son’s father or 
Lorraine’s proximity to a child’s death as well personal values—exemplified most clearly by 
Sarah’s devotion to being a good citizen—are at the foundation of these constructions. In 
these ways, the decision to vaccinate becomes much more than an evaluation of risks and 
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benefits, but rather is entangled with ethical considerations of how one should live—and 














CHAPTER THREE: EMPOWERMENT, AMBIVALENCE, AND PHARMACEUTICAL MARKETING 
 
Pharmaceuticalization functions as a three-way bridge among the 
universalizing assertions of biomedical science, the moral imperative to treat 
the world’s sick, and the subjective experience of illness. The pharmaceutical 
industry claims privileged access to each of these three domains.  
–Kalman Applbaum19 
 
Since the FDA regulatory change allowing for direct-to-consumer (DTC) 
advertisements, a disorder, like depression or erectile-dysfunction, is frequently marketed in 
conjunction with a new drug claiming to cure or alleviate its symptoms (Fishman 2004; 
Healy 2006; Potts et al., 2004). In the United States, human papillomavirus (HPV) and the 
vaccine followed a similar progression, emerging concurrently into the public sphere through 
direct-to-consumer (DTC) advertising backed by public awareness campaigns and an 
aggressive (albeit hidden) lobbying campaign by Merck to have the HPV vaccine added to 
the list of mandatory vaccines for 6th grade girls20. In this chapter, I will provide detailed 
analysis of initial marketing campaign employed by the pharmaceutical company, arguing 
that the initial campaign utilized a feminist empowerment model in an attempt to advert 
public backlash. Following, I will present an overview of more recent public health and 
pharmaceutical marketing approaches, as well as highlights from the larger political and 
                                                        
19 http://somatosphere.net/2009/02/pharmaceutical-marketing-and-capitalism_28.html 
20 Merck also worked with public health departments and patient advocacy groups to garnish support and 
increase public awareness of and for Gardasil (See Gottlieb (2013) for further discussion). 
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cultural debates regarding HPV vaccination. I will then situate these discussions in the 
thoughts and decisions of parents with whom I spoke, drawing from Emily Martin’s work on 
ambivalence and meaning in pharmaceutical practices, and arguments from Biehl and others 
regarding the “pharmaceuticalization of public health” to highlight how vaccination decisions 
are scripted with and come to reflect political and economic values and practices in the 
United States. Lastly, I will discuss novel ways social workers can assist in clinical efforts to 
understand and communicate how particular lived experiences of patients, including 
structural, social, and economic conditions, influence health outcomes and practices (beyond 
individual-level factors or “cultural variables”) amid recent shifts in the healthcare system 
(Metzl & Hansen 2014). 
 
I. PHARMACEUTICAL INTERESTS AND VACCINE DEVELOPMENT 
Since the widespread support of the polio vaccine in late 1950s, pharmaceutical 
companies’ interest in developing vaccines has greatly decreased, resulting in repeated 
vaccine shortages across several of the recommended childhood vaccines and the flu vaccine 
(Offit 2005; Cohen 2002). Several factors contribute to pharmaceuticals reluctance to 
develop vaccines. In comparison to other drugs—for example, cholesterol-lowering agents 
that need to be taken daily—vaccines are only used several times across one’s lifetime, 
resulting in a much smaller market, and much smaller potential for revenue (Offit 2005). 
Additionally, the 1994 enactment of Vaccines for Children, a federally funded program that 
provides free vaccines for all underserved children, has greatly reduced the private market for 
vaccines. In addition to smaller financial benefit, vaccines also carry additional risk, 
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regulatory burden, and potential product liability21. While many decry public health's 
reliance on the private market to produce what is framed as a public good, the practice 
remains, indicative of both the power of the pharmaceutical industry in the United States, and 
growing reliance on "magic bullet" solutions for both illness and prevention (Abraham 2010; 
Biehl 2007). 
However, beginning in the late 1990s, the vaccine industry entered into a renaissance 
of sorts. Between 1995 and 2008, the total number of vaccines in development more than 
doubled globally, and, although the number of pharmaceutical companies remained relatively 
the same, three of the four major manufacturers active in the U.S. market increased the 
proportion of their product portfolio dedicated to preventive vaccine development by three-
to-four fold (Davis et al. 2010). In the case of Merck, the company also began investing 
heavily into the production of preventive vaccines, including Gardasil, in the early 1990s. 
This investment seemed to pay off as Merck earned 1.5 billion in revenue from Gardasil in 
2007 (Herper 2012). Although in 2010 sales dipped to about $1 billion, sales again increased 
to $1.6 billion in 2012 following the expansion of licensure to include young boys. This is in 
comparison to their competitor, GlaxoSmithKline (and their bivalent vaccine, Cervarix), who 
"only" earned $408 million in 2012 sales (Silverman 2013). In addition to gaining U.S. FDA 
approval and licensure first, many credit Merck’s expansive marketing and lobbying 
campaign for their initial and continued success over their competitor. 
                                                        
21 Following numerous lawsuits against pharmaceutical companies claiming harm inflicted by the pertussis 
vaccine, the United States Congress passed the National Childhood Vaccine Injury Act (NCVIA) of 1986, 
which nearly eliminating liability of vaccine manufacturers for any potential harm resulting from vaccination 
(thus encouraging them to continue to manufacture vaccines), and created a no-fault, federally funded 
compensation program (National Vaccine Injury Compensation Program) for children who suffer a 
scientifically-proven reaction to a vaccine. This act also established regulations regarding the reporting of 
adverse events following vaccination, centralizing these reports in the Vaccine Adverse Event Reporting 
System—VAERS. In 2011, in the case of Bruesewitz v. Wyeth, the U.S. Supreme Court upheld the NVCIA, 
reaffirming that pharmaceutical companies cannot be held liable for adverse vaccine effects, unless they actions 




II. PROMISE OF EMPOWERMENT: INITIAL MARKETING OF THE HPV VACCINE 
Following the initial FDA approval of Gardasil in June 2006 for young girls and 
women, Merck employed a widespread marketing campaign, known as the "One Less” 
campaign (See Figure 7). The campaign was directed primarily at the initial target 
population, young women between 
the ages of 11-26 and their 
mothers22. Simultaneously, Merck 
also launched an aggressive lobbying 
campaign (funded through a third 
party advocacy group, Women in 
Government) to enact legislation that 
would require HPV vaccination for 
6th grade girls. On marketing alone, 
Merck reportedly spent $100 million 
to promote Gardasil in 2007 (Taylor 
2013), followed by $96 million in 
2008 (Silverman 2013). The One 
Less campaign, designed in part by 
two worldwide advertising agencies, 
DDB and RAPP, received critical acclaim, winning top honors for Best Branded TV, Best 
Branded Print and Best Integrated Campaign at the 2008 Pharmaceutical Advertising and 
                                                        
22 Merck simultaneously ran a Spanish version of the One Less campaign ("Una Menos"), which some believe 
helped to drive high rates of vaccination among Hispanic adolescents in the United States.  




Marketing Excellence (PhAME) awards (Arnold 2008). In addition to receiving critical 
acclaim, the marketing campaign seemed to pay off, boosting sales of the vaccine from $235 
million in 2006 to $1.5 billion in 2007.  
The architects behind the initial campaigns carefully designed the approach to 
encourage the target audience of young women (and their mothers) to identify with the 
projected message: “choose to be one less, choose to be vaccinated.”  In a seeming effort to 
avoid cultural backlash and promote consumption, public awareness and media campaigns 
were constructed to produce a social identity that reconciled the precarious link between the 
limits of acceptable public discussion of female sexuality and sexual health, and the need to 
connect with the collective intimacy of women and young girls in the United States 
(Appadurai, 1986; Shryock, 2004). In this section, I will examine the ways in which the 
initial marketing campaign of Gardasil employed cultural markers and discourses of female 
empowerment to attempt to engender acceptance among the target population and to 
(unsuccessfully) evade scrutiny and resistance among this public.   
The female empowerment model projected in HPV vaccine advertisements and public 
awareness campaigns drew from extant feminist rhetoric to frame vaccination as an 
empowered “choice” and for many young women and parents, vaccination may be.  
However, the “choice” to be vaccinated against HPV is an embodied practice, which reworks 
subjectivities and is situated within networks of power (Foucault 1979). Governing 
institutions and disparities in healthcare access, which are influenced by social and structural 
factors, regulate access to this practice, restricting (but not removing) the ability of 
individuals to freely “choose”.  Examination of marketing materials gives clear insight into 
how HPV is being formatted and visualized as a disease that is ubiquitous and curable, 
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especially in contrast to other (less 
visible) sexually transmitted 
diseases associated with the virus. 
This formatting excluded discussion 
of structural barriers to vaccination 
including the high cost of the 
vaccine and disparities in access to 
healthcare, and simultaneously 
created parents and young women 
as moral subjects of the vaccine 
(Mamo, Nelson & Clark 2010). 
Through this process, the vaccine 
became emblematic of a certain 
type of mother, daughter, woman, 
and biological citizen. The 
examination of HPV and the HPV 
vaccine as a formatted, constructed phenomenon does not discredit claims of medical 
potential or seek to exclude the possibility that the vaccine can possibly save thousands of 
lives.  Understanding the formatting of HPV does, however, illuminate how cultural 






Figure 8: Print images from Merck’s One Less campaign 
Source: Rosenthal 2008  
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One Less Campaign 
The One Less campaign employed a variety of print, electronic, and social media 
pathways to market its message (Figure 8), including a highly designed and interactive 
website, which more resembled a social networking site than other pharmaceutical websites. 
Beyond online tools, between 2007 and 2009, two commercials, modeled after the messaging 
campaign, aired frequently on national television stations across the United States as well as 
on the official Gardasil website and YouTube.  
The commercials matched the framing of the initial website and projected an image 
of vaccine as connected to modernity, beauty, and empowered femininity. The invisible side 
of HPV, presented as the “other HPV diseases” in the commercial and on the website, acted 
as a buffer to absorb the negative associations between the vaccine and stigma of sexually 
transmitted diseases (Brandt 1987).  Each commercial had a primary audience, one targeted 
mothers of young girls and the other targeted young women, and both stressed the 
empowerment of those who choose to be vaccinated against cervical cancer. 




 The commercial aimed at mothers begins with a white woman stating: I chose to get 
my daughter vaccinated because I want her to be one less woman affected by cervical 
cancer.  She and her daughter are sitting on a couch, with a skateboard, laughing (Figure 9).  
The daughter is presented as the classic teen rebel, dressed in baggy, skater clothes with a 
flawlessly disheveled haircut.  The mother closes the frame with a kiss on her daughter’s 
head.  This interaction illustrates that the commercial is selling the vaccine as socially 
desirable, and Merck is attempting to align HPV vaccination with modern idealizations of 
hipness and individuality. 
The next frame is of a Black mother who is putting braids in her daughter’s hair as 
she sits at the kitchen table (Figure 10).  She states: I chose to get my daughter vaccinated 
when her doctor told me the facts.  Like other vaccines, it’s about prevention.  The frame 
closes with her daughter looking up at her and saying, I like it, which the audience can 
assume refers to the braids, but also to the vaccine.   




 The next white mother and daughter team are situated in the kitchen (Figure 11).  The 
daughter is doing her homework, while the mother prepares dinner and reiterates that HPV 
vaccine protects against four types of HPV, saying: Two types that cause 70 percent of 
cervical cancer and two more types that cause other HPV diseases.  Another white teenager 
adds: I chose to get vaccinated after my doctor told me Gardasil does more than help prevent 
cervical cancer.  Her mother, with whom she is playing checkers, confirms: It helps prevent 
other HPV diseases too.  The actors allude to the “other HPV diseases,” but the commercial 
is carefully formatted to exclude the verbal use of “genital warts”.  The commercial 
continues with the disclaimer describing potential side effects and limits of the vaccine and 
ends with quick frames of each group of women and girls, spelling out: O-N-E L-E-S-S, One 
Less, Gardasil, Gardasil, Gardasil.  You have the power to choose.  This is audible over the 
last frame, which reiterates the slogan, “choose to be vaccinated”.   




The second commercial is aimed at the other initial target population: young women 
aged 18-26.  There are similarities between the two commercials; however, the second 
commercial portrays the empowered young woman, rather than the empowered mother.  The 
commercial begins with the statement: I chose to get vaccinated because I will do everything 
I can to help protect myself from cervical cancer.  A young woman in her early twenties says 











vaccinated when my doctor told me HPV can affect women my age and how Gardasil can 
help protect me.  This character sits in a fashionably decorated room, with a bicycle and 
helmet visible in the background.  These cultural cues provide the audience with information 
about the identity of the character, a modern woman (of all races) who is active, creative, and 
vaccinated against HPV.  The commercial ends with the first actor restating: I chose to get 
vaccinated because my dreams don’t include cervical cancer.  Gardasil, Gardasil, Gardasil.  
You have the power to choose (Figure 13).  





Throughout the commercials, the theme and rhetoric of choice is reiterated.  This 
tactic is reminiscent of the strategies employed by reproductive rights activists who, 
beginning in the 1980s, reformatted abortion rights as the right to choose (Gordon, 2002)23. 
Choice is connected to a larger individualistic and mainstream feminist ideology in the 
United States, and as such, carries considerable cultural authority and familiarity.  Each 
character depicted in this commercial is linked to a certain cultural identity that projects 
modern idealized traits including health, beauty, individuality, creativity, independence and 
empowerment.  Gardasil is formatted as a feminist, modern vaccine that transcends race.  
                                                        
23 Second-wave feminism in the United States has been highly criticized for ignoring how other factors—such 
as race, class, and sexual identity—intersect with gender to impact the experience and discrimination of women 
(Collins 1999; hooks 1981; Roth 2004). In the context of these commericals, I believe Merck attempted to 
transcend race by carefully depicting women of all diverse ethnicity to expand its market. However, the 
message largely ignores historical structural and social barriers or experiential dissonances invoked by choice 
rhetoric. 




The message is clear: Take this vaccine if you are a young woman who chooses to fight back 
against the repression of disease.  
As anthropologists working in media studies have pointed out, the producers of media 
and mass culture should not be viewed simply as projectors of hegemonic images and 
messages, but as creative individuals that are both encompassed by and contributing to the 
development of formatted ideas (Dávila, 2001; Ginsburg, Abu-Lughod, & Larkin, 2002).  
The “Behind-the-Scenes” video clip on the initial Gardasil website gives some insight into 
the formatting work that is being done with the HPV vaccine.  This episode gives the viewer 
an “insider” look into the making of the commercials, which is supposed to give the audience 
the feel of spontaneity and lack of formatting.  However, it is clear that as much formatting is 
put into the “Behind-the-Scenes” episode as is put into the commercials.   
One interaction is particularly illuminating in which the two actors, a mother and 
daughter, reflect on their roles and the perception that they are representatives of the vaccine 
(depicted in Figure 10).  The audience learns that the Black actors (who are shown braiding 
hair in the commercial) are named Ashley (mother) and Kammie (daughter).   
Mother: It’s something that is going to help people.  You know, it is good to be 
a part of it. 
 
Daughter: And it is like you are representing it.  So, if you know that it is that 
important, and then you see it, and it’s like, wow, I am representing something 
that is that important.  It makes you feel good inside. 
 
The actor, Kammie, is cognizant of the fact that she, by being part of the marketing 
campaign, will be viewed as representing the type of young girls who choose to be 
vaccinated.  She is visibly proud of this fact, as is the mother, Ashley, as they both interpret 
their actions as helping other women.  It is unclear if this aspect of the “Behind-the-Scenes” 
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episode is scripted, but it indicates how the media creates a formatted image for public 
consumption. 
Pharmaceutical companies, through advertising, construct an image, which is 
connected to larger cultural ideologies and backdrops. The formatting, beginning with the 
clinical trials and the direct-to-consumer “public awareness” campaigns, proffers HPV and 
its vaccine as a trimmed product available for consumption, accompanied by a productive 
and transformative quality.  The representation of a disease and its cure has drastic 
implications for the cultural acceptance or rejection of not only the disease, but of those 
persons inflicted with it.  An historic example of this is the ongoing battle fought by 
HIV/AIDS activists against the stigma first associated with the disease (Epstein 1996). In 
contrast, although it is also preventing against a sexually transmitted disease, the HPV 
vaccine is being framed (or attempted to be framed) by the pharmaceutical industry with 
desirable traits such as modernity, independence, and beauty.  
The formatting of HPV and its associated vaccine offers the illusion of access to a 
safe, healthy, empowered sense of being that is connected to modern views of control over 
the “natural world” through technological advances and employs discourses of womanhood 
and sexuality to connect to its audience.  The empowered female is resisting viral power 
through vaccination. This view plays off normative views of gender, sexuality, and 
womanhood that maintain boundaries of legitimacy and normalcy.  Individuals who do not 
conform to these cultural norms will be excluded from the benefits of vaccination; moreover, 
relying on gendered notions of empowerment including beauty and charisma inevitably 
perpetuates hierarchies that serve to exclude individuals who do not fit gender roles.  The 
rhetoric of choice ignores structural and cultural boundaries that inhibit (or mandate) certain 
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individuals from being vaccinated, and reifies the notion of the informed health consumer. 
However, despite the initial marketing and formatting by Merck, the HPV vaccine has been 
plagued by cultural critique and debate, tied in part to cultural anxieties regarding female 
sexuality, pharmaceutical and government distrust, and uncertainty regarding the safety of 
the vaccine. 
 
III. PUBLIC DEBATES, CONTROVERSIES AND RESISTANCE TO HPV VACCINATION  
Since its licensure, the HPV vaccine has been shrouded in public debate, controversy, 
and political attention. These debates are part of a seemingly growing public distrust of the 
need for and risk of vaccines in the United States, stemming in part from (scientifically) 
unfounded claims of the causal link between autism and MMR vaccination (Kaufman 2010) 
as well as lack of lived experience with diseases such as measles and polio that vaccines have 
nearly eradicated from the U.S. population24. However, debates have followed vaccines since 
their inception (Figure 14), beginning with the small pox vaccine and continuing through to 
the HPV vaccine (Colgrove, 2006).  
                                                        
24 A number of outbreaks of vaccine-preventable diseases including whopping cough (pertussis) and measles 
have occurred in the last ten years in the United States that many believe are fueled by vaccine fears and 
increased numbers of parents “opting out” of childhood vaccination. In California, the whooping cough 
outbreak resulted in 2011 legislation (AB 354) mandating that all 7th graders receive the pertussis vaccine 
booster (Tdap). Worldwide outbreaks of polio and measles (mostly due to lack of access to vaccines not opt out 
policies) have resulted in global initiatives, most notably the Global Alliance for Vaccines and Immunizations 
(GAVI), to provide vaccines to impoverished nations at lower costs. In 2013, Merck recently agreed to provide 











concerns of the 
time. In the case 
of the HPV 
vaccine, these debates have taken various forms including concern over parental rights, 
religious convictions, sexuality of young women, and governmental distrust. What may be 
novel to the current public controversies is the speed at which news stories and subsequent 
controversies can spread across the nation (and world) through the range of devices 
ubiquitous in the digital age. In this section, I will review highlights of media coverage (and 
corresponding controversies) that have followed the HPV vaccine since its licensure. 
 
Initial Reactions: Parental Rights, Sexual Promiscuity, and Legislative Mandates 
As discussed previously, Governor Rick Perry of Texas caught much media spotlight 
early on due to his decision to circumvent normal legislative pathways, and pass an executive 
order to mandate HPV vaccination for young girls in the state of Texas (Perry 2007). This act 
received much media attention in political and popular media sources. A story published in 
People magazine in April 2007 highlights some of the central public reactions to the 
Figure 14: Anti-vaccination poster from 1890s. 




proposed Texas law and the vaccine in general.  Jan Gustafson, a mother of three shows 
hesitation to vaccinate due to the novelty and unknown long-term efficacy of the HPV 
vaccine.  “We just don’t want to rush into anything…since it’s a new vaccine, we want to 
give it time and not let our daughter be a guinea pig.  After all, she is just 12, and we are 
confident she is not having sex” (Lang 2007:89).  Another mother, Cheryl Swope Lieck, a 
cervical cancer survivor, plans to vaccinate her daughter, as she feels it is her responsibility 
as a parent to protect her children.  “Am I teaching my kids abstinence? Absolutely.  Do I 
think abstinence is the main way to prevent HPV?  Absolutely.  But what are you going to 
say to women who get HPV from their husbands, even when those women were virgins when 
they married?” (Lang 2007:90).  Both of these mothers expressed concern over how HPV 
vaccination would influence her daughter’s sexual behavior.   
The concern of some parents is that the HPV vaccine will encourage young females 
to have sex, as it will take away one of the potential “consequences” of engaging in sexual 
behavior.  Ellen Rossini, a mother of two daughters, exemplifies this view.  “Our daughters 
are being raised in the moral tradition of chastity…Julia [her daughter] has a purity of heart 
and confidence that practicing moral traditions will lead to true happiness—chastity, 
followed by monogamous marriage.  It’s not a dream.  Her dad and I have lived it” (Lang 
2007:90).  Each of these viewpoints highlights initial moral arguments over the use of the 
HPV vaccine.  Running through each of these viewpoints are cues into how individual bodies 
(namely, those of adolescent females) became the subjects of not only physical vaccination, 
but subjects upon which moral and cultural arguments over the rights of parents, sexuality, 
and public health are scripted. 
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The following cartoon25, written by Mike Adams, the “Health Ranger,” highlights 
some of these concerns (Figure 15):  
 
The message here argues that the HPV vaccine, rather than empowering young women and 
girls as indicated by Merck, exploits their bodies for the goals of private corporations and 
politicians.  Also represented in this comic is the view that the vaccine is a “sex vaccine” 
rather than a cancer vaccine as framed by public health and pharmaceutical marketing.   
                                                        
25 This comic was published on the Natural News website, a website which advocates for healthy, homeopathic 
alternatives to pharmaceutical drugs.  
 




Social or religious conservatives echoed concerns of the sexual implications of HPV 
vaccination, often 
using religious 
belief to frame HPV 
(as in the case of 
other STIs) as 
indication of the 
need to remain 
abstinent until 
marriage. In these 
ways, vaccination, 
as this comic 
indicates, becomes a 
sign of promiscuity (Figure 16). For example, Focus on the Family, the Colorado-based 
Christian group that promotes socially conservative public policy, released a position 
statement on HPV vaccination in which it urged abstinence: 
The seriousness of HPV and other STIs underscores the significance of God’s design 
for sexuality to human wellbeing. Thus, Focus on the Family affirms – above any 
available health intervention – abstinence until marriage and faithfulness after 
marriage as the best and primary practice in preventing HPV and other STIs. 
—Focus on the Family26  
 
The Family Research Council, another Christian-based, social conservative and lobbying 
organization, also promoted the message that abstinence is the best way to protect against 
HPV, even using the CDC to support their claims: 
                                                        
26 Focus on the Family Position Statement: HPV Vaccine 
(http://media.focusonthefamily.com/topicinfo/position_statement-human_papillomavirus_vaccine.pdf ), 
accessed December 10, 2013.  
Figure 16: Wasserman editorial cartoon 
Source: Wasserman 2007 
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According to the CDC, limiting sexual activity to the context of a “monogamous 
relationship” with an uninfected individual is the surest way of preventing future 
HPV infection. Therefore, practicing sexual abstinence until marriage and fidelity 
within marriage are the best ways to avoid genital HPV infection. However, in some 
cases HPV infection may result from involuntary sexual activity, such as abuse or 
assault, and/or if a woman marries someone who is carrying HPV. Therefore it is 
possible that even someone practicing abstinence and fidelity could benefit from 
vaccines designed to prevent HPV infection 
—Family Research Council27 
 
Despite urging abstinence, surprisingly, both Focus on the Family and Family Research 
Council did not oppose widespread availability of the vaccine, arguing that even a (virtuous) 
girl who was abstinent may be exposed to HPV if she "marries someone who is carrying 
HPV." Both organizations did, however, strongly oppose mandatory vaccination due to 
concerns over its infringement on parental rights.  
We feel that a mandate infringes on the right of parents to make decisions regarding 
their children’s medical care. Since genital HPV is not spread by casual contact, 
there is insufficient public health justification to require vaccination for school 
attendance. A mandate may also lead parents to believe that the vaccine is the only 
available way to reduce the risk of cervical cancer and HPV infection, which is 
untrue 
—Family Research Council24 
 
Although these sources position HPV vaccination in an opposite manner than the 
pharmaceutical company, they invoke similar cultural norms regarding appropriate sexual 
behavior and gender roles to encourage abstinence, as well as values regarding parental and 




                                                        
27Gaul, Moira (2007) Gardasil: What every parent should know about the HPV vaccine. Washington, DC: 
Family Research Council (http://www.frc.org/content/gardasil-what-every-parent-should-know-about-the-hpv-




Impact of Public Response 
Due to growing pressure from advocacy groups and negative public reaction, Merck 
announced in February 2007 that it would be suspending lobbying for the school-mandated 
vaccination. Dr. Richard Haupt, executive director for medical affairs in Merck’s vaccine, 
stated: “Our goal is to prevent cervical cancer. Our goal is to reach as many females as 
possible. Right now, school requirements and Merck’s involvement in that are being viewed 
as a distraction to that goal” (Quoted in Pollack & Saul 2007). The executive secretary of the 
Advisory Committee on Immunization Practices (ACIP), Dr. Larry K. Pickering, applauded 
Merck’s decision noting that lobbying “has been somewhat counterproductive. Anything that 
takes away from the process of getting vaccine into people is deleterious to the whole 
process” (Quoted in Pollack & Saul 2007). Merck’s decision to end lobbying, in addition to 
the growing public and scientific resistance to mandatory vaccination, effectively halted all 
public discussions of legally requiring young girls to be vaccinated.  
In 2006-2007, 24 states (California) introduced legislation that would require young 
girls (usually 11-12 year olds) to be vaccinated against HPV unless parents opted out (which 
depending on the state could be on religious, philosophical, or medical grounds). Of these 
states, only two28, Virginia and District of Columbia, have enacted legislation that requires 
HPV vaccination—Virginia in October 2008 and District of Columbia in 200929. More 
recently, the issue has been introduced again into some state legislatures (for example New 
York in 2013), stemming potentially from growing scientific evidence that the vaccine is safe 
(Chao et al. 2012; Gee et al. 2011; Klein et al. 2012), and early evidence that it is effective in 
                                                        
28 Texas also temporarily required HPV vaccination following an executive order by Governor Rick Perry in 





preventing precursors to cervical cancer (Gertig et al. 2013) and the spread of the virus 
(Markowitz et al. 2013). However, discussions over mandating vaccinating have not 
resurfaced publically as markedly as they did following initial licensure. 
 
Adding Boys: Shifts in Marketing Content and Volume 
Since the initial marketing campaign, much has changed in both the money spent on 
advertising and the approach by Merck (including elimination of their television campaign in 
2009) in large part due to the shifts in the licensures and reaction of the vaccine itself. In 
contrast to the nearly $100 million spent by Merck in 2008 on advertising, Merck only spent 
$44 million in 2012. Additionally, following the 2011 expanded recommendation by the 
ACIP to also routinely vaccinate young boys, Merck dramatically shifted its marketing 
campaign towards a more gender-neutral approach. As shown in the image, below, taken 
from the most recent version of the official Gardasil website (accessed January 2014), Merck 
has removed its choice-laden language, and replaced with an approach that utilizes a 
symbol—which combines both the male, Mars symbol and the female, Venus symbol—that 




has been historically used to indicate gender equality or transgender identity (Figure 17). 
Furthermore, the website (Figure 18) has been transformed from the interactive, 
playful website of 2007 to a much more text laden—or scientific—website that is more 
reminiscent of a pharmaceutical pamphlet than a social media site (as the initial website 
was). While marketing has substantially been reduced and reformatted arguably to invoke 
gender neutrality, the debates over sexuality, safety, and political influence have continued. 
 
IV. CONTINUED CONTROVERSIES: PERRY, BACHMANN, AND DR. MERCOLA  
 Nearly eight years after the initial FDA licensure, controversies30  around the HPV 
vaccine remain, exemplified by a series of media events surrounding the 2011 Republican 
                                                        
30 Although not discussed in detailed due to its recent development, on December 4, 2013, Katie Couric (on her 
daytime talk show, Katie) aired a segment titled "The HPV Vaccine Controversy" that has been highly criticized 
for unfairly exaggerating the potential risks of the vaccine. In the episode, she interviewed a mother who 
claimed her daughter's death was caused by the HPV vaccine. Following the high criticism by public health 
officials calling it "alarmist", on December 10, Couric issued apology for spending a disproportionate amount of 
time on claims of adverse effects, stating, "We simply spent too much time on the serious adverse events that 
have been reported in very rare cases following the vaccine. More emphasis should have been given to the 




Presidential debates. In February 2011, at a CNN debate moderated by Wolf Blitzer, an 
exchange occurred between Republican Governor Rick Perry of Texas, and Congresswoman 
and staunch Tea Party supporter, Michele Bachmann that had lasting impact not only the 
final selection of a Republican Presidential Nominee, but HPV vaccination in general. The 
exchange31 began with Blitzer asking Governor Perry if signing the executive order requiring 
"little girls" to get a vaccine was a "mistake." Perry answered: 
Perry: It was. And indeed, if I had it to do over again, I would have done it differently. 
I would have gone to the legislature, worked with them. But what was driving me was, 
obviously, making a difference about young people's lives. Cervical cancer is a 
horrible way to die. And I happen to think that what we were trying to do was to 
clearly send a message that we're going to give moms and dads the opportunity to 
make that decision with parental opt-out. Parental rights are very important in state 
of Texas. We do it on a long list of vaccines that are made, but on that particular 
issue, I will tell you that I made a mistake by not going to the legislature first.  
 
Blitzer then asked Bachmann if she had anything to say—as a mother herself. 
 
Bachmann: I'm a mom. And I'm a mom of three children. And to have innocent little 
12-year-old girls be forced to have a government injection through an executive 
order is just flat out wrong. That should never be done. It's a violation of a liberty 
interest. That's—little girls who have a negative reaction to this potentially dangerous 
drug don't get a mulligan. They don't get a do-over. The parents don't get a do-over.  
 
In response, Blitzer asked Perry to react to suggestions by his critics that his order mandated  
or "forced" vaccination. Perry responded that it had not, as "it had an opt- out. And at the end 
of the day, this was about trying to stop a cancer and giving the parental option to opt out of 
that.”  Perry and Bachmann both used parental and individual rights as a way to distinguish 
themselves from President Obama and healthcare reform, which was framed as an 
infringement on individual rights.  
                                                                                                                                                                            
safety and efficacy of the HPV vaccines." (http://www.huffingtonpost.com/katie-couric/vaccine-hpv-furthering-
conversation_b_4418568.html). This event happened after my time in the field; however, it indicates the 
continued controversies regarding HPV vaccination in the United States.   
31 See Appendix E for transcript of the full exchange. 
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The conversation continued with Bachmann reminding everyone that "in the midst of 
this executive order, there is a big drug company that made millions of dollars because of this 
mandate" and strongly suggested that Perry signed the order not to save lives, but to gain 
political capital through campaign donations: 
Bachmann: The drug company gave thousands of dollars in political donations to the 
governor, and this is just flat-out wrong. The question is, is it about life, or was it 
about millions of dollars and potentially billions for a drug company?  
 
The conversation moved onto another topic after Perry responded that he only received 
$5,000 from Merck and it is "offensive" that this amount of money could sway his actions.  
 Within this exchange, Congresswoman Bachmann invoked her creditability—as a 
female and a mother—to discredit Governor Perry’s decision to pass the executive order 
regarding HPV vaccination, positioned as a “potentially dangerous drug” that infringes upon 
parents’ liberties. Bachmann also insinuated (strongly) that Perry made this decision due to 
political contributions made by Merck to his campaign and his close connection to the chief 
lobbyist. Perry attempted to circumvent her argument, agreeing that this was a mistake, but a 









Despite his attempts, many media analysts claimed this debate as a victory for 
Bachmann, greatly damaging Perry’s ultimately failed attempt to become the 2012 
Republican Presidential nominee (Figure 19). However, the debate did not ultimately prove 
to be a success for Bachmann either, stemming in part from the statements she made in the 
days following the debate.  
During an interview with Fox News the day after the debate, Bachmann continued to 
criticize Perry for his involvement with Merck. However, she made a crucial political error 
when she made claims that the HPV vaccine is not only unnecessary, but also causes serious 
mental harm. Bachmann stated, “There’s a woman who came up crying to me tonight after 
the debate. She said her daughter was given that vaccine. She told me that her 
Figure 19: Branch editorial cartoon 
Source: Branch 2011 
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daughter suffered mental retardation as a result. There are very dangerous consequences” 
(Stein 2011). She reiterated these comments on the Today show as well. 
Although Bachmann’s comments of the “very dangerous consequences” of the 
vaccine prompted immediate dismissal by medical groups (Burton 2011), her statements did 
resonate with public discussions of the uncertain risks and benefits of HPV vaccination. Most 
of these debates have occurred in the expert realm of scientific conferences and journals 
(Huang 2009; Tomlijenovic & Shaw 2011); however, Dr. Diane M. Harper, who conducted 
early clinical trials for the HPV vaccine, has been outspoken in her opinion that the 
promotion of HPV vaccination has glossed over many of its potential risks. “Gardasil is 
associated with serious adverse events, including death. If Gardasil is given to 11 year olds, 
and the vaccine does not last at least fifteen years, then there is no benefit—and only risk—
for the young girl” (Harper quoted in Yerman 2009) More than mere words, these claims of 
risk and danger are thought to be having a direct effect on the uptake the HPV vaccine as 
public health officials argue “misinformation” and “myth” are the central reasons behind 
lagging numbers of vaccination rates in the United States (Tucker 2011). 
 
Dr. Mercola and Growing Public Distrust of Vaccines 
In addition to claims in the medical community, continued attacks by alternative 
medicine “experts” or critics of biomedicine—most notably Dr. Joseph Mercola—have 
spread concerns over the potential risks of HPV vaccination. Between 2006-2013, on his 
website, Mercola ran 38 different articles that centered on the potential physical harms and 
lack of social benefit of HPV vaccination32. Three recurrent themes are used by Mercola to 
                                                        
32 In the Appendix F, I have included a list of the titles of the 38 articles to document the range of framing used 
by the website. 
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discredit scientific claims and promote a negative view of HPV vaccination: 1) 
pharmaceutical companies are profiting from and promoting the vaccine; 2) there is scientific 
evidence (or uncertainty) of the risks and lack of benefit from HPV vaccination; and 3) HPV 
vaccination is an attack on parental and individual rights in the United States. For example, 
in the following article, Mercola (and his team) frame the vaccine as harmful due to its 
association with the pharmaceutical company, Merck, due to its past handling of the now-
recalled arthritic drug, Vioxx, in early 2000s, and then substantiates claims by using 
scientific knowledge strategically to show evidence of the lack of necessity of HPV 
vaccination: 
 
Merck, maker of the notorious Vioxx, now wants to make their needless human 
papillomavirus (HPV) vaccine Gardasil a requirement for young women. Although 
Merck openly admits its lobbying ties with Women in Government, the mega-
drugmaker won't say how much money they're funneling through the non-profit. But 
here's a possible measuring stick: With Merck doubling its spending on lobbying, just 
in Texas, to some $250,000, multiply that by 18 and you get almost $5 million. 
Spending $5 million (or some $12.5 million if you're considering the whole country) 
is mere chump change compared to the $1 BILLION Merck could earn annually from 
Gardasil, says one drug industry analyst. A New England Journal of Medicine study 
found the use of condoms reduces the incidence of HPV by 70 percent. And just a 
reminder, more than 6 million women contract HPV annually, but a woman's immune 
system is often strong enough to clear up this infection on its own; it's virtually 100 
percent avoidable without a vaccine33  
 
While this presentation is factually true (although claims of the money spent on lobbying are 
not documented), it utilizes extant cultural tropes regarding growing distrust of the power of 
pharmaceutical companies with a well-known scientific journal to invoke both fears of 
parents and trust in scientific knowledge to substantiate its claims. These discussions 
highlight the tensions between pharmaceutical use, governmental distrust, and media 
                                                        




influence in the United States, and the uncertainty parents’ face in making decisions 
regarding HPV vaccination.   
 
V. IMPACT OF MEDIA ON HPV VACCINATION DECISIONS 
 The influence of media, including pharmaceutical marketing, on health behavior 
changes is increasingly becoming a focal point within public health and allied health fields; 
however, it is difficult to measure its specific impact due to challenges in tracking individual 
media exposure as well as the potential role of mediating factors (such as access) in 
information-seeking behaviors or practices. As described earlier, political debates regarding 
mandatory HPV vaccination or perception that HPV vaccination would lead to sexual 
promiscuity did not seem to greatly impact parents’ decisions whether or not to vaccinate 
their son or daughter. Most parents disregarded these debates (and often their supporters) as 
not credible or even rational. However, media exposure did seem to play some part in 
parents’ vaccination decisions.  
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In the questionnaire, I asked parents to reflect upon the general tone, positive, neutral or 
negative, of media coverage that they heard regarding HPV vaccination (Figure 20). A chi-
square test of independence was conducted to compare framing of media exposure in parents 
who had vaccinated and not vaccinated at least one child aged 11 or above, and not 
surprisingly, I found a significant relation between responses and vaccination status, X2 (2, 
n=41) = 6.595, p=.03734, whereby parents who remembered hearing more positive media 
were more likely to have vaccinated at least one of their children. During interviews, parents 
elaborated upon the influence of media, explaining that hearing negative or positive stories 
regarding the risks and benefits of HPV vaccination did have some impact on their 
decisions—however, the level of impact often depended on from what source they heard the 
                                                        
34 Due to the small sample size, not all chi square assumptions were met, and therefore, these results should not 
be viewed as conclusive without further data and analysis. 
Figure 20: Parental responses to “In general, have you heard positive, negative, or 
neutral sotries about the HPV vaccine in the media?” by vaccination status 
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information. As Charlotte who vaccinated her 12-year old son as soon as he turned 11 
described: 
Charlotte: There’s always the crazies who weigh in, in the letters to the editor, 
afterwards.  No, in my reading of it, [the media] portrayed it as a necessary and 
positive development—improvement.  I’m in the camp that vaccines are good though. 
 
While aware of negative media or marketing, these claims did not seem to make much 
impact on her decision due to evaluations of the sources ("crazies), and her general support 
of vaccinations. For others, the more recent discussions, and expansion of vaccination to 
boys as well as girls, made a positive impact on their perception of the vaccine. As Sadie, a 
mother of an unvaccinated 19-year old son and vaccinated 17-year old daughter, explained:  
Sadie: I thought it was great that they started promoting it for boys and girls, and I 
thought that was great, to make it as visual as possible and present to people’s daily 
life, to disseminate the importance of the vaccination.  
 
Cristina reiterated these sentiments when I asked her if she had seen any public health or 
pharmaceutical marketing: 
Cristina: Yeah, I certainly—both probably at the time that I was looking and at other 
times I know that I’ve seen it on billboards, I’ve see it in magazines, although 
probably not print piece magazines. It was probably something I was looking at 
online, but the magazines still had the same ads on their pages.  The ones that really 
stuck out for me, cause I just hadn’t thought about it, was when they started having 
more media about having boys vaccinated for it.  I remember thinking, oh yeah, that’s 
a kick ass idea.  That totally makes sense (Mother of 13-year old vaccinated 
daughter). 
 
For others, hearing about those who had resisted the vaccine or general controversies 
regarding the safety of the vaccine served to further solidify their decisions. As Krista 
explicated: 
Krista: If anything, [hearing about public debates] made me more happy that I made 
the decision.  I mean I’m hearing a lot more…about people who refuse to vaccinate 





Beyond feeling happy about their decisions, Sarah explained that media coverage of vaccine 
safety or controversies actually drove her to want to vaccinate her son and daughter more.  
Kate: Did any of the media coverage or marketing impact your vaccination decision 
in any way? 
 
Sarah: You know in a reverse way because so much of the media around here is, not 
necessarily anti-vaccine, but they always give that, that view time in the articles, 
equal time. When you read an article about vaccines, they give equal time to both 
sides and I don’t really think it should be equal time to both sides. So sometimes I get 
so annoyed by reporting or media that, in disgust, it’ll make me feel more strongly 
about being vaccinated, if that makes sense. It’s a pet peeve of mine (Mother of 
vaccinated 14-year old son and 17-year old daughter). 
 
David, a father of an eight-year old unvaccinated son, also reflected upon the general 
presentation of vaccines in the local media, identifying how the "mass hysteria"—even if a 
parent does not completely agree—can begin to influence one's thinking. 
David: The more I hear about it, it does put a little more of an inkling in my head. Is 
there some sort of truth to it?  But then it always seems like its ‘mass hysteria’.  It’s 
one person saying it. And then another person saying ‘Yeah, I sort of got that too.’ 
And then a third person—my wife actually put it this way. She said, ‘This is how riots 
start. It’s one person in a crowd going down with this, and then one person throws a 
rock through a window and then the next thing you know, cars are flipped over and 
trash cans are on fire and then you have a full riot.’  She says, ‘It only takes one 
instigator in a crowd to just go—DO IT’! And then a rock gets thrown and that’s all it 
takes, just that one little rock through a window. The next thing you know a whole city 
block is on fire. I think it’s like that. It’s one person says, ‘Hey, my son got sick’, and 
then she turns around and then another guy says, ‘Yeah I think my son got sick to.’ 
And then this mass hysteria builds up.  I think that’s how it happens and it is like a 
virus where people start building on that. 
 
For Mona, rather than mere hysteria, these stories—and the initial marketing of the 
vaccine—greatly shaped her perspectives of the vaccine:  
Mona: If I’m remembering the commercial right, it talked about four of the possible 
strains for HPV, Gardasil only had four. And I remembered listening to that and 
remember thinking that was a very small number to go against the vaccine. So it’s 
like why four? That seemed small.  So that was weird, and I think around that same 
time, maybe within a year of then, I started seeing articles of people who were having 
adverse reactions.  So right off the bat the very first knowledge of this vaccine I was 





While for some parents media exposure did seem to play a role in their vaccination decisions, 
many parents did not describe media as having a significant impact on their decision, which 
often reflected distrust or suspicion of pharmaceutical marketing in general, as these quotes 
indicate:  
Thomas: I took a neutral stance on it, where I took it with a grain of salt that the 
reporting is correct. But I’m not going to believe everything that’s in there (Father of 
unvaccinated 8-year old daughter and 10-year old son). 
--- 
 
Lorraine: I’m aware of them. I didn’t focus on them a lot. I’m skeptical of this vaccine 
so I put a little less stock in the advertising.  I’m skeptical of advertising in general, 
but I have been aware of it, I’ve seen it.  When it first started to come out my niece, 
my sister was trying to decide. My kids were quite a bit younger at that time; I don’t 
know what year it first emerged. And my niece was considering what to do, should 
she have it or not.  I think they decided not to do it. At that time was the first I had 
heard about it and she asked what I thought, and I remember looking it up and 
reading about it and being skeptical then and remaining skeptical (Mother of 
unvaccinated 10-and 15-year old daughters). 
 
Reflections of skepticism, suspicion, and distrust emerged not only specific discussions 
regarding the marketing of the HPV vaccine, but in reflections regarding the role and power 
of the pharmaceutical industry in the United States. 
 
VI. HOPE AND HARM: REFLECTIONS ON THE PHARMACEUTICAL INDUSTRY 
Hope and harm—the balance of hope and harm. Reminds me of a see-saw where 
someone has to slide forward depending on how heavy the other side is—that as a 
parent or as a user of pharmaceuticals, one has to balance that (Alice, mother of 12 
year-old unvaccinated daughter). 
 
As part of my conversations with parents, I explicitly asked each individual to give 
me their general opinion of pharmaceutical companies. The majority responded with mixed 
feelings—or ambivalence—illuminating tensions between positive feelings regarding the 
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potential for the pharmaceutical industry to improve the health of the population, and 
negative feelings of distrust regarding their financial motives and unmitigated influence over 
politics. In her examination of pharmaceutical pills, Emily Martin (2006) also identifies this 
ambivalence—or how “people surround the same object with two sets of social meanings—
one positive and one negative” (274) surrounding pharmaceutical practices in the United 
States. Using the Greek word, Pharmakon (which invokes meanings of both remedy and 
poison), Martin examines the social process by which the negative parts of pills are 
“displaced” from primary view. “In the American Pharmakon, pills are split into good and 
bad parts: the bad parts with their negative meanings can thus be displaced to the side and 
kept out of awareness, or so it might seem” (Martin 2006:274). While attempts are clearly 
being made to displace the potential negative effects of the HPV vaccine, I did not find that 
parents were keeping these effects “out of awareness,” but rather held each (albeit 
precariously) in their viewpoint of the positive and negative potential of pharmaceuticals 
(Taussig, Hoeyer & Helmreich 2013). Within these tensions, emerged notions of economic 
and political values, as well as articulations of parental responsibility to balance the "hope 
and harm" of pharmaceutical use.    
 
Ambivalence 
 Many parents expressed mixed feelings regarding pharmaceutical companies, 
reflecting tensions between good allotted to the industry for their role in advancing health, 
and potential evil due to their driving desire to earn profits. As these two parents explained: 
Florence: I’m a bit jaded about – I mean on the one hand we’ve gotten some 
marvelous inventions and vastly improved our quality of life.  Then on the other hand 
I think they are largely motivated by profit and they need to be regulated (Mother of 
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unvaccinated 9-year old daughter, and vaccinated 12- and 16-year old daughter, and 
14-year old son). 
--- 
 
Thomas: When I think of a pharmaceutical company I think of—they definitely play a 
huge role on society in terms of, hopefully, developing vaccines and medicines that 
can further our lives or prevent a lot of diseases. But at the same time too, they’re 
beholden to their shareholders.  So their goal a lot of times is to maximize their 
profits, which is at the detriment of patients, and with healthcare costs escalating, 
especially with pharmaceuticals, you get mixed feelings about it (Father of 
unvaccinated 8-year old daughter and 10-year old son). 
 
For some, framing pharmaceutical companies within the lens of free market, capitalist 
values, helped to make sense of tensions between public good and economic profit. As 
Rebecca stated plainly: “I think nothing different about a pharmaceutical for profit multi-
national corporation, any other business in it to make money” (Mother of unvaccinated 11-
year old daughter). 
Another father went further to place these values as not only reflective of economic 
values, but at the center of the "American way": 
David: It’s a business. They’re in the business to make money.  That’s what a 
business does. It’s not a non-profit organization; it’s a for-profit organization. So 
they’re there to do things to make a profit to keep their company going—to make 
more profit. That being said, that’s the American way.  A drug company is the same 
thing. They’re providing a service or a product to help society—and this is drugs. It’s 
more important than a tire or a toothbrush necessarily, but it’s still providing 
something (Father of 8-year old unvaccinated daughter). 
 
The motive driving the pharmaceutical industry may be profit, but this motive is evaluated 
through values inherent and representative of the American—or capitalistic—way, and as 
such, is not only understandable, but desirable. However, as David went on to explain, these 
motives are also subject individual greed, highlighting the limits of economic profit as an 
American value:  
David: I guess my answer to your question—pharma companies, biotech companies 
are just like any other company, there’s going to be good and bad to it.  In general, I 
115 
 
think they’re a positive to society where they are creating products that are going to 
help us live longer and healthier lives.  But there’s going to be bad apples; they’re 
humans. And humans are flawed and dirty and greedy and filthy people that have bad 
tendencies. They fall into what’s easy and not what necessarily what’s best. 
 
Invoking images of the original sin, profit is understandable as an economic motive, but must 
be regulated due to the potential flaws or weakness inherent in all humans. For other parents, 
the economic profit gained by pharmaceutical companies is beyond what is necessary—or 
morally just. As Antonia explained: 
Antonia: I, of course in general, think that it is very wrong that somebody is making a 
lot of money on pharmaceuticals.  Having said that I also, I guess it’s my ‘middle of 
the road-ness’. I don’t think it’s so simple.  I think the whole development, I think it’s 
just part of our entire decisions about resources.  It is resource intensive to develop 
drugs, and of course, I think everyone should have equal access to the drugs and of 
course, I think nobody should be getting rich off of drug.  On the other hand, I believe 
people who are supporting the development should have a good living. They should 
be well supported so that they can do this valuable work—of course so should 
teachers—And I do think it’s wrong when pharmaceuticals are sold when they 
shouldn’t be, when the decisions on when to take something aren’t so influenced by 
somebody’s ways to make money.  But I think it’s really complex.  The simple truth is 
I do not think somebody should be getting rich on pharmaceuticals (Mother of 
unvaccinated 11- and 19-year old daughters). 
 
Anthropologists and others have criticized the use of "magic bullet" solutions proffered by 
pharmaceutical industries to cure or prevent disease, rather than address larger structural 
factors that impact health and perpetuate inequalities (Applbaum 2009; Nguyen and Peschard 
2003). This "pharmaceuticalization" of society is based in part on the pharmaceutical 
industry's ability to obtain funds allocated for promotion of public health (often over other 
organizations and industries)—and governmental support for their endeavors in the United 
States and globally (Abraham 2010; Biehl 2007). In the United States, as noted earlier in the 
chapter, the federal government not only gave funds, but passed legislation protecting 
pharmaceutical companies from liability lawsuits (NCVIA) to ensure pharmaceutical 
companies would continue to make vaccines. This act created a direct link between—and 
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reliance upon—the pharmaceutical industry to supply vaccines. In the context of HPV 
vaccination, the public and moral discomfort between the development of public health 
policies and power of pharmaceutical influence entered the public stage, exemplified by 
criticisms of Merck's lobbying efforts and HPV vaccine legislation. While unnerving for 
most parents, most did not argue that pharmaceutical companies should not be able to make a 
profit, but rather their power—and potential evil—should and must be checked through 
governmental (FDA or otherwise) regulation. As Kelsey explained:  
Kelsey: I guess they’re one of our new safe evils.  I’m skeptical of them.  I do think 
profit making is their primary motive, so it has to be monitored.  And I think there 
needs to be oversight, which I guess means regulation.  But I think on the other hand, 
we have to have companies that do the research and make the product, so they can’t 
be a pure evil.  They perform a needed service and they need to be heavily overseen.  
I wouldn’t trust them.  I mean it’s not enough for them to say my product is excellent.  
That’s like McDonald’s saying my hamburger is delicious.  But I still appreciate that 
they make the product as long as someone is watching over their shoulder with some 
care, which I’m not sure we are – cause they have a pretty strong lobby in 
Washington I’m sure, and probably every state capital (Mother of unvaccinated 12-
year old son). 
 
In the digital age, the circulation and impact of media and marketing is increasingly 
difficult to understand and measure. The rapidity at which information emerges, circulates, 
and vanishes makes understanding its meanings and influences a daunting task indeed. 
Despite its elusiveness, public discourses (whether through media, marketing or controversy) 
are scripted and re-scripted using extant—often normative—beliefs, practices, and 
relationships of power. In the context of HPV vaccination, these norms are guided in part by 
historic constructions (and limits) of sexuality, science, and the nation-state. Throughout 
these public debates—whether it be by the pharmaceutical industry or Tea Party activists—
information technologies are being harnessed to promote certain understandings of what it 
means to live and be healthy. However, these strategies are not merely implanted onto the 
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minds of parents and other collectives, but resisted and reworked through ethical and 
experiential practices occurring in everyday life. Beyond mere intellectual or ethnographic 
inquiry, these practices have direct connection to the health and wellbeing of the nation. In 
conclusion, I will consider how social workers and other care professionals working the field 
of health promotion or healthcare may help parents to make sense of the cacophony of voices 
claiming to know what is best for the health of children. 
 
VII. GROWING OPPORTUNITIES FOR SOCIAL WORKERS IN HEALTHCARE  
The paternalistic model of healthcare in the United States—in which the physician is 
viewed as the primary decision maker—has long been challenged by medical social workers 
who have fought to bring a more person-centered approach to healthcare since the early 
1900s (Gehlert 2006). Recently, national healthcare organizations and legislation (including 
the Affordable Care Act) have also shifted to promote a more balanced, patient-centered 
medical model (Institute of Medicine 2001; Shafir & Rosenthal 2012). This shift toward 
patient-centered care is not only happening in the United States, but also worldwide with 
similar policy and intervention efforts occurring throughout Europe, Asia, and Australia 
(Légare et al. 2012). 
Patient-centered care prioritizes the values and preferences of patients, and positions 
healthcare providers as collaborators rather than dictators in determining the best treatment 
option. Medical decision-making in this model is viewed as a shared or collaborative process 
between the patient and his or her healthcare team—often referred to as shared decision-
making (SDM) (Charles, Gafni & Whelan 1997). SDM incorporates the patients’ preferences 
and values into treatment decision-making, and is reliant upon clear, open communication 
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between the patient and his or her healthcare team. Patient-centered care and shared decision-
making have been shown to have a positive impact on patient satisfaction as well as health 
outcomes in both acute and chronic conditions (Stacey et al. 2011).  
Although the patient-centered model is increasingly becoming the ideal standard of 
care, it has been difficult to incorporate shared decision-making into routine medical care. 
This is due in part to the values, practices and structure of the healthcare system in the United 
States that discourages patient-centered care in many ways. For example, systemic policies 
may impede patient-provider communication by the placing strict time limits on 
appointments. Additionally, time spent engaging in the behaviors necessary for shared 
decision-making including asking about patient’s needs and listening attentively to patient 
concerns is not often reimbursed by private and public insurance companies (Légare et al. 
2012). There may also be cultural attitudes among patients and practitioners that act as 
barriers including traditional views that place physicians as unquestioned experts and patients 
as passive recipients of their knowledge (Frosch et al. 2012). Patients also face a variety of 
barriers to engaging in shared decision-making, particularly patients with low health literacy 
or those who do not have access to regular preventive care (Galesic & Garcia-Retamero 
2011). Furthermore, there has been some indication that patients of different racial or ethnic 
backgrounds have different preferences for the level in which they want to be involved in 
medical decision-making (Levinson et al. 2005); however, these may be more a reflection of 
structural inequalities than cultural. Marginalized populations also may not have access to 
information about the risks and benefits of treatment options in a format that is linguistically 
and culturally appropriate (King, Eckman & Moulton 2011)  
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A growing amount of research in health services, medical decision-making, and 
related fields have focused on developing tools for both patients and providers to support 
shared decision-making—most notably in the form of decision aids, which have been proven 
to be efficacious for promoting patient engagement (Stacey et al. 2011). However, decision 
aids have been difficult to incorporate into routine medical care outside of clinical trials, and 
very few have been tested among or adapted to the needs of low-income patients or people of 
color. As well, decision aids are only modestly successful without institutional support by 
doctors and healthcare team members to encourage patients to voice their preferences (Lin et 
al. 2013). 
In this shifting environment and increased focus on expanding communication 
between patients and providers, social workers have the potential to help fill the gap between 
the ideal of shared decision-making and the variegated and often absent practice in routine 
healthcare, particularly among vulnerable populations. Although subject to the dominant 
medical model, medical social workers have always pushed to place the contextual needs of 
patients within the clinical encounter. Much of the attempt to elicit patients preferences focus 
on values (which is not often defined, but often infers quality of life concerns) and 
communication of risk and benefit. In a previous article, my colleagues and I argued that 
communication regarding the everyday experiences—meaning structural, lived barriers—and 
strategies of low-income patients needs to be central to clinical decisions regarding diabetes 
self-management (Rendle et al. 2013). For example, in the context of diabetes care, recent 
guidelines have argued that clinical flexibility in determining target A1c levels based on 
individual circumstances may actually lead to better self-management (“adherence”) than 
rigid standardization. Without direct communication regarding structural conditions, the 
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physician would not be aware of how factors, such as access to fruits and vegetables, are 
shaping health outcomes among ethnic minorities or impoverished groups, and not be able to 
consider how to tailor recommendations to match the context in which the patient lives. 
In the context of HPV vaccination, while most of my sample did not face structural 
factors to care, they did face communication barriers to discussing the risks and benefits of 
HPV vaccination, and often barriers to discussing the sexual activity of their child. Also, the 
literature shows that most of the barriers to HPV vaccination among underserved populations 
are structural—such as lack of health insurance or lack of healthcare provider 
recommendation. While it is essential that physicians directly communicate with patients and 
engage in extra-clinical efforts to reduce structural inequalities that patients face, I argue that 
social workers have a role to play to assisting in this communication, particularly due to 
increased structural limitations facing physicians’ time in medical appointments. In some 
healthcare care settings, shared medical appointments or information sessions offer 
opportunities for patients to ask questions and communicate concerns, whether they are 
structural or otherwise, regarding a particular treatment decision or condition, and these are 
often run by medical social workers or health educators. Due to their training and 
commitment to social justice, social workers are trained and capable of assisting efforts to 
incorporate structural competency as part of medical care, as well as continue to lead efforts 
outside the clinical encounter to eliminate social, economic, and structural conditions that 









CHAPTER FOUR: TEMPORALITY, SEX, AND DESIRES TO DELAY 
In this chapter, using fundamental cause theory (FCT), I will explore how the 
theoretical concept of countervailing mechanisms may help to explain HPV vaccination 
patterns that document both disparities by race and socioeconomic status, and low uptake 
among high-resource populations (Link & Phelan 1995). Following a brief explanation of the 
core components of FCT, I will examine patterns in HPV vaccination rates among different 
populations in the United States to give an overview of who is being vaccinated from a 
national standpoint. Then, drawing from anthropological work on temporality, risk and 
potentiality, I will consider how two mechanisms—specifically sexual norms regarding 
teenage sexuality (particularly among young girls) and lay challenges to scientific and expert 
knowledge35—may be contributing to low and stagnating vaccination rates among resource-
laden populations, acting as countervailing mechanisms against (debatably) beneficial health 
behaviors, in this case HPV vaccination.  
In my fieldwork, I found that parents challenged expert knowledge and the 
universalizing assertions of public health and biomedical practices, by refusing to vaccinate 
their children at the recommended age. Although some of the parents did report delaying 
                                                        
35 Several scholars have examined how non-expert or lay individuals have challenged the dominant, biomedical 
model in the field of breast cancer (Zavestoski, McCormick & Brown 2004; Brown et al. 2006), AIDS (Epstein 
1996) and other afflictions. Drawing from this work, I argue here that these challenges are also occurring in the 
realm of HPV vaccination. 
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other vaccinations, overall, most of the parents had their children receive the other childhood 
vaccinations on schedule. To defend their desire to delay HPV vaccination, parents often 
invoked claims to experiential evidence validated by a sense of knowing their child and his 
or her sexual and emotional development—attempting to redraw the lines of power based on 
their claim to parental knowledge that no "expert" can possess (Gieryn 1983; Nader 1996). 
Entangled within these claims (or acts of boundary work) are temporal assessments of risk—
whereby parents weighed their child’s (perceived) present risk of HPV exposure against the 
unknown risks of the vaccine itself. In the future, however, parents anticipated that these 
risks would be identified—made knowable through the experiences of other children 
vaccinated in the present.  
 
I. FUNDAMENTAL CAUSE THEORY AND COUNTERVAILING MECHANISMS 
Due to the strong link between receipt of healthcare provider recommendation and 
socioeconomic status, some researchers have contended that HPV vaccination is an empirical 
example of fundamental cause theory (FCT) (Polonijo & Carpiano 2013). Originally 
proposed by Link and Phelan (1995), FCT argues that due to differential access to resources, 
distribution of and benefit from novel medical technologies or practices often replicate extant 
social inequities. While inequities regarding certain technologies can be short-term or long-
term, FCT predicates that, despite changes, inequities are reproduced through established, 
underlying mechanisms that limit access to key resources such as preventive healthcare, 
knowledge, or prestige. These mechanisms can be latent or explicit, and while the specific 
mechanisms might change over time, the inequities continue. For example, Link and Phelan 
(2005) examined shifts in mortality rates of diseases whereby great preventive or 
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technological advancements have been made in the twentieth century (heart disease, lung 
cancer, and colon cancer). While overall mortality rates declined following increases in 
prevention and treatment, race and SES gradients shifted toward relatively higher mortality 
rates for these groups, indicating that extant mechanisms—possibly inequities in access to 
treatment or preventive behaviors such as healthful diets—are replicating disparities despite 
technological changes. 
An important, but often overlooked, component of FCT is the notion of 
countervailing mechanisms (Phelan, Link & Tehranifar 2010). In most cases, populations 
with access to resources will select health behaviors and practices documented to be linked to 
improved health—which most often is reflective of scientific or expert arguments that a 
certain behavior leads to increased likelihood of longer life expectancy or in some cases 
improved “quality of life”—which may infer increased physically activity, decreased pain, 
positive mental health, or positive impact on mood or social relationship. However, in some 
cases, countervailing mechanisms (such as power or social norms) may result in these 
populations selecting against beneficial health behaviors. For example, the historic 
association between masculinity and smoking promoted by popular media may have 
contributed to continued high rates of smoking (even after public warnings emerged of the 
health hazards) in the late twentieth century even among populations with access to social 
and material resources. Although interventions have often focused on individual behaviors, 
FCT argues that structural factors, similar to arguments made more recently by Metzl and 





II. POPULATION PATTERNS AND HPV VACCINATION IN THE UNITED STATES 
Despite the significant marketing and promotion of the HPV vaccine, uptake of the 
vaccine continues to be low across all populations in the United States, and according to 
some studies is disproportionately low among groups at higher risk for developing cervical 
cancer and high-risk HPV infection, including African Americans and populations with low 
socioeconomic status (Krieger 2005; Kahn, Lan, & Kahn 2007; Downs et al. 2010; Niccolai 
et al. 2011). Additionally, differences by socioeconomic status and race in factors associated 
with vaccination uptake, including HPV-related knowledge, healthcare provider 
recommendation, and geographic location, have been shown. For example, numerous studies 
have shown gaps in knowledge (which has been linked to vaccination uptake) among lower 
socioeconomic status and minority groups concerning what HPV is, how it is spread, and 
how it can be prevented (Friedman & Shepeard 2007; Olshen et al. 2005; Scarinci et al. 
2007). These gaps are likely due to numerous social and structural factors, including 
differential access to education as well as information from both doctors and other sources 
(Kontos et al. 2012; Hughes et al. 2009; Viswanath 2005). As such, in the information age, 
narrowing gaps between "information rich and information poor" may help reduce disparities 
in cervical and other cancers (Viswanath et al. 2006).  
In addition to patterns of uptake, the specific design of HPV vaccine may actually 
lead to further disparities among the most vulnerable groups. As noted, the quadrivalent HPV 
vaccine is argued to protect against two strains of HPV linked to cervical cancer (HPV-16 
and HPV-18) and two strains linked to genital warts (HPV-6 and HPV-11). Although these 
strains are claimed to be the most prevalent strains in the United States, a recent study by 
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Vidal and colleagues36 examined prevalence rates of specific HPV strains among White and 
Black women, and found that the quadrivalent vaccine does not include those strains most 
prevalent in Black women—and thus those at greatest risk may not be benefit equally from 
vaccination. Disparities in the enrollment of minorities in clinical trials—as well as the 
meaning and impact of inclusion efforts by the NIH and others—highlight the multitude of 
levels at which health disparities and politics of difference are made and remade (Epstein 
2007; Joseph & Dohan 2012; Mol & Berg 1998). However, despite evidence of health 
disparities in some studies, national data from the National Immunization Survey (NIS) does 
not fully support these patterns, and actually in some ways shows quite the opposite.   
 
NIH-Teen Survey Results 
Based on results of the 2012 NIS-Teen, only 33.4 percent of girls (aged 13-17) have 
completed the three-dose regimen and 53.8 percent have received at least one dose. Of boys 
(aged 13-17) only 6.8 percent have completed the three-dose regiment and 20.8 percent have 
received at least one dose (US Department of Health & Human Services 2013)37. In addition 
to low completion rates, the rate of vaccination completion among young girls seems to be 
stagnating, as coverage in 2012 (33.4 percent) actually decreased slightly from coverage in 
2011 (34.8 percent). The graph below (Figure 21) depicts estimated HPV vaccination 
coverage among adolescents, aged 13-17, based on 2007-2012 NIS-Teen data: 
 
                                                        
36 The findings were presented on the Oct. 28, 2013 at the 12th annual International Conference on Frontiers in 
Cancer Prevention Research and have not yet been published 
(http://www.dukehealth.org/health_library/news/hpv-strains-affecting-african-american-women-differ-from-
vaccines). 
37 The ACIP announced its recommendation for boys to be routinely vaccinated in 2011; therefore, conclusions 





While vaccination coverage is low across the population, vaccination coverage patterns by 
race and socioeconomic status as estimated by the NIS-Teen data are surprising. As 
illustrated in Figure 22, HPV vaccine initiation rates among those living below the poverty 
level are estimated to be higher than those living above the poverty level (Stokely et al 2009). 
When looking at vaccination completion rates, between 2008-2010, completion rates were 
higher among adolescent females living at or above poverty level. In 2011, this shifted 
whereby those living at or above the poverty level (females and males) are less likely to have 
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Figure 21: Estimated HPV vaccine coverage among U.S. adolescents, 
aged 13-17 
Source: NIS-Teen, 2007-2012 
≥1 dose, females 
≥3 doses, females 
≥1 dose, males 





Similar patterns exist when looking at estimated vaccination rates by race or 
ethnicity. Hispanic adolescents seem to be initiating vaccination at higher rates than Black 
and Non-Hispanic White adolescents (Figure 23). However, before 2011, Non-Hispanic 
White female adolescents were completing the three-dose series at higher rates than both 
Hispanic and Black females. Beginning in 2011, the estimated rate of Hispanic adolescents 
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Figure 22: Estimated HPV vaccine coverage among U.S. adolescents, 
aged 13-17--by poverty level 
Source: NIS-Teen, 2008-2012 
≥1 dose (females below 
poverty level) 
≥1 dose (females at or above 
poverty level) 
≥3 doses (females below 
poverty level) 
≥3 doses (females at or above 
poverty level) 
≥1 dose (males below poverty 
level)  
≥1 dose (males at or above 
poverty level)  
≥3 doses (males below poverty 
level)  
≥3 doses (males at or above 





Through the lens of FCT or health disparities, these patterns are surprising as one 
would expect those groups facing structural and cultural barriers would have lower rates than 
those who historically do not—and based on this data, one could argue that HPV vaccination 
is not an example of FCT. However, based on the data and analysis discussed earlier (which 
often examined mediating factors), disparities have been demonstrated by race and 
socioeconomic status. Furthermore, based on my dissertation findings, I argue that 
fundamental cause theory—and its notion of countervailing mechanisms—does help explain 
current patterns of HPV vaccination. In the next section, I will examine how two 
mechanisms—norms regarding teenage sexuality, and lay challenges to expert knowledge 
increasingly present in risk societies—may help to explain why populations with access to 
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FIgure 23: Estimated HPV vaccine coverage among U.S. adolescents, 
aged 13-17--by race 
Source: NIS-Teen, 2008-2012 
≥1 dose (Black females) 
≥1 dose (Hispanic females) 
≥1 dose (White females) 
≥3 doses (Black females) 
≥3 doses (Hispanic females) 
≥3 doses (White females) 
≥1 dose (Black males) 
≥1 dose (Hispanic males) 
≥1 dose (White males) 
≥3 doses (Hispanic males) 
≥3 doses (White males) 
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Intertwined within each of these mechanisms are constructions and challenges to 
universalizing claims of biomedical practices as well as temporal assessments of risk, 
sexuality and science. 
 
III. ASSESSMENTS OF TIME, SEX, RISK, AND SCIENCE 
 In media coverage and scientific literature concerning HPV vaccination, parents are 
often placed into a binary model of those who support vaccination and those who oppose. 
However, surprisingly, very few parents with whom I spoke expressed strong or definitive 
opposition to HPV vaccination, even if they had not vaccinated their child. Rather most 
parents expressed uncertainty regarding HPV vaccination, in large part due to the novelty of 
the vaccine, and the age at which it is recommended (11-12 years of age). As noted earlier, 
even among parents who had not yet vaccinated their children, most parents reported that 
they planned to so in the future. Even among those who stated that they were unlikely to 
vaccinate, most conveyed the possibility of vaccinating their children, depending on if in the 
future the safety of the vaccine is confirmed,38 but wanted time to pass to allow for more 
"evidence" to be gathered. As Rebecca described,  
Rebecca: The only question mark that I would have when it comes down to whatever 
the right time is, or the suggested time, would really be just—doing a second check. 
Cause childhood vaccines cause they have been utilized for so many decades, that 
it’s, like, tested.  I am kind of a fan of letting a full period of time run in the market 
before taking any kind of drug...I wouldn’t want my kid to be the first real application 
of it even if it’s gone through field trials (Mother of unvaccinated 11-year old 
daughter) 
 
The novelty of the vaccine gave parents pause, which as Eric explained, reflected general 
                                                        
38 Although post-licensure large-scale studies continue to show the safety of the vaccine (Chao et al. 2012; 
Klein et al. 2012), even among parents who described using academic journals (or "PubMed") to guide 




approaches to not only health, but consumerism as well: 
Eric: It’s a lot of, I guess, unknown skepticism as I would call it. That’d be a good—it 
would be a good defining word that I would use. It’s basically, what it amounts to 
being, do you wanna be an early adaptor and believing the Center of Disease Control 
and your medical professional? Or are you a risk adverse and you want to have a 
little more development as far as the findings of the drug and its known side effects in 
individual boys? Do you want to buy that first year of that model of car or do you 
wanna wait for a few models to see what’s gonna, what’s really underneath the 
hood? I mean if it’s gonna keep it humming. It would be a good analogy (Father of 
unvaccinated 9- and 12-year old sons). 
 
The decision to delay was also articulated through parents’ assessments of present 
day risk—from HPV—to their child based upon assessments of their child's sexual 
(in)activity, and often supported by recommendation of their child's doctor. As Jeanne 
explained: 
Jeanne: Well, at first [the doctor] said, ‘Let’s just wait a few years until we see that 
this is a good vaccine.’ Then the most recent visit, the sixteen-year visit, basically 
[the doctor] said that it would probably make more sense to wait until she was either 
ready to be sexually active or off to college. They don’t know yet what the drop off is 
going to be in the effectiveness over time. 
 
Kate: Have you talked to your daughter directly about it? 
 
Jeanne: She’s been in the room with me and the doctor while this conversation is 
going on. I have told her when you get ready to have sex you have to have these shots 
first (Mother of 16-yr old unvaccinated daughter). 
 
The decision to delay is based in part on parental assumptions that their child is being 
completely honest and open regarding their sexual activity, and that the parent will have 
preparatory time to have their child complete the three-dose series prior to onset of sexual 
activity39. Like Jeanne, many parents expressed that the doctor played a key role in either 
recommending or at least supporting their decision to delay. Beyond recommendation for 
                                                        
39 In the interviews, I did not explicitly explore what constituted sexual activity in the views of parents (for 
instance, intercourse, genital touching, or any intimate contact). In the context of HPV vaccination, this notion 




their own children, parents also often asked if doctors planned to vaccinate their own 
children and at what age. In these moments, the expertise of the doctor comes from not their 
status as a doctor, but as parent charged with the same responsibility to protect their children. 
As Delia explained: 
Delia: I plan to have both children have this vaccine; however, I would like to wait 
another few years even though my daughter is 12. I would actually like to wait until 
ever there is a little more research behind it. There will be a bigger pool of people 
who have taken it, and I’m sure all parents say this, but I’m 100% certain she’s not 
sexually active.  I think my doctor said the same thing.  She has three daughters and I 
think she was waiting a little bit—instead of twelve—until about 14 to 16 (Mother of 
unvaccinated 12-yr old daughter and 9-yr old son). 
 
Claims to knowing their child's sexual activities were sometimes supported by parental 
claims to having open conversations with their children regarding sex. As Ruth, mother of 
two teenage daughters, both unvaccinated, explained:  
Ruth: I have to tell you I’m one of these mothers who goes, ‘You DO not have 
unprotected sex. You ALWAYS use a condom. You get tested beforehand.’  
 
Kate: So you have pretty open conversation- 
 
Ruth: Very, with both of my girls. 
 
Kate: And how do they respond—do they ask questions? Do they shy away? 
 
Ruth: Um, it depends on the mood they’re in. They will ask me questions. They will 
roll their eyes and go, ‘Yes, Mom. We know.’ Then I say, ‘Knowledge is power. You 
have to know. You are responsible for your own health. You’re responsible for your 
sex life.’ 
 
However, parents also used claims to generally knowing their children—physically and 
emotionally—to assess their sexual activity and readiness as well as potential physical 
reaction to the vaccine, rather than providing indication that they have explicitly asked their 
children about their sexual activity. When I asked Joyce why she had decided to have her son 
vaccinated at age 15, she replied: 
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Joyce: I think the general consensus was [the age] is somewhat child dependent. 
Some kids are more socially and sexually active earlier, and so you might think about 
it sooner than you would with the slower child. At some point, you just kind of have to 
start ‘cause you don’t know when they’re going to be sexually active. I know he’s not 
and he hasn’t been, and so there’s no need to do it earlier.  He’s a small kid, and so 
to wait a little bit just to be bigger made sense.  The pediatrician may have initiated 
that process.  I think her idea was just even to bring them in together so that I had 
fewer appointments (Mother of unvaccinated 13-year old daughter and vaccinated 15-
year old son).   
 
Although the pediatrician wanted to vaccinate both children as the same time to reduce the 
burden of multiple appointments on this mother, Joyce decided ultimately not to have her 13-
year old daughter vaccinated at the same time as her son, explaining: "I think partly, when he 
had the appointment she wasn’t available, partly because she’s “not there yet” so I wasn’t 
feeling the urgency."  By ‘not there yet,’ she is assessing his physical and emotional 
readiness to engage in sex from her evaluation. 
Beyond assessments of their own child's sexuality (which may or may not reflected 
actual behavior), numerous parents—supported by their doctor often—expressed similar 
notions of the "right time" or ideal age to vaccinate, often right before college. The right time 
to vaccinate, for many parents, is much later than the recommended age of 11-12 for boys 
and girls, which is founded upon expert claims that vaccine is more effective at this earlier 
age, and population statistics estimating the average age when young girls and boys become 
sexually active40. Drawing upon claims to parental and experiential knowledge, parents 
resisted the universalizing assertions of biomedicine that position ages 11-12 as the right time 
to vaccinate. Intertwined within these assertions are also normative views of when and where 
                                                        
40 Based on Advisory Committee on Immunization Practices (ACIP) meeting notes, three factors formed the 
foundation of the target age selection. 1) Population statistics estimating the average age when adolescents first 
have vaginal intercourse; 2) Population statistics estimating rates of sexually transmitted infections (STIs) 
across the different age groups; and 3) Immunogenicity data that showed that the vaccine is slightly more 
effective at producing an immune response in 10-15 year old boys and girls than 16-23 years. These statistics 
mostly came from two nationally administered surveys, the National Survey of Family Growth (NSFG) and the 
Youth Risk Behavior Survey (YRBS). 
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young girls should first become sexually active. The story of Alice, an elementary school 
teacher and mother of one daughter, highlights these connections and complexities well.  
 
IV. DEBATING THE ‘RIGHT TIME’ TO VACCINATE 
 When I asked Alice to tell me about who makes up her family, as I often did to begin 
interviews, she started with the challenges—and benefits—of conceiving her daughter 
through a sperm donor. "So in the beginning [my female partner and I] thought we wanted all 
kinds of things, and then, when you look at the profiles, you realize only a few things really 
matter." For Alice and her partner, the things that really mattered was the ability for their 
daughter to be able to contact her biological father at age 18, and to "weed out for some 
sensitivities...cancer, alcoholism, and mental illness" in her family history. For Alice, 
protecting her daughter began before conception, and throughout our conversation, she 
continued to express a great concern for providing the best care for her daughter. 
 In asking her if she had heard about any negative aspects of the HPV vaccine, she 
explained that she had heard about general rumors that the HPV vaccine may not be effective 
long term and that it may have resulted in the death of a local girl. I asked if she had looked 
into any of these rumors, she explained when she first heard, she "had a visceral reaction and 
I shut down and I stopped looking at it. And I said, I’m not going to look at this for a while 
because it is not something [my daughter] is going to get at twelve—She is not."    
When I asked her to explain further why she did not want her daughter to be 
vaccinated at age 12, she invoked similar concerns that other parents had mentioned 
regarding evidence of the vaccine effectiveness and known risks, but also normative 
assertions to when and where girls (should) become sexually active: 
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Joyce: See, I don’t think there’s enough research to tell us how effective it is, and I 
don’t think there’s enough research to tell us, well here’s my problem. You vaccinate 
a girl, and she’s twelve and she’s not sexually active, and then she goes off to college 
thinking she’s ok.  She has partners and then she’s followed or whatever, but if you’re 
done at twelve, the research I saw didn’t even show all the way through college, so 
there’s not enough evidence and there’s not enough evidential partners to tell me jack 
crap.  That’s my problem, is that really I could traumatize my daughter for absolutely 
nothing, or I could traumatize her and protect her.  I need to see longer-term 
studies…I want her to be protected and I’m not gonna give her the vaccine until—my 
ideal age is seventeen, so she has a year before she goes off to college. 
 
 Her decision to delay is shaped by both a need for "evidence" of the safety and 
effectiveness of the vaccine as well as the desire—and obligation—to protect her daughter. 
As such, her decision to delay is also an act of boundary work, in which parents (lay 
individuals) are challenging scientific knowledge through claim to experiential expertise. 
These assessments are constructed through claims to knowing her daughter (and her sexual 
activity) and normative understandings of when the ideal time for her to be vaccinated is. 
Many other parents expressed this moment (“right before college) as well, which I argue 
reflects not only individual claims to knowing their child, but also normative assertions 
regarding the appropriate time for young girls to become sexually active. 
 In these ways, I argue that sexual norms and lay challenges to scientific knowledge 
may be acting as a countervailing mechanism in the context of HPV vaccination, resulting in 
low and stagnating vaccination rates among highly educated and resource-laden groups. In 
other words, parents are selecting against beneficial health behaviors for their children (HPV 
vaccination) due to perceived negative social consequences of vaccinating, supported by 
experiential assessments of when their child will become at risk for exposure. These social 
consequences are not in the form of behavior disinhibition (i.e. risky sexual behavior), but 
rather are more subtle and may be centered on concerns that vaccinating at an earlier age may 
give the impression that their daughter "needs" to be vaccinated because she is sexually 
135 
 
active. They may also reflect general societal resistance to discussing sex between parents 
and child, and even patients and doctors. 
Moreover, doctors are supporting these decisions to delay and parental claims to 
knowing if their child is sexually active in many cases. Stemming from current and historic 
discrimination of ethnic minorities in the United States, it is reasonable to hypothesize that 
doctors may not believe parental assertions of knowing their child equally across all patient 
populations41, leading to disparities in not vaccination uptake, but rather disparities in who is 
encouraged (or allowed) to delay vaccination. While I do not have data to speak to provider's 
assessments, parents did convey notions that the right age to vaccinate may be different for 
different "types" of girls.  
 After describing her strong feelings regarding the age at which her daughter would be 
vaccinated, Alice explained that for some adolescents, it might be necessary to vaccinate 
earlier. As she noted:  
Alice: I don’t believe that the vast majority of children twelve to sixteen are sexually 
active. I just don’t believe that.  So I don’t believe it’s appropriate.  However, when 
you look at generational…when you’re looking at three generations of pregnancies 
under age sixteen, they need to be vaccinated at twelve...The thing is, this is horrible 
to say, but I know several of the parents of my students, in Oakland in particular, who 
are not afraid of their girls having babies because then they could be the caregiver 
and the checks would continue.  There was a cycle of poverty of depending on the 
checks.  Part of it quite honestly, I think they were just too afraid of not being able to 
work or not finding work or didn’t know how. But this generational poverty, it’s not a 
shame to be a grandparent, or a great grandparent at forty. 
 
Although race is never explicitly mentioned, this parent’s reflections, particularly the 
mentioning of Oakland, a predominantly Black city, and use of tropes of "welfare queens,” 
reveals how discriminatory notions of race and poverty come to bear on assessments of not 
                                                        
41 In my future research, I plan to investigate these findings further to examine how social norms may be 




only when adolescents should be vaccinated, but parenting as a moral and ethical practice as 
well.  
 
V. FUTURE DIRECTIONS AND CONCLUSIONS 
 In this chapter, I have argued that social norms regarding sexuality and growing 
uncertainties regarding science and vaccines may help explain low and stagnating HPV 
vaccination rates across affluent and educated parents, particularly with regard to the age of 
vaccine initiation. For many of the parents I spoke with, defining the right age was not based 
on scientific experts or population level data on risk, benefit or behavior, but rather on 
experiential, parental knowledge backed by claims of knowing their child and their child's 
sexual behavior. In some cases, it also included a challenge to the authority of the ACIP and 
other experts, due to concerns regarding the long-term effectiveness of the vaccine. At the 
cores of these temporal debates are contested claims over when—and through what specific 
encounters—the individual body becomes at risk for HPV exposure. For biomedical actors, 
in order to create national guidelines, this individual moment was translated into a collective 
moment, estimated on population statistics of age of sexual debut and rates of STIs.  
However, for many of the parents with whom I spoke, the right time to vaccinate is perceived 
to be much later, often supported by recommendations from their child's doctor. 
  From the perspective of public health and health social work practice, these findings 
suggest that interventions designed to increase HPV vaccination need to identify ways to 
mitigate not only structural barriers such as access to care, but also parental concerns 
regarding the safety and efficacy of the vaccine, perceptions regarding their child’s sexual 
activity, and the timing of vaccination. Further research is needed to understand if and how 
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“blind spots” among healthcare providers—and potentially latent discrimination—may be 
shaping how providers frame HPV vaccination to different populations. Are ethnic minorities 
or low-income parents given less allowance to delay? Are these allowances guided by 
normative assumptions regarding parenting among underserved and high-resource 
populations? Furthermore, if parents are making decisions regarding HPV vaccination based 
on perceived sexual activities of their children, interventions should help to assist providers 
in communicating directly to adolescents regarding their actual behavior to ensure 
vaccination is occurring prior to sexual debut. Social workers have a significant role to play 
not only in conducting this research, but also in the mediating the delivery of this information 
in the clinical setting, due to their training and understanding of how to communicate in 
comprehensive and sensitive ways.  
The need to address cultural factors and health communication may become 
increasingly important amid the current changes in the healthcare system, stemming in large 
part from the passage and approaching full implementation of the Patient Protection and 
Affordable Care Act (ACA). Through insurance reform and expansion, the statute’s primary 
goal of providing all individuals with health insurance is well aligned with population 
health’s focus on eliminating structural barriers to health. The ACA also offers opportunities 
and incentives to directly incorporate population health goals into healthcare practice, 
including reconfiguring provider and health plan reimbursement rates to include 
measurements of health promotion activities and health outcomes. While the ACA offers the 
potential to more closely integrate population health with healthcare delivery, it is unclear 
how these policy-level changes will be enacted in practice, and how these policies will 
impact the long-term health of specific populations across the nation. Furthermore, although 
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the ACA aims to remove systemic barriers to health by transforming the healthcare system 
and providing universal health coverage, other structural and institutional mechanisms 
contributing to population health disparities are not as directly addressed.  
My findings also raise the larger questions (to which I do not have the answers) of the 
ethics and implications of designing interventions that target patients with access to material, 
social, and structural resources, and conversely, the limits of health promotion as a moral 
mandate. In some ways, the parents I spoke with are informed—maybe too informed—with 
access to arguably some of the best healthcare in the United States and, privileged 
educational training enabling them to understand and critically examine health promotion 
materials. They face no significant structural barriers to care, and their decision not to 
vaccinate could be framed as merely an act of informed agency. However, in my 
conversations, these parents did not have complete scientific understanding of the risks and 
benefits of HPV vaccination, nor did they communicate that their provider had been 
completely open or available to answer their questions. Therefore, it would be reasonable to 
design educational interventions for medical care providers and health promotion materials 
that fill these identified needs. As Metzl and Hansen (2014) argue patients in power are also 
a result of the economic, political and structural conditions in the United States. However, in 
the context of structural competency, under what circumstances are interventions designed to 
translate and communicate medical information actually challenging structural inequalities 
(resulting from for example lack of access to education, or lack of transparency of clinical 
trial results) and when are these interventions merely supporting a deficit model of health 
promotion whereby individuals not engaging in a certain behavior are positioned as merely 








CHAPTER FIVE: MORAL RESPONSIBILITIES, INDIVIDUAL RIGHTS, AND COLLECTIVE GOOD 
 In this chapter, stemming from public conversations regarding parental rights and 
mandatory HPV vaccination, I will examine how tensions between individual rights and 
collective good, often scripted through political and social values, emerged in my discussions 
with parents. Within these discussions, I will consider how notions of responsibility and 
obligation as both a parent and member of society guided HPV vaccination decisions, and 
how each parent conceptualized their relationship to not only their child, but to the nation-
state and its members, through these considerations. Drawing from literature critically 
engaging with health promotion as a practice and mandate, I will examine how moral 
obligations to prevent social and corporeal risk—and desires to care—shaped these notions. 
In these ways, the act of vaccinating (or not vaccinating) gained meaning as an ethical act of 
protection guided by constructions of morality, responsibility, and risk—an act that is guided 
by questions of how we choose to live (Lakoff & Collier 2004). These ethical reflections also 
expose the processes by which health has become a new morality (Metzl 2010). In 
conclusion, I will consider the ways in which parents positioned HPV vaccination as distinct 
from other vaccinations based the manner in which it is transmitted, revealing how normative 





I. PARENTAL RIGHTS AND MANDATORY VACCINATION 
 As previously discussed, concerns regarding parental rights erupted following initial 
legislative pushes to include HPV vaccination in the suite of immunizations required for 
public school entry. Although levels of documentation and justifications required differ, 
every state in the United States has some form of "opt-out" policy regarding required 
childhood vaccinations. All allow for exemptions based on medical reasons and most allow 
for exemptions based on religious or philosophical beliefs. Despite presence of opt-policies, 
policy groups (largely conservative) and some parents pushed back against legislative efforts 
to require HPV vaccination, stating that it would infringe on a parent's right to decide what is 
best for their child. While discourses regarding individual rights—whether it be parental, 
patient or otherwise—in contrast to government mandates have long been part of the 
economic and cultural landscape of the United States (Colgrove 2006), these debates have 
recently become more polarized (or at least become more visible) centered on differing views 
of the proper role (and size) of government and the rights of individuals. Although 
interwoven throughout various political parties, these sentiments have become quite visible 
in the emergence and actions of the Tea Party movement.   
 Although there is much argument on the origins of the Tea Party movement, framed 
by supporters as an example of a "grassroots political movement" and by opposition as a 
movement driven by the funds and desires of elite conservatives like the Koch Brothers, the 
movement and its followers have played a central role in political and cultural events in the 
last five years. Following 2008-2009 federal government economic stimulus plans to assist 
failing corporations and struggling mortgage owners, national Tea Party protests surfaced, 
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beginning with the actions of Rick Santelli on the floor of the Chicago Mercantile exchange 
in February 2009 (McGrath 2010) and spreading from there across the nation. At the core, 
Tea Party activists are in support of "fiscal responsibility, constitutionally limited 
government, and free market economic policies.”42 Although once at the fringe of political 
discussions, the values of Tea Party followers have recently become more incorporated into 
mainstream politics—especially the Republican Party platform—due in part to the successful 
election of individuals such as Congressman Paul Ryan of Wisconsin and Representative 
Michele Bachmann of Minnesota43. 
 As mentioned earlier, most of the parents with whom I spoke did not express support 
for statements made by Bachmann, or for conservative politics in general, which is not 
entirely surprising due to the general political climate of the San Francisco Bay Area. Most 
parents I interviewed identified as Democratic (76 percent) with some identifying as 
Republican (13 percent), and the rest identifying as Green, Independent, or Libertarian (11 
percent). The majority also described their political values as extremely liberal or liberal (64 
percent) 44. Purposively employing language present in U.S. political media coverage of the 
Tea Party, I asked parents the following question in the written questionnaire: If you had to 
choose, which would you rather have a) a smaller government that provides fewer services to 
citizens or b) a bigger government that provides more services to citizens? 
The majority (82.9 percent) stated that they would prefer a bigger government, which 
is not surprisingly given the liberal political values expressed by most parents. However, I 
                                                        
42 Tea Party Patriots website (http://www.teapartypatriots.org/). 
43 In 2010, Michele Bachmann launched and organized the Tea Party Caucus, comprised of 52 members, all of 
who identified as Republican (http://teapartycaucus-bachmann.house.gov/about-me/history).  




also asked parents to respond to the following question regarding parental rights and 
governmental involvement: 
Which of the following statements do you agree with more a) government should let 
parents decide for themselves how best to protect their children even if it means they 
don’t always do the right thing; b) government should pass laws to ensure all 
children are protected even if it sometimes interferes with parents’ rights to make 
their own decisions? 
 
Overall, more parents selected wanting more government involvement (57.5 percent), but 
only by a slight margin, with 42.5 percent stating that they would prefer to let parents decide 
(Figure 24). Also, based on the results of an independent t-test, there was a significant 
relation between responses to this question and vaccination status, X2 (2, n=42) = 6.247, 
p=.044. When I excluded those parents who answered not sure, I found an even stronger 
Figure 24: Parental responses to “Which of the following statements do you agree with more a) 
government should let parents decide for themselves how best to protect their children even if it 
means they don’t always do the right thing; b) government should pass laws to ensure all 
children are protected even if it sometimes interferes with parents’ rights to make their own 
decisions?” by vaccination status 
143 
 
relation between two variables, X2 (1, n=35) = 6.217, p=.013, indicating that those parents 
who valued parental rights over government laws were less likely to have vaccinated. 
 Parental rights have been at the center of public debates regarding HPV vaccination 
since licensure (as described in a previous chapter). As evidenced by questionnaire data as 
well as interview data, opinions regarding parental rights seemed to play a clear role in 
vaccination decisions and deliberations among parents with whom I spoke. For example, 
Lillian, mother of one unvaccinated 16-year old daughter, stated it most plainly when she 
said: “I’m the type person—like, I don’t let government rule over what I’m gonna do to my 
child.  And [HPV vaccination] is one of them that I’m not gonna let them rule." 
However, views on parental rights did not always fall in line with general political 
values expressed by parents. As Valerie explained: 
Valerie: I certainly think that it’s the government’s responsibility to help promote 
health.  I mean, I identify as a Democrat, and I generally believe that the government 
should be here to help people.  It’s kind of like saying pharmaceutical company when 
you say government.  There’s all this implied negativity.  But I think at its best that 
the government should be involved, you know, in the public school system, in the 
counties, in advertising—and they do. You know the five a day, trying to get people to 
eat healthier, exercise more, and I think that’s great (Mother of a 5-year old son and 
7-year old daughter, both unvaccinated). 
 
However, when I asked Valerie her opinion on childhood immunizations, she surprisingly 
stated she did not think they should be required: 
Valerie: But I think generally, you know for things like mumps, measles – things that 
are serious illnesses that people should vaccinate their children.  However, I do not 
thing that the government should mandate that people’s children be vaccinated.  I 
really believe truly that it’s a parent’s decision even if—yes even if there’s parents 
out there that don’t vaccinate and there is potential to put people at risk.  That’s the 
way life is. It’s random. You know what I mean? 
 
Kate: So you’re willing to take the risk that there may be people that decide not to 







Although a supporter of governmental policies promoting public health in general, she placed 
higher value on parental rights so much that she was willing to accept potential individual 
and collective risk to maintain these rights. Sarah, on the other hand, a libertarian in support 
of small government, strongly supported mandatory vaccinations. As she explained:  
Sarah: I had trouble answering the question…I kinda lean libertarian or more 
moderate. And so, therefore, I’m kinda in favor of a smaller government. But on the 
other hand, there’s a few, like the topic of vaccines, I feel like vaccines should be 
mandatory for everyone that can get them. So in that area, I’m more in favor of a 
large government. So I really—I have an internal conflict there (Mother of vaccinated 
14-year old son and 17-year old daughter). 
 
Although the questionnaire forced parents to choose one versus the other, many parents 
expressed an uncertainty and tension regarding the role of government in relationship to their 
vaccination decision during interviews. Within these tensions, questions of freedom and 
ethical responsibility as parents and members of society—specifically in relation to health—
are invoked and articulated to help negotiate uncertainties of risk and desires to care for their 
children. 
 
Notions of Freedom 
 Across our conversation, David, a city planner and father of one daughter, expressed 
his opinions in a way that allowed for complexity, controversy, and care to emerge. Born in 
China, he moved with his family to San Francisco at a young age, and never left. When I 
asked him about his views on what role the government should play in his parenting 
decisions, using Christian Scientists as an example, he explained: 
David: It’s tough. It’s hard for me to say. I don’t want a child to die un-needed for 
something I consider so little, but [Christian Scientists] whole-heartedly believe in 
their religion. And I can’t step on their religion and say no, what you believe in is 
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completely ridiculous; your God would never want a child to die. Whatever their 
belief is, that’s a tenet of American society—religious freedom. It’s what our country 
was founded on; that’s why we came here.  It’s not like I was on the Mayflower or 
something, but you’re asking such a very, very difficult decision, that question. 
Because I don’t want the government to one day—it is a slippery slope to demand 
this, this and this. You know, they won’t sell soda over a certain ounce because it’s 
going to cause obesity, which is going to cause your kid to have diabetes, which is 
going to cause them to have all these diseases. That right there is over-governing, you 
know?  I don’t want the government telling me what I can and cannot eat.  That goes 
back to my eating ice cream for breakfast. If that’s gonna be illegal, if I do that, the 
government is going to come down to my house and take my daughter because I fed 
her ice cream for breakfast.  These are extremes, where the government forces that 
they think is best for you, versus what a parent is free to do; eat ice cream, or not take 
asthma medication.   
 
Earlier in our conversation, in the context of his view of health, David had disclosed that he 
sometimes likes to eat ice cream for breakfast, and for him, this behavior, while he 
recognizes may not be the most healthful, should be a choice allotted to him as an individual 
and parent, not governed by the external policies. He further explained: 
David: It’s hard. I want something in the middle where it’s—if I had to choose, you’re 
asking for me to choose, and this is partly political, partly, I’m going to edge towards 
the side of a parent’s freedom. I think it is human nature to protect your child, and I 
will believe in the goodness of a parent’s heart that they want the best for their child.  
Yeah, there are extreme cases. You see tiger’s eating their babies. You see parent’s 
selling their babies on E-Bay, pimping out their kid for crack. So there are 
abnormalities. There are outliers, but I still believe the vast majority of parent’s 
believe what’s best for their kids. They want what’s best for their kids.    
 
In these deliberations, David and other parents invoked more than personal political values, 
but situated parental decision-making (including vaccination decisions) as representative of a 
core American value—freedom. These notions of freedom are also shaped—and reassured—
by a general hope that parents will do what is best for their children. Jessica, a mother of five 
children who identified strongly with the Mormon religion, also invoked the importance and 
existence of freedom, even if she felt her own values were not always supported by larger 
public health promotion. 
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Jessica: I think [public health] is limited sometimes because of just different 
viewpoints, say on things like sexual health. Certainly public views on that, in my 
opinion, don’t always correspond with mine, and I believe mine actually promote 
more health. But I feel like we can’t talk about it ‘cause it’s feels like you’re saying 
you have to live a certain way, and we want freedom of how we live. 
 
Kate: And do you feel that what’s out there and what you hear allows you to have the 
freedom to live your life? 
 
Jessica: Yeah, I feel like we do have freedom in this country, though there are a lot of 
things you know talked about at schools that if you are in the minority opinion, um, 
you can feel silenced about your opinions. It’s just easier not to say anything, and to 
promote something that you really do think is healthy…But I do feel free to live how I 
want to and have a difference of opinion on things and do what’s best for my family. I 
do feel the freedom to do that.  
 
Sharon Kaufman (2010) in her work on vaccination and autism discussed how notions of 
freedom and doubt are shaping rising uncertainty regarding vaccines in the United States. 
Beyond vaccines, these notions underlie much of what constitutes broader political 
discussions regarding healthcare—and scientific knowledge—amid increased risk 
management and assessment as a way to organize life (Lupton 1995) and growing vaccine 
anxieties (Leach & Fairhead 2007). These values—and uncertainties—shape not only 
healthcare decisions, but are embedded in the way in which we—as a nation and collective—
parent and care. Although there are great differences between individuals, these values and 
practices are also culturally shared. To those outside of the United States, the commonalities 
and differences are made clearer. As one parent born and raised in Northern Ireland noted: 
Natalie: Why are people, why are families not getting [the HPV vaccine]? Well, it’s, 
interesting. It’s—we’re all so towed to our kids. I have a kid who really, the eldest 
one tried to rule our home and kind of did. It was kind of like constant battle to try 
and take control. So it’s interesting you know, culturally, why we’re not obedient to 
our doctors. That’s not how I grew up in Northern Ireland…for vaccines we were 
lined up at school and had them. And there was just no, no fuss about it. Nobody 
wanted it, but you just got on and had it...That whole, that’s sort of a movement that 
we’re in charge of our health destiny, not the recipients of medical care. So it’s that 
whole self-care movement is therefore questioned. The whole, you know, you’re going 
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in and you’re telling your doctor what new drug you should, you know, it’s ridiculous 
(Mother of vaccinated 16- and 20-year old daughters). 
 
Whether or not these values are unique to the United States is unclear, as there has been 
much discussion of the broader patient empowerment movement across (at least) Europe, 
Australia and other more westernized countries. However, as Natalie suggested vaccination 
decisions are more than questions of safety and risk, more than questions of biomedicine, but 
rather are entangled in questions of—and given meaning through—our cultural, political, and 
moral values. 
 In the next section, I will further examine the notion of responsibility and how this 
came to bear on vaccination decisions. Considerations of responsibility and parenting are 
also imbued with moral assessments—an othering of sorts—whereby individual parents 
construct lines between themselves as responsible parents who should be free to parent as 
they deem, and other (often unnamed) irresponsible parents who should not be given the 
same freedom they expect for themselves. Through these lines, moralizing discourses 
construct clear demarcations between the right and wrong way to parent.  
 
II. MORAL ASSESSMENTS 
Pearl: So I’d like to say [government policies] shouldn’t impact mine at all cause I’m 
a responsible parent.  But I think for things like this that can have a big impact on 
other people that it makes a lot of sense for the government to have required vaccines 
or treatments or whatever.  But I tend to see it more a recommendation kind of thing, 
but I know there are people out there that aren’t going to pay attention to that or are 
not even educated enough to see the benefit of doing things like that (Mother of 
unvaccinated 3-year old son, and 5-and 8-year old daughters). 
 
Pearl, a biomedical researcher and mother of three children, supports mandatory vaccination 
as a safeguard against the harms that other (uneducated) parents' actions may have on 
society. However, for her, she does not "need" these policies, as she is "a responsible parent." 
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For many parents, similar to Pearl, their support for government intervention regarding 
parenting choices came from a benevolent desire to protect children, and a realistic (or 
pessimistic) understanding that not all parents placed children first. As Sadie explained: 
Sadie: My response in the questionnaire was that I would rather have a large 
government and more services for everybody, and that government should be 
involved in making regulations for parenting. And my thinking is just because the 
person could live through a lot of abuse, and you know in my case I likely don’t need 
regulations, but I may not be the common. There are many, many children who suffer 
because their parents are not doing the right things.  So for those who are not 
protected by the parents, the government should intervene.  That’s why we remove 
children from the abusive parents, and that’s very unfortunate. But otherwise, they 
would just continue to be abused.  Yeah, I think they should intervene, it’s unfortunate 
but I can’t think of just me and not think of everybody who will treat their children 
well. That doesn’t guarantee anything.  People can still be abused at any level of 
society (Mother of vaccinated 17-year old daughter and unvaccinated 19-year old 
son). 
 
Although often unnamed or invisible, many parents invoked these "other" parents as 
evidence of the need for governmental policies to protect all children. However, for some, 
these parents are known intimately, as in the case of Marlene. In our conversation, Marlene 
discussed her niece, a mother who did not vaccinate and homeschooled her children, to 
situate her own beliefs. For example, when I asked if she believed parents should be in 
charge of whether or not their children are vaccinated, she explained:  
Marlene: Yes, I think parents should have the right not to vaccinate their children, but 
I think there should be pretty aggressive education campaigns for parents.  I know my 
particular pediatrician’s office, if you do not believe in childhood vaccines you 
cannot be their patient. They’ll talk to you about it, and they’ll probably maybe do a 
modified schedule or something. But they feel very strongly that it’s a public health 
issue and it’s not a for your individual child’s issue.  I mean they’re still your kids, 
and it’s not like you should have no rights, but I think it should be very carefully 
researched.  Unfortunately not all parents do that. I know it’s colored by my 
particular niece, but you know you get into these communities that are all very like-
minded, and they all home school so they’re not getting any information from the 
public schools or private schools. And they’re not taking their kids to regular doctors. 
They’re going to these alternative doctors…So there are, I think, an awful lot of 
people that it’s hard to reach them with information, particularly because there’s a 
whole, kind of, God defense that even if you did reach them with the information they 
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would refuse it.  Which then if they’re refusing it, as opposed to not knowing it 
(Mother of unvaccinated 7-year old son and 12-year old daughter, and vaccinated 14-
year old daughter). 
 
Although education is an important step in ensuring the safety of children, as Marlene and 
others explained, it may not resonate with parents who refuse to vaccinate based on 
intersecting moral, religious or social practices. For these parents, not vaccinating is 
constructed as not protecting or caring for children. However, what constitutes care is clearly 
not uniform across parents with regard to vaccination, as the meaning attributed to the act 
(vaccinating or not vaccinating) differed depending on constructions of risk. Regardless of 
views on HPV vaccination, many parents stressed the government had a responsibility to 
protect children when parents were not fulfilling their moral obligation to care. In these ways, 
responsibility—in the shape of caring for children—becomes central to the construction and 
subjectivity of what it means to be a parent.  
 
III. RESPONSIBILITY TO PROTECT 
Nowhere does it seem that kinship, as a system of subjectivation, has assumed the 
exclusive character of a system of subjection. Perhaps it has come close, and in its 
various interfusions with class or race or gender, closer still. Yet it seems always to 
have stopped short of sheer imprisonment, sheer slavery. It thus seems always to have 
left a bit of room--if greater room for some (usually adult heteronormative male) 
beings-in-relation than for others--for what Foucault would have us understand as 
ethics (Faubion 2011:18). 
 
Foucault and those who speak through or against his work have discussed the ways in 
which individuals become subjects of certain moral and ethical orders. As noted in earlier 
chapters, I originally used these theories as the primary focus of my dissertation project. 
However, as noted by Faubion, in terms of kinship or parenting, there has always been room 
for individuals to resist and rework "systems of subjectivation" through practices. In my 
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conversations with parents, responsibility to care—or protect—emerged as key to how 
parents understand and construct what it means to be a parent. As Annie, mother of 16- and 
18-year old daughters, both vaccinated, explained: 
Annie: I’m not inclined to be a permissive parent and I’m not inclined to see 
parenting as a partnership with a child, the fact that I’m going to make this decision.  
I know parents that, particularly with this [HPV] vaccine, have left it up to the 
daughter to decide. And to me that’s up to the parent.  If you want it fine, if you don’t 
want it fine, but I think it’s your job to make these decisions.  I think it’s my role to 
make these decisions and to provide the best protection and to give them the best 
chance to have a healthy adult life, and, relieving them of a certain amount of worry 
if I possibly can. 
 
Annie stresses that although parents can decide what they want with regard to vaccination, it 
is their job—and their job alone—to decide. Other parents invoked this notion of protection 
as part of a parent's obligation as a parent, yet, as Ruth noted, parental power to protect 
becomes increasingly difficult as children age: 
Ruth: I think as a parent I would like to keep her safe from as many things as I can, 
but I’m very aware that you know she’s gonna be an adult soon and she’s gonna be 
separate from me. And quite frankly, um, even though she may not be ready to be an 
adult at eighteen, she will be. And at that point in time, there are fewer things that I 
can compel her to do. I can ask her, I can cajole and beg, but I can’t make her. But I 
can right now and um, I suppose if she said to me, ‘Mom, I’m absolutely against this. 
I don’t want to do this,’ that I would strongly consider her opinion. But she doesn’t 
have that opinion formed yet and if I, if I can protect her from something, I think it’s 
my job (Mother of unvaccinated 12-and 16-year old daughters). 
 
In these ways, parents are choosing to vaccinate in the present to help extend protection over 
their children in the future. As Rebecca explained: “Where vaccinations come into play, if I 
feel I’m not aware of tremendous down sides and high risks, taking preventative action—It’s 
just kind of my personality, and planning for the best outcome in the future” (Mother of 
unvaccinated 11-year old daughter).   
For many parents with whom I spoke, the driving reason to vaccinate their child 
reflected a larger obligation and desire to care for their child. As Delia simply stated, "I think 
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[HPV vaccination] is part of me taking good care of my child." Beyond caring for their 
children, for many, vaccination also represented a moral obligation to help protect other 
children and society in general. As Joyce explained: 
Joyce: I don’t really see [vaccination] as a parenting issue except that parents 
typically make the decision for their kids and are the ones to get their kids to the 
vaccination channel, wherever that is.  But I see it much more as a social obligation 
than a parenting obligation...I just think that some of the diseases that have come 
back, because parents or whomever has opted not to vaccinate their families, I think 
is socially irresponsible and unfair to everybody else.  I don’t see it as a political 
issue and I don’t see it as a religious issue.  To me it’s like stopping at a red light 
(Mother of unvaccinated 13-year old daughter and vaccinated 15-year old son). 
 
When I asked Pearl how she sees her decision to vaccinate fitting in with overall parenting 
values, she responded:  
Pearl: I think it promotes healthy lifestyle, and I also think it’s the responsible thing to 
do. 
 
Kate: Responsible in what way? 
 
Pearl: Society. So it protects them, but it also protects other people from potentially 
getting whatever they could carry. 
 
Some parents viewed the act of vaccinating their child as primarily a way to protect their 
child, and only secondarily a way to protect society. As Ruth described: “I think with [HPV 
vaccination,] in particular, it’s a very personal, you know, that’s my child. And I guess that 
you can extrapolate out that I’m protecting other peoples’ children, but in the process I’m not 
really thinking about them.” While others, like Emily, acknowledged that they were willing 
to take the minor potential for risk to their child to protect others. 
Emily: I can make decisions for my own children, but many of those decisions and the 
things that happen to them might affect the other people, either in their own 
generation or broadly.  So, for example, with vaccinations I know that even though, 
the more people get a particular virus or disease, the more likely it is to spread, so in 
the interest of public, the general health of the public—of the society—sometimes we 
need to take more care to those things.  So I’m very concerned about contagion and 
spreading issues. So, for example, when I talk to my children about sexuality I talked 
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a lot about [that] it might not be that it’s a problem for you, but there’s a problem for 
the society doing such and such.  So I keep that in mind in making the decisions—
meningitis and HPV. At this point, I can see socially, and if I think my son is going to 
be of risk to society in not having [the HPV vaccine], then I would probably urge it—
despite any risk to him (Mother of unvaccinated 16-year old son). 
 
For these parents, they viewed vaccinating their child as part of their subjectivity and 
responsibility as parents to protect. For some protection extended only to their child, while 
for other protection extended to broader society. As detailed in an earlier chapter, other 
parents viewed not vaccinating as the best way to protect their child as they viewed the HPV 
vaccine as a source of risk, not protection. Beyond protecting their children, whether they 
vaccinated or did not plan to vaccinate, many parents invoked other ways to protect children 
against HPV that reflected not only the nature of transmission, but moral assessments of 
certain behaviors and constructions of vulnerability (Nichter 2003). 
 
IV. VULNERABILITY, RISK, AND NEW MORALITIES 
Although often conspicuously absent from the marketing of the HPV vaccine, a early 
concern from the perspective of health advocates regarding uptake of HPV vaccines was the 
nature in which the virus is spread: through intimate, sexual contact. Although Hepatitis B is 
also primarily spread through sexually contact, very little public resistance occurred when 
this vaccine became part of the suite of recommended childhood vaccines45. This may be 
partly due to the differences in the recommended timing of the vaccine, which for Hepatitis B 
begins at infancy (six months old), while for HPV vaccination it is recommended at 11—
closer to an age when a child might become (or be perceived to be) sexually active.  
                                                        
45 More recently, more parental resistance has been noted, which may be reflective of larger societal resistance 
to vaccinations in the United States (See Comis 2011 for further discussion). 
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 In the context of HPV vaccination, for many parents, particularly those who 
supported other childhood vaccinations, but not necessarily the HPV vaccine, the 
transmission of HPV situated the vaccine and vulnerability to the virus as different. Lorraine, 
who I introduced in an earlier chapter, stated it simply that "the HPV one is different in 
character." When I asked her why she explained: 
Lorraine: Cause you’re talking about a behavior that leads to some diseases, and the 
case of chickenpox or polio, you’re talking about exposure.  You can’t avoid the 
diseases by avoiding behaviors.   
 
Kate: In the case of HPV, what are the behaviors? 
 
Lorraine: I mean if you can practice safe sex, and of course, my kids aren’t having 
sex yet and I’m sure at some point I’ll need to know more about it when they do, but 
I’m not an expert at it at all.  Having PAP smears regularly, of course, to look for 
cervical cancer, and again, I don’t really know what the incidence rates are.  I’m 
sure they’re big enough numbers to want people to want to do this... You’re not going 
to sit next to somebody on a bus and get it.  You could sit next to someone with 
whooping cough. 
 
Pearl also used the notion of riding the bus to explain differences between HPV vaccination 
and other required immunizations: 
Pearl: Whooping cough doesn’t require sexual interaction with another person, which 
is more intimate that sitting next to someone.  Hopefully that’s a decision that you 
make as opposed to—with whooping cough you could be sitting next to somebody on 
a bus or something like that. 
 
Beyond the intimacy and perceived control, vulnerability to the disease is constructed 
through notions of ethics—whether it ethical reflections in the form of personal convictions 
or parental obedience. As Mona explained in the context of her opinions on requiring HPV 
vaccination for school children: 
Mona: I don’t think this country is in a position for that right now.  I think that 
people– for right or wrong—people are, a lot of people, like to bury their head in the 
sand about what their kids sexual activity is anyway. But because of that, and you’ve 
got parents who believe that their kids are not sexually active or are expecting that 
their kids won’t be until they’re married, it’s asking them to do something that is 
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gonna prevent something that they shouldn’t be getting because they’re following 
their parents rules.  That’s intruding in a way every family—it’s not your convictions 
that stop you from getting whooping cough. It’s a different thing.  You get these 
things from very specific activity; it’s not from being in the wrong place at the wrong 
time on a bus (Mother of 9-year old unvaccinated daughter).  
 
In these reflections, developing and transmitting communicable diseases—such as 
pertussis—are constructed through innocence—a shared vulnerability that even moral 
individuals have from "being in the wrong place at the wrong time"—innocent bystanders 
vulnerable to the randomness of life. However, even among this randomness, there is 
meaning and power. Let us take, for instance, the act of riding the bus used by many parents. 
This is an act that is purposive in some cases—particularly in a geographic region that prides 
itself as “green” or environmentally conscious—I choose to ride the bus because I care about 
the environment. However, riding the bus may also be a forced choice—due to economic 
status, structural inequalities, or lack of other alternatives. In this case, this act can be 
stigmatizing. While this single act carries many meanings, parents used this as an example of 
innocence and susceptibility beyond the control of the individual to be exposed to disease, 
and thus reason for why one would be vaccinated. HPV transmission, on the other hand, 
requires intimate contact. While sexual behavior is a practice that has been in existence 
arguably as long as humans themselves have, it carries distinct meaning and judgment, even 
among liberal communities. 
 For other diseases, blame is removed from the individual through perceived lack of 
control. In the case of HPV, parents constructed the ability to prevent the spread of this 
communicable disease through "convictions" and other morally just behaviors. Despite its 
near ubiquity across the population, HPV is entangled with moral assessments of behavior 
and values, reflecting historic and current norms regarding sex. Even for parents who may 
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not view the act as distinct for themselves, they recognized that, for others, this might be a 
reason for resisting vaccination. As Ruth explained: 
Ruth: There are certain vaccines that should just be required. Um, hepatitis, you 
know all of those, why you would want to be at risk for that. I just can’t imagine. And 
HPV, well you know, that’s, that’s a harder one for me to require. You know people 
can be weird about sex...I kinda look at it as it’s where you get babies from, you 
know, I mean let’s be real here...I don’t think of it in terms of public health but it is 
actually a public health issue 'cause I think at first you think of sex as being a one-on-
one. But then when you think about if you have sex—If you’ve had sex with how many 
other people than it becomes a public health issue. Which is why I go back to my kids 
and say, ‘Always use barrier method’…I’m the crazy lady who says when my kid goes 
to piano lessons she comes home and I say, ‘Wash your hands.’ She’s like, ‘Why?’ 
‘Cause you been playing piano with sixty-seven other people'...You know, well it goes 
for sex too. [laughing]. 
 
Kate: That might actually be an effective public health slogan—Playing piano with 
sixty-seven others [laughing]. 
 
Although joking, in thinking through the public health implications of my findings, I do think 
beyond identifying ways to ensure parents of different classes, races, and ethnicities have 
equitable access to comprehensive information regarding potential risks and benefits of HPV 
vaccination, public health promotion and physicians may need to directly address the 
parents’ concerns—embedded in normative concerns of parenting rights, sexuality, and 
prevention—to increase vaccination uptake. Training programs for health educators should 
aim to open communication pathways between parents, healthcare providers, and children 
regarding not only HPV vaccination, but also sexual health in general. Additionally, I believe 
public health campaigns should directly address parents’ concerns regarding the sexual 
health—not only cancer prevention—implication of HPV vaccination, as well as clearly 


















CHAPTER SIX: FUTURE DIRECTIONS 
 
How can we facilitate a more informed debate about the uncertainties of the science, 
effectiveness, and true costs of therapeutic advancements? (Biehl 2011:281).  
 
Increasingly, in the field of anthropology, scholars have called for action-oriented 
ethnography in which we use the richness of our methods and closeness to those with whom 
we study to challenge the networks and practices of power that result in unequal conditions. 
While not a mandate, I have struggled to place action and implication as driving forces 
behind the research questions I find most relevant and meaningful, even when working with 
those communities who have access to power. In the field of social work, action has always 
been at the core of the discipline. However, amid limited resources and devaluation of the 
practice, the need to act may not leave much room for critical engagement or reflection, 
opening up the potential for action to be misplaced or misguided.  
As an interdisciplinary scholar, I have experienced these tensions, feeling the pressure 
to conduct quickly translatable research without losing the value and detail that (by nature 
time-consuming) ethnography offers. How does one translate the richness of ethnographic 
findings into action without succumbing to such levels of reduction that the value is lost? On 
the contrary, rapid intervention that focuses on only one predictive factor, while missing the 
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complexity of lived experience, does not necessarily mean one is chipping away at the 
underlying causes, but rather through reduction, the value once identified may be lost 
completely.  
In this dissertation, I have not come close to achieving balance—between the hope 
and harm—of illuminating complexity while identifying clear, actionable ways to improve 
health and reduce inequitable conditions. It may stem from my own uncertainty of what 
“improvement” or “action” means in the context of HPV vaccination or health promotion in 
general. I have reviewed the scientific evidence, and I understand why parents are uncertain 
regarding both the potential benefit and risk regarding HPV vaccination. However, I also 
understand the potential benefit of a vaccine that possibly prevents cancer, and the history of 
initial, public resistance to a new vaccine that several years later, hardly anyone questions. 
Additionally, I am critical of the influence and power of the pharmaceutical industry, but also 
critical of those outright against vaccination as they also have an agenda, and use information 
in strategic ways to achieve their own motives. Furthermore, the people with whom I studied 
are largely privileged with access to material and social resources beyond what most of the 
world can imagine. So, what, then, are the implications of my research? When those in the 
position of power reject, resist, or avoid what biomedical experts’ position as ‘health’, what 
if anything is there to be done? 
 In nearly each interview, parents concluded by asking me questions, not about my 
project or my thoughts as an anthropologist or social worker, but as a person—an expert—
with access to (and time to reflect upon) information. Is the HPV vaccine safe? Is the HPV 
vaccine harmful? Will the vaccine protect my child from cancer? What would I do if I had to 
decide for my daughter now? Careful to first convey that I am not a medical doctor (covering 
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my own liability as just a researcher), I would turn off the recorder and give my honest 
answer—I do not know. I would follow up stating that based on scientific evidence, it seems 
the HPV vaccine is as safe as any other vaccine, and that it has been shown to reduce 
precursors to cervical cancer, but more time is needed to evaluate its impact on cancer 
incidence. However, in the end, I could never with certainty answer the questions parents 
asked me. Uncertainty prompted this project, and at its end, the uncertainty remains. 
However, much to my surprise, when I answered parents, they did not seem 
disappointed, or entirely surprised by my answers. My acknowledgment that I—an expert of 
sorts that has spent the better part of a decade trying to understand the topic—am also 
uncertain made sense, and usually did not sway their intentions or decisions regarding 
vaccination in the slightest. It did, however, open up the potential for informed debate and 
acknowledgement of the uncertainties of not only science, but the ethical challenges of 
deciding how best to care and live amid technological change.  
In the end, where I see the most clarity regarding the implications of my research, is 
to help promote and encourage open conversations about the uncertainties of the HPV 
vaccination in the United States as well as the structural factors associated with HPV 
vaccination. Medical information and care is not being shared equally, and those engaging in 
critical examination of health promotion may be as much to blame as any others. From my 
observations, I do not believe an informed debate is occurring, between scientists and 
parents, between parents and providers, between parents and adolescents, and between those 
in staunch support of HPV vaccination and those strongly against. This is not to say that 
informed debate will lead to uptake of certain behaviors (or should it), but I do believe access 
to knowledge should be shared equally. Amid a flurry of information, many parents felt that 
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healthcare providers, public health pamphlets, and pharmaceutical industry are not answering 
the questions they have. For example, many parents asked Why age 11? Is it because the 
vaccine is more effective, or is merely a matter of making sure to vaccinate before children 
are sexually active? After searching clinical trial data, I did find scientific data supporting the 
potential increased immunogenicity of the vaccine at earlier ages, but even if parents can find 
it, the information does not mean anything necessarily either because they may not 
understand the highly specialized jargon or because it is based on a small sample of other 
people’s children. Even among my highly educated sample, medical knowledge is not easily 
communicated or understood, but without attempts to open up the conversation, we are not 
acting to help improve conditions. While the parents with whom I spoke are in a position of 
power in comparison to some, there are those in much higher positions—namely, 
pharmaceutical industry and even physicians—who are access to more power and are making 
decisions that shape health outcomes across the population. 
Beyond the need for researchers and providers to more fully communicate, many 
parents, as patients and caretakers, may not be even attempting to ask these questions. This 
may be due to inherent power relations between providers and parents, more pressing 
concerns due to structural inequalities, or general lack of awareness (or desire) regarding how 
to evaluate and decide on medical care. Furthermore, parents may not be communicating to 
their own child regarding sexual activity and why vaccination should or should not be 
delayed. Each of these communication breakdowns offers an opportunity for action. 
As such, my findings suggest that interventions—whether they are at the level of 
mass media or clinical encounters—need to address how we can help communicate not only 
the uncertainty of science, but also the true costs—and potential benefits—of medical care. 
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This is not to devalue or dissuade or even persuade individuals from engaging in preventive 
health behaviors, but rather by opening up communication, make space for informed debate 
to occur. Social workers have a key role to play in these discussions as they have unique 
training in communicating—and listening—to individuals to not only elicit their preferences 
for care, but also ensure information is presented in a manner that is both comprehensive and 
comprehensible for all individuals. Anthropologists, whether in the form of direct practice or 
research methodology—can also provide invaluable insight into the complexities—and 
inherent uncertainties—in deciding how and what it means to care. 
In addition to communication interventions, structural inequities that not only prevent 
access to healthcare, but restrict access to education, employment, and safe environments 
need to be reduced to allow parents the opportunity to think through the costs and benefits of 
medical care. Additionally, it should not be assumed by researchers, providers, or others that 
parents of low levels of education, lower income status, or different cultural or ethnic 
background all desire (or do not desire) to learn more about the uncertainties of medical care 
or engage in open communication. Although most of the parents with whom I spoke came 
from privileged backgrounds, those who did not, expressed great interest, reflection, and 
thought into why and how they decided to vaccinate or not vaccinate their child against HPV. 
I would agree that without access to basic needs and healthcare, these considerations may 
seem secondary, but to make presumptions either way serves to perpetuate, rather than 
eliminate, health and resource inequities. In many ways, those most vulnerable have suffered 
the greatest costs with regard to therapeutic advancement, and thus potentially stand to 













APPENDIX A: VACCINE EXEMPTIONS BY STATE 
 
  












APPENDIX B: INTERVIEW GUIDE 
 
Introduction 
1. Please tell me a little about yourself and your family 
2. Please imagine your child as an adult and describe what kind of person you would like 
your child to be (emphasizing the three most relevant characteristics). 
3. Please imagine your child as an adult and describe to state what kind of person you 
would not like the child to be (emphasizing the three most relevant characteristics). 
4. Lastly, please describe which of your main values (emphasizing top three) that you 
would like to pass onto your child.  
 
Theme I: Health Care 
1. How many times in the last year did your child visit a doctor of any kind in the last 
year? 
2. Who took the child to these visits (e.g. yourself, child’s other parent, other)? 
3. How many of these visits were for preventive reasons (e.g. shots, physicals, check-
ups)? 
4. What kind of health care provider does your child usually see (e.g. primary care, 
emergency care)? 
5. How would you describe the care your relationship with your child’s doctor? 
6. Has your child received any childhood vaccines? If so, did you follow a standard 
schedule or different? 
 
Theme II: Learning about the HPV Vaccine 
1. When did you first become aware of the availability of the human papillomavirus 
(HPV) vaccine? 
2. Were you aware of HPV before learning about the vaccine?  If so, how did you learn 
about it? 
3. With whom in your life (e.g. friends, family members, health professionals) have you 
discussed HPV vaccination? 
4. What public sources (e.g. newspapers, internet) have you used to learn about HPV 
and HPV vaccination? 
5. Are you aware of the public debates surrounding HPV vaccination?  If so, what is 
your opinion on this issue? 
6. Have you seen any media advertisements or commercials for the HPV vaccine?   
7. Have you seen any public health outreach on the HPV vaccine?   




Theme III: Personal Constructions of Risks, Benefits, & Facts 
1. From your understanding, what does the HPV vaccine claim to protect against?   
2. Who can be vaccinated against HPV?   
3. What evidence are you aware of concerning the efficacy of HPV? 
4. What are the risks of HPV? 
5. What are the risks and/or benefits of HPV vaccination? 
6. What sources did you use to learn about the risks and benefits? 
7. When someone says something is a fact, what does that mean to you? 
 
Theme IV: Salient Factors in Decision-Making 
1. Have you vaccinated your son(s) or daughter(s) against HPV? 
a. If so, has your child completed all three doses? Which type (Cervarix or 
Gardasil) did he or she receive? Where did you child receive the vaccine 
(location)? Did your child have a reaction to the vaccine? 
b. If not, are you planning on vaccinating your child in the future? 
2. Have you been vaccinated yourself? 
3. What factors influenced your decision to vaccinate or not to vaccinate your child (e.g. 
information, other parents, doctor, or personal experience)? 
4. Who made the decision to vaccinate or not to vaccinate your child (e.g. you, other 
parent, doctor, or child)? How involved were you in the decision to vaccinate or not 
to vaccinate your child? 
5. How, if at all, has the media and marketing campaign affected your decision? 
6. Did you find the decision difficult? Why or why not? 
7. How long it take you to decision? 
8. Did you feel confident about your decision? Why or why not? 
9. How often do you worry about your child contracting HPV? Developing cervical or 
other HPV-related cancers? 
10. What do you think is the chance of your child developing a HPV-related cancer 
(cervical, anal, or head & neck) in his or her lifetime? 
11. What do you think is the chance of your child contracting HPV in his or her lifetime? 
 
Theme V: Influential Values and Norms 
1. Please describe your overall parenting style (e.g. values, approaches). 
2. What factors have contributed to your parenting style (e.g. family, classes, religion)? 
3. How do you see your decision to vaccinate or not to vaccinate fitting in with your 
parenting values? 
4. Do you think both boys and girls should be vaccinated? Why or why not? 
5. Would you support the HPV vaccine if it only prevented genital warts? 
6. What is your opinion of the role of pharmaceutical companies in public health 
policies? 
7. What is your opinion of childhood immunizations in general? 
 
Theme VI: Role and Responsibility of Parents to Protect Children and Nation 
1. Is vaccination the best way to protect against HPV?  
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2. Do you feel parents should be in charge of deciding whether children should be 
vaccinated against HPV? 
3. Who should be responsible for ensuring the safety of vaccines? 
4. What role do you believe you play in ensuring your child’s overall health? Sexual 
health? 
8. In general, do you support mandatory vaccines for children? Why or why not? 
9. In your opinion, what role should public health or government policies play in your 
parenting decisions? 
10. What does public health mean to you? 
 
Closing 














APPENDIX C: CODING DICTIONARY 
 
ATLAS CODE DEFINITION 
AUTISM Any text referencing autism or the autism spectrum. 
AWARE_AGE_WHO Any text indicating parent’s awareness of who is recommended to receive the vaccine. 
AWARE_AGE_WHY Any text indicating parent’s awareness of why 11-12 are target age (or of target age). 
AWARE_GWARTS Any text indicating parent’s awareness that HPV is linked to genital warts. 
AWARE_HPV_BEFORE Any text indicating parent’s awareness of HPV prior to the vaccine. 
AWARE_HPV_RISK Any text indicating parent’s awareness of the risks associated with HPV. 
AWARE_PROTECT Any text indicating parent’s awareness of what the HPV vaccine claims to protect against or prevent. 
AWARE_SPREAD Any text indicating parent’s awareness of how HPV is commonly spread. 
BACHMANN 
 
Any text referencing explicitly Michele Bachmann or 
indication of her. 
BACKGROUND Any text referencing the upbringing or background of parent (e.g. education, childhood). 
BELIEF_ADULTS_VAC Any text referencing parental views on adults (over age 18) receiving HPV vaccine. 
BELIEF_ANTIVAC Any text describing parent’s general view of people who do not vaccinate their children in general. 
BELIEF_BIOMEDICAL Any text describing the parent’s perception of biomedical practices. 
BELIEF_BOTH_SEXES Any text describing parent’s view on whether boys and girls should be vaccinated. 
BELIEF_EVIDENCE Any text describing evidence (scientific or experiential) regarding vaccination (for or against). 
BELIEF_IMMUNITY Any text describing parent’s construction of immunity or immune system. 
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BELIEF_MAND_VAC Any text describing parent’s perception of mandatory vaccines. 
BELIEF_PHARMA Any text describing thoughts or perceptions of pharmaceutical companies. 
BELIEF_STI_ONLY 
Any text referencing parent’s view of HPV vaccination for 
prevention of sexually transmitted infection (beyond 
cancer). 
BELIEF_VACCINES Any text describing parent’s general view of childhood vaccines. 
CDC Any text referencing explicitly the CDC. 
CDC_FACTSHEET Any text describing the CDC factsheet about the HPV vaccine. 
CHILD_DESCRIBE Any text describing parent’s children in general. 
CHILD_EMOT_SELF Any text referencing parent’s perception of child’s emotional self. 
CHILD_MED_HIST Any text referencing child’s medical history (e.g. serious illness). 
CHILD_PHYS_SELF Any text referencing parent’s perception of child’s physical self. 
CHILD_SEX_ACTV Any text referencing parent’s perception of child’s sexual activity. 
CHILD_VAC_PERC Any text referencing child’s view or awareness of the HPV vaccine. 
COMM_CHILD_MD Any text describing communication between doctor and child. 
COMM_PARENT_CHILD Any text describing communication between parent and child. 
COMM_PARENT_FRIEND Any text describing communication between parent and friend, acquaintance, or coworker. 
COMM_PARENT_GYN Any text describing communication between parent and own doctor. 
COMM_PARENT_KIN Any text describing communication between parent and other family members. 
COMM_PARENT_MD Any text describing communication between doctor and parent. 
COMM_PARENT_SPOUSE Any text describing communication between parent and spouse/partner. 
CONTRACT_HPV Any text describing parent’s perception of likelihood of child contracting HPV. 
DELAY_MD_SUGGEST Any text indicating that doctor suggested delaying to parent. 
DELAY_MD_SUPPORT Any text indicating that doctor supported parents’ decision to delay. 
DEVELOP_CANCER Any text describing parent’s perception of likelihood of child developing cancer. 
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DM_CHILD_SEX_ACT Any text referencing perceived sexual activity (or inactivity) as a decision-making factor. 
DM_CORP_RISK Any text referencing potential corporeal risk of the vaccine (e.g. death, fainting) as a decision-making factor. 
DM_COST Any text referencing the cost of the vaccine as a decision-making factor. 
DM_EVIDENCE 
Any text referencing general evidence or information 
(either limited or substantial) about the vaccine as a 
decision-making factor. 
DM_FUTURE_PRTNR Any text referencing the desire to protect future partners (girls or boys) as a decision-making factor. 
DM_INSURANCE Any text referencing insurance status as a decision-making factor. 
DM_MD_REC Any text referencing provider recommendation as a decision-making factor. 
DM_OTHER Any text explicitly referencing factor contributing vaccination decision not already a code. 
DM_PREV_CANCER Any text referencing cancer prevention (other than cervical cancer) as a decision-making factor. 
DM_PREV_CANCER_CV 
Any text referencing cervical cancer prevention as a 
decision-making factor. Do not use for general cancer 
prevention. 
DM_PREV_SPREAD Any text referencing the desire to prevent the spread of the virus as a decision-making factor. 
DM_PROTECT_GEN Any text referencing prevention of genital warts as a decision-making factor. 
DM_VAC_EFFECT Any text referencing effectiveness of the vaccine as a decision-making factor. 
ETHNICITY Any text referencing cultural, ethnic or racial identify. 
FACT_CONSTRUCT Any text referencing how parents construct facts. 
FDA Any text referencing explicitly the FDA. 
FIRST_HEARD_HPV Any text describing when first heard about the HPV vaccine and from what source. 
FLU Any text referencing explicitly the flu or flu vaccine. 
FORMAL_ ED Any test referencing the public education their child received. 
FREEDOM Any text indicating freedom (as an American ideal). 
GENDER Any text indicating normative gender roles or behaviors. 
HEPATITIS Any text referencing explicitly hepatitis or hepatitis vaccine (A, B, or C). 
HERD_IMMUNITY Any text discussing the concept of herd immunity. 
HERPES Any text referencing explicitly genital herpes. Do not use for genital warts. 
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HPV_DIFF_TRANS Any text indicating transmission of HPV as different from other communicable diseases. 
HPV_OTHER_HAS Any text indicating parent has personal experience with HPV (not self). 
HPV_SELF_HAS Any text indicating parent has personal experience with HPV (self). 
HPV_VAC_AGE Any text referencing the age that child received the first dose of HPV vaccine. 
HPV_VAC_BENEFIT Any text describing general perceived benefits of vaccination 
HPV_VAC_DEC_QUAL Any text describing decision quality including decision confidence, regret, or satisfaction. 
HPV_VAC_DECISION Any text referencing vaccination decision explicitly (including past or future decision). 
HPV_VAC_DELAY 
Any text referencing delaying vaccination for specific age, 
moment, or situation (including past or present 
considerations). 
HPV_VAC_DM_PROCESS Any text describing the general decision making process (e.g. weighing pros and cons) for HPV vaccination. 
HPV_VAC_DM_ROLE Any text describing past or future decision-making role or role preference. 
HPV_VAC_EFFECT Any text describing parent’s perception regarding the effectiveness of the HPV vaccine. 
HPV_VAC_EVIDENCE Any text describing parent’s perception of the evidence regarding the efficacy, safety, or risk of HPV vaccination.. 
HPV_VAC_LOCATION Any text describing the location where child received the HPV vaccine. 
HPV_VAC_NOVELTY Any text referencing the amount of time since licensure (novelty) of the HPV vaccine. 
HPV_VAC_REACTION Any text description vaccine reaction experienced by child (HPV specific). 
HPV_VAC_RISK Any text describing general perceived corporeal or social risks of vaccination. 
HPV_VAC_SAFETY Any text describing safety of HPV vaccine. 
HPV_VAC_SCHEDULE 
Any text describing scheduling the vaccine series or 
efforts provided by doctor to assist in scheduling (e.g. 
reminder cards/calls). 
HPV_VAC_TYPE Any text referencing the type of HPV vaccine child received. 
ILLNESS_EXP Any text indicating personal experience with serious illness (self or other people in his/her life). 
ILLNESS_EXP_CVCAN 
 
Any text indicating personal experience with cervical 
cancer (self or other people in his/her life). 
IND_COLLECT Any text highlighting tensions between or constructions of individual and collective. 
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INFO_SEEKING Any text describing information seeking behaviors for general medical or HPV specific information. 
INFO_SOURCE_GEN Any text describing information sources usually sought out by parent about any medical information. 
INFO_SOURCE_HPV Any text describing information sources sought out by parent about HPV or HPV vaccine. 
INSURANCE_STATUS Any text referencing the insurance status of the parent or child. 
KNOW_CHALLENGE Any text references challenges to expert knowledge (scientific or otherwise). 
KNOW_EXPERIENCE 
Any text describing knowledge produced from 
experience—either from own experience or others. Do not 
use to indicate professional experience. 
KNOW_EXPERT 
Any text describing expert knowledge that is not explicitly 
scientific or biomedical but references experts (e.g. trained 
professional, policy) 
KNOW_SCIENCE Any text describing scientific or biomedical knowledge. 
LAW_PUB_HEALTH Any text referencing public health or health policy laws (other than vaccines). 
MCCARTHY Any text referencing Jenny McCarthy. 
MD_CARE Any text indicating larger quality of healthcare received (including access to care). 
MD_RECOMMEND Any text regarding doctor’s recommendation for HPV vaccination. 
MD_REGULAR Any text referencing if the child has a regular doctor he or she sees. 
MD_RELATIONSHIP Any text describing the quality of relationship with doctor. 
MD_TYPE Any text referencing the type of doctor the child sees (e.g. pediatrician). 
MD_VISITS Any text referencing how many times the child went to the doctor in the last year. 
MD_VISITS_TAKES Any text referencing who usually takes the child to the doctor. 
MEDIA Any text referencing media coverage of HPV vaccination in general. 
MEDIA_DEBATES 
Any text describing thoughts or reactions to public 
controversies regarding the HPV vaccine or vaccines in 
general. 
MEDIA_DTC Any text describing pharmaceutical marketing for HPV vaccination or in general. 
MEDIA_HEALTH Any text describing the public health promotion of the HPV vaccine. 
MEDIA_POLITICS Any text explicitly describing the political debates regarding HPV vaccination. 
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MERCOLA Any text referencing Dr. Mercola or his website/literature. 
MMR Any text referencing explicitly the MMR vaccine or MMR. 
MORAL_OBGAT Any text framing medical or parenting practices as a moral obligation. 
NEW_CAR Any explicit use of new car/technology as metaphor for HPV vaccination. 
PARENTING_CHI_HL Any text referencing parent’s perception or belief of their role in their child’s health (including sexual health). 
PARENTING_CHI_RESP Any text describing how parent believes child responds to his/her parenting. 
PARENTING_FACTOR Any text describing factors contributing to parenting style (e.g. books, upbringing, experience). 
PARENTING_INDV_CHOICE 
Any text referencing individual rights to decide what is 
best for their child (often in contrast to what is best for 
society. 
PARENTING_SEX_ED Any text referencing parent’s approach or practices to talking with kids about sex. 
PARENTING_SPOUSE Any text referencing partner’s approach to parenting. 
PARENTING_STATE Any text referencing parents’ view on the role of the state, government, or public health in parenting decisions. 
PARENTING_STYLE Any text describing general approach to parenting (e.g. parenting style, type). 
PARENTING_VAC Any text referencing how vaccination decision fits into parenting values. 
PARENTING_VALUE Any text explicitly referencing values of parent as they relate to parenting practice. 
PATIENT_RIGHTS Any text describing healthcare in terms of patient rights. 
PERRY Any text referencing explicitly Rick Perry or indication of him (e.g. Governor of Texas). 
PERTUSSIS Any text referencing explicitly pertussis/whopping cough or TDAP vaccine. 
PH_PERCEPTION Any text referencing parents’ perception of what public health is. 
PH_SOCIAL_DUTY Any text referencing public health as a social duty or responsibility that all individuals should support. 
POLITICS Any text referencing personal political beliefs or practices. 
POX Any text referencing explicitly chicken pox (varicella) or chicken pox vaccine. 
PROACTIVE_PREV Any text referencing the desire to vaccine as a representative of a proactive behavior. 
RELIGIOUSITY Any text referencing personal religious or spiritual beliefs. 
RESP_VACC_SAFETY Any text describing who the parents thinks should be responsible for vaccine safety 
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RIGHT_TIME Any text indicating constructions of the right time to vaccinate (HPV only). 
RISK_PERCEPTION Any text referencing personal perceptions or constructions of risk. 
ROLE_PREF Any text describing role preference of parent. 
SEX_ED Any text referencing the formal sexual education their child received. 
SEXUALITY Any text describing sexuality in a general or conceptual manner. 
SOCIAL_RISK Any text describing risk as socially shared or practiced. 
SPOUSE Any text referencing parent’s description of spouse (e.g. traits, beliefs) 
SUBJECTIFY Any text indicating parents as subjects, or young children as subjects. 
TEMPORALITY Any text indicating time (future, past, or present). 
TETLOCK Any text referencing explicitly her, her parents, or indication of her. 
TRAIT_SELF Any text referencing what trait parent has that he or she hopes to pass onto their children. 
TRAITS_NOT_WANT Any text referencing what three traits parent hopes child/children will not have as an adult. 
TRAITS_WANT Any text referencing what three traits parent hopes child/children will have as an adult. 
TRUST Any text describing trust as a concept or practice. 
UNCERTAINTY Any text indicating uncertainty or doubt. 
UNDERSERVED Any text referencing public health in connection to underserved populations. 
VACCINATE_SELF Any text referencing parents who considered HPV vaccination for themselves. 
VACCINATE_BEST_WAY Any text describing parents view on HPV vaccination as the “best way” to prevent transmission. 
VACCINE_CARD Any text referencing the immunization card that parents and providers use to track immunization record. 
VACCINE_RECEIVED Any text explicitly referencing what childhood vaccine their child has received (or not received). 
VACCINE_SAFETY_RESP Any text referencing who parents believe should be responsible for ensuring vaccine safety. 
VACCINE_SCHEDULE Any text referencing vaccine schedule for vaccines other than HPV vaccine. 















APPENDIX D: QUESTIONNAIRE 
 
B1. How many children do you have?  
 
B2. What are the ages and genders of your children? 
  





   
B4. In what year were you born? 
  





B6. What other languages do you speak? 
 
B7. Which racial categories do you identify with? (Check all that apply) 
 White  
 Black or African American  
 Asian or Asian American 
 Pacific Islander or Native Hawaiian 
 American Indian or Alaskan Native  
 Other Race 
 Decline to answer 
 
B8. Do you consider yourself Latino/a or Hispanic?  
 Yes 






B9. If so, which group(s) do you identify with? (Check all that apply)  
 Mexican, Mexican American, or Chicano/Chicana 
 Puerto Rican 
 Cuban 
 Other 
 Decline to answer 
 
B10. Of the following statements, which best describes your current relationship status?  
 I am married and living in the same household as my partner. 
 I am living as married and my partner and I live in the same household. 
 I have a steady partner, but we don’t live in same household. 
 I do not have a steady partner. 
 




 None of the above 
 
B12. What social class do you most identify with? 
 Lower class 
 Working class 
 Middle class 
 Upper class  
 
B13. Approximately, what was your household income in 2011? 









 $120,000-$149,999  
 $150,000 or above 
 I don’t know 
 Decline to answer 
 
B14. What is your current employment status? 
 Working full-time 
 Working part-time  







 Decline to answer 
 
B15. Were you born outside of the United States?  
 Yes  
 No (Skip to B17) 
 Decline to Answer 
 
B16. If not born in the United States, in what country were you born? 
 
B17. Were any of your children born outside of the United States? 
 Yes  
 No (Skip to B19) 
 Decline to Answer 
 
B18. If not born in the United States, in what country(s) were your children born?  
 
B19. Were your parents born outside of the United States? 
 Yes 
 No (Skip to B21) 
 Decline to Answer 
 
B20. If not born in the United States, in what country(s) were your parents born? 
 
B21. What is the highest level of education you have completed? 
 8th grade or lower 
 High School Diploma or equivalent  
 Technical/Vocational Certificate 
 Associate’s Degree 
 Bachelor’s Degree 




B22. In what field or area is your highest degree or certificate? 
 
B23. What type of health insurance do you have for yourself? 
 None/Uninsured 
 Private or Employer Plan 








B24. What type of health insurance do you have for your children? 
 None/Uninsured  
 Private or Employer Plan 
 Healthy Families or Medi-Cal 
 Other 
 





 Tea Party 
 Other 
 Do not identify with any political party 
 
B26. With respect to your political values, which of the following do you consider yourself? 
 Extremely liberal 
 Liberal 
 Moderate or Middle of the Road 
 Conservative 
 Extremely Conservative 
 Not sure 
 
B27. If you had to choose, which would you rather have? (Choose one) 
 A smaller government that provides fewer services to citizens  
 A bigger government that provides more services to citizens 
 Not sure 
 
B28. Which of the following statements do you agree with more? (Choose one) 
 Government should let parents decide for themselves how best to protect their 
children even if it means they don’t always do the right thing. 
 Government should pass laws to ensure all children are protected even if it sometimes 
interferes with parents’ rights to make their own decisions.   
 Not sure 
 
B29. Do you consider yourself a member of any of the following religious traditions? 
 Evangelical Protestant 
 Mainline Protestant 











 Other  
 Decline to Answer 
 
B30. How often do you attend religious services?  
 Never 
 About once a year 
 A few times a year 
 Once or twice a month 
 At least once a week 
 Every day 
 Decline to Answer 
 
B31. Which of the following statements comes closest to what you believe about the 
existence of God or a Universal Spirit? 
 I don’t believe God exists. 
 I am unsure if God exists. 
 I am fairly certain that God exists. 
 I am absolutely certain God exists. 
 Decline to answer 
 
B32. In your opinion, who should determine what medical care you receive? 
 Doctor alone 
 Mostly doctor 
 You and the doctor equally 
 Mostly you 
 You alone 
 
B33. In your opinion, who should determine what medical care your child receives? 
 Doctor alone 
 Mostly doctor 
 You and the doctor equally 
 Mostly you 
 You alone 
 
B34. In your opinion, how much should a child be involved in deciding what medical care he 
or she receives?  
 Very involved 
 Involved 
 Somewhat Involved 
 Involved very little 







M1. Do you own any of the following items? (Check all that apply)  
 Personal computer 
 Mobile phone 
 Smartphone 
 Tablet (e.g. iPad) 
 Television 
 
M2. How often do you go online or use the internet?  
 Every day 
 A few times a week 
 Once a week 
 Less than once a week 
 Never 
 
M3. What device do you use most often to access the internet?  
 Home computer 
 Work computer 
 Public computer (e.g. at library or school) 
 Smartphone  
 Tablet (e.g. iPad) 


















M4. How often do you read news stories online?       
M5. 
How often do you visit 
social media sites (e.g. 
Facebook, Twitter) 
online? 
      
M6. 
How often do you visit 
health-related websites 
(e.g. WebMD)? 
      
 
M7. Thinking about the past 12 months, did you actively look for information about the HPV 
vaccine from doctors, other people, or from the media?  
 Yes 
 No 






M8. In the past 12 months, did you actively look for information about the HPV vaccine 
from any of the following sources (Check all apply)?  
 Doctors or other health professionals 
 Family, friends, or coworkers 
 Television or radio 
 Newspapers, magazines, or newsletters 
 The Internet 
 Other sources: _______________________________________ 
 
M9. Thinking about the past 12 months, did you hear or come across information about the 
HPV vaccine from doctors, from other people, or from the media even when you were not 
actively looking for it?  
 Yes 
 No 
 I don’t remember 
 
M10. Thinking about the past 12 months, how many times did you hear or come across 
information about the HPV vaccine from each of the following sources?  
 Not at all 
One or two 
times 




Doctors or other health 
professionals     
Family, friends, or coworkers     
Television or Radio     
Newspapers, magazines, or 
newsletters     
The Internet     
 
M11. In general, have you heard positive, negative, or neutral stories about the HPV vaccine 
in the media? 
 Generally Positive 
 Generally Negative 
 Neutral 
 I don’t remember 
 
M12. If you needed more information on the HPV vaccine, where would you go first? 
 Doctors or other health professionals 
 Family, friends, or coworkers 
 Television or radio 
 Newspapers/magazines 
 The Internet 







Section II: General Opinions 
In this section, you will read a list of statements describing different opinions on a 
variety of current topics in the United States. Please mark how much you agree or disagree 
with each of the statements. 5-point Likert Scale, 1=Strongly Agree, 5=Strongly Disagree. 
 
O1 Whenever religion and science conflict, religion is always right. 
O2 On the whole, technology is making our lives easier. 
O3 On the whole, science is making our lives healthier. 
O4 Technology is decreasing our ability to connect with other people in meaningful ways. 
O5 It is not important for me to know about science in my everyday life. 
O6 Most men are better suited emotionally for politics than are most women. 
O7 If my party nominated a woman for President, I would vote for her if she were qualified for the job. 
O8 A working mother can establish just as warm and secure a relationship with her children as a mother who does not work. 
O9 A preschool child is likely to suffer if his or her mother works. 
O10 It is much better for the family if the father works outside the home and the mother takes care of the home and children. 
O11 Family life often suffers when men concentrate too much on their work. 
O12 Men are better at making rational decisions than women. 
O13 On a whole, men make better business executives than women do. 
O14 Women are natural caretakers. 
O15 Men should openly express their emotions. 
O16 Women make better nurses than men do. 
O17 Women make better scientists than men do. 
O18 Women should wait to have sex until marriage. 
O19 Men should wait to have sex until marriage. 
O20 Same-sex couples should have the right to marry one another.  
O21 It is wrong for an adult man and an adult woman to have sexual relations before marriage. 
O22 It is wrong for a 16-year boy and a 16-year old girl to have sexual relations before marriage. 
O23 It is wrong for a married person to have sexual relations with someone other than their marriage partner. 
O24 It is wrong for two adults of the same sex to have sexual relations with each other at any time. 
O25 Birth control should be available to teenagers between the ages of 14 and 16 even if their parents do not approve. 
O26 Sex education should be taught in public schools. 
O27 Sometimes it is necessary to discipline a child with a spanking. 
O28 Abortion should be legal in all cases. 
T1 All patients receive high quality medical care from the health care system in the United States. 
180 
 
T2 The health care system in the United States puts making money above patients’ needs. 
T3 Patients get the same medical treatment from the health care system in the United States—no matter what the patient’s race or ethnicity. 
T4 Patients get the same medical treatment from the health care system in the United States—no matter what the patient’s income status.  
T5 I trust doctors’ decisions about which medical treatments are best. 
T6 I trust doctors to tell me all the risks and benefits of medical treatments. 
T7 I trust doctors to put the needs of patients before what is most convenient or best for them. 
T8 I trust doctors to tell me if they are not certain about the risks and benefits of a certain medical treatment. 
T9 All in all, I trust doctors completely. 
 
Section III: Opinions about Vaccines 
In this section, you will read a list of statements describing different opinions about 
vaccines in the United States. Please mark how much you agree or disagree with each of the 
statements. Five-point Likert Scale, 1=Strongly Agree, 5=Strongly Disagree. 
 
I1 Vaccines are more harmful than helpful 
I2 The government should not have the right to force children to be vaccinated. 
I3 Vaccines should be mandatory for all children. 
I4 Tax dollars should be used to pay for vaccines for children who cannot afford the cost. 
I5 Vaccines are pushed mostly to make money for drug companies. 
I6 Vaccines have greatly improved the health of American citizens. 
I7 We no longer need vaccines to protect us from diseases like polio because no one gets this disease anymore. 
I8 Childhood vaccines are safe. 
I9 Parents who decide not to vaccinate their children are putting other people’s children at risk. 
H1 I am concerned that the HPV vaccine costs more than I can pay. 
H2 Both girls and boys should be vaccinated against HPV. 
H3 Only girls should be vaccinated against HPV. 
H4 Adults should also be vaccinated against HPV 
H5 The HPV vaccine is safe. 
H6 There is not enough scientific evidence that the HPV vaccine is safe. 
H7 The HPV vaccine is being pushed to make money for drug companies. 
H8 I think laws to require children to be vaccinated against HPV are a good idea. 









Section IV: Claims of the HPV vaccine 
In this section, you will read statements describing claims made by different people about the 
HPV vaccine. Please mark how much you believe each of these statements to be true or 
false. Five-point likert scale from 1=Absolutely True to 5=Absolutely False 
 
F1 The HPV vaccine protects against cervical cancer. 
F2 The HPV vaccine protects against genital warts. 
F3 Being infected with HPV may lead to cervical cancer. 
F5 Being infected with HPV may lead to anal cancer.  
F6 Being infecting with HPV may lead to neck and head cancer. 
F7 The HPV vaccine, Cervarix, protects against only cervical cancer. 
F8 The HPV vaccine, Gardasil, protects against both cervical cancer and genital warts. 
F9 HPV is a sexually transmitted virus. 
F10 The HPV vaccine may cause mental retardation. 
F11 The HPV vaccine may cause children to have sex at an earlier age.  
F12 Men who have sex with men are at higher risk of contracting HPV. 
F13 HPV is only associated with cancers that affect women. 
F14 There is only one type of HPV. 
F15 Condoms are very good at preventing the spread of HPV. 
F16 Girls who are vaccinated against HPV do not need to have regular pap smears as adult women. 




Section V: Perceptions of Risk 
 
R1. How informed do you consider yourself about the risks and benefits of childhood 
vaccines? 
 Very informed   
 Somewhat informed  
 Neither informed nor uninformed  
 Somewhat uninformed  
 Very uninformed  
 Not sure 
 
R2. How informed do you consider yourself about the risks and benefits of HPV 
vaccination? 
 Very informed   
 Somewhat informed  
 Neither informed nor uninformed  
 Somewhat uninformed  
 Very uninformed  




R3. How effective do you think the HPV vaccine is in preventing genital warts? 
 Not at all 
 Slightly effective 
 Moderately effective 
 Very effective 
 Extremely effective 
 I don’t know 
 
R4. How effective do you think the HPV vaccine is in preventing cervical cancer? 
 Not at all 
 Slightly effective 
 Moderately effective 
 Very effective 
 Extremely effective 
 I don’t know 
These questions are about your thoughts on developing cancer. If you have already had 
cancer in your lifetime, please answer the questions in relation to your perceived chance of 
developing cancer again.  
 
R5. What do you think your chance is of developing cancer in your lifetime (Between 0% = 
no chance of cancer and 100% = will definitely get cancer)?  
 
R6. How would you rate your chance of developing cancer?  




 Very High 
 
R7. Overall, how do you think your chance of developing cancer compares to the average 
woman or man your age?  
 Much lower 
 Lower 
 About the Same 
 Higher 
 Much Higher 
 
R8. How often do you worry about developing cancer?  









R9. How much does worrying about developing cancer interfere with your everyday life? 
  
















APPENDIX E: CNN REPUBLICAN PRESIDENTIAL DEBATE TRANSCRIPT46 
 
BLITZER: Governor Perry, as you well know, you signed an executive order requiring little 
girls 11 and 12-year-old girls to get a vaccine to deal with a sexually transmitted disease that 
could lead to cervical cancer. Was that a mistake? 
 
PERRY: It was. And indeed, if I had it to do over again, I would have done it differently. I 
would have gone to the legislature, worked with them. But what was driving me was, 
obviously, making a difference about young people's lives. Cervical cancer is a horrible way 
to die. And I happen to think that what we were trying to do was to clearly send a message 
that we're going to give moms and dads the opportunity to make that decision with parental 
opt-out. Parental rights are very important in state of Texas. We do it on a long list of 
vaccines that are made, but on that particular issue, I will tell you that I made a mistake by 
not going to the legislature first. Let me address Ron Paul just a minute by saying I will use 




BLITZER: Congresswoman Bachmann, do you have anything to say about what Governor 
Perry just said. You're a mom.  
 
BACHMANN: I'm a mom. And I'm a mom of three children. And to have innocent little 12-
year-old girls be forced to have a government injection through an executive order is just flat 
out wrong. That should never be done. It's a violation of a liberty interest. 
 
That's -- little girls who have a negative reaction to this potentially dangerous drug don't get 
a mulligan. They don't get a do- over. The parents don't get a do-over. That's why I fought so 
hard in Washington, D.C., against President Obama and Obamacare. 
 
President Obama in a stunning, shocking level of power now just recently told all private 
insurance companies, you must offer the morning-after abortion pill, because I said so. And 
it must be free of charge. That same level coming through executive orders and through 
government dictates is wrong. And that's why again we have to have someone who is 
absolutely committed to the repeal of Obamacare and I am. I won't rest until it's appealed. 
 
                                                        




BLITZER: Let's let Governor Perry respond. Was what you signed into law, that vaccine for 
11 and 12-year-old girls, was that, as some of your critics have suggested, a mandate? 
 
PERRY: No, sir it wasn't. It was very clear. It had an opt- out. And at the end of the day, this 
was about trying to stop a cancer and giving the parental option to opt out of that. And at the 
end of the day, you may criticize me about the way that I went about it, but at the end of the 
day, I am always going to err on the side of life. And that's what this was really all about for 
me.  
 
BLITZER: Senator Santorum -- go ahead. 
 




BLITZER: Hold on a second. First Congresswoman Bachmann, then Senator Santorum.  
 
BACHMANN: I just wanted to add that we cannot forget that in the midst of this executive 
order there is a big drug company that made millions of dollars because of this mandate. We 




BLITZER: What are you suggesting?  
 
BACHMANN: What I'm saying is that it's wrong for a drug company, because the governor's 
former chief of staff was the chief lobbyist for this drug company. The drug company gave 
thousands of dollars in political donations to the governor, and this is just flat-out wrong. 
The question is, is it about life, or was it about millions of dollars and potentially billions for 
a drug company?  
 
BLITZER: All right. I'll let Senator Santorum hold off for a second.  
 
You've got to response to that.  
 
PERRY: Yes, sir. The company was Merck, and it was a $5,000 contribution that I had 
received from them. I raise about $30 million. And if you're saying that I can be bought for 




BACHMANN: Well, I'm offended for all the little girls and the parents that didn't have a 

















Article Title47 Publication Date 
Feds approve unnecessary cervical cancer vaccine that will make drug company 
billions 15-Jul-06 
More U.S. states considering HPV vaccine requirement 27-Jan-07 
Will the HPV vaccine soon be mandatory for schoolgirls? 17-Feb-07 
Opponents rally against Texas forcing sixth grade girls to receive unnecessary 
HPV vaccine 20-Feb-07 
Growing controversy over new Merck vaccines 10-Mar-07 
Gardasil reactions and deaths on the rise 24-Jun-07 
Absurd vaccine marketing -- cervical cancer vaccinations for boys 18-Sep-07 
Doctors in denial about vaccine reactions? 6-Oct-07 
Thousands have gotten sick from Gardasil HPV vaccine 22-Dec-07 
Is the rise in male oral cancer related to HPV? 8-May-08 
The HPV vaccine: Preventive care or human sacrifice? 10-May-08 
HPV vaccine blamed for teen's paralysis 2-Aug-08 
Drug company marketing leads to HPV vaccine rise 9-Sep-08 
Gardasil is dangerous as well as unproven 7-Oct-08 
Prominent scientist warns of HPV vaccine dangers 25-Oct-08 
How the U.S. government is covering up HPV vaccine side effects 15-Nov-08 
Katie Couric reports on serious vaccine safety issues 19-Feb-09 
Spain withdraws Gardasil after illnesses 24-Feb-09 
Hundreds of thousands of reactions to Gardasil…Is your child next? 8-Aug-09 
Inconvenient truths about Gardasil and swine flu vaccines 19-Sep-09 
Grieving mother blames Gardasil 28-Jan-10 
Time for the truth about Gardasil 17-Apr-10 
Does Gardasil actually increase your risk of cervical cancer? 20-Jun-10 
Don't give this to your daughter - despite what your doctor says 5-Nov-10 
                                                        
47 Most of the articles (24/38) did not list an author. Of the 14 that list an author, Dr. Mercola is listed on 12 and 
Barbara Loe Fisher (president of National Vaccine Information Center) is listed on two articles. 
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The lethal medical failure that's still recommended by your doctor 29-Dec-10 
60 lab studies now confirm cancer link to a vaccine you probably had as a child 18-Feb-11 
Don't let your child be the next victim of this deadly vaccine 5-Apr-11 
A parent's horrid nightmare: coming soon to YOUR state? 16-Sep-11 
How vaccine policy & law threatens parental rights in America 26-Oct-11 
49 sudden deaths, 213 permanent disabilities - And the silent plan to poison 
your child 29-Nov-11 
213 women who took this suffered permanent disability 24-Jan-12 
The worthless way to prevent cancer 29-Jan-12 
This foolish cancer "prevention" may only extend your life by 2.8 days 13-Mar-12 
This could give women deadly blood clots - US health officials admit 27-Mar-12 
New evidence demolishes claims of safety and effectiveness of HPV vaccine 16-Oct-12 
UBC researchers advocate HPV vaccine scrutiny 13-Nov-12 
Avoidance of HPV vaccine may contribute to increase of some cancers? 24-Jan-13 
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